home0007 - COVID-19 Pandemic : Emails from 2021 FOIA request of Dr. Anthony Fauci (2)

COVID-19 Pandemic : Emails from 2021 FOIA request of Dr. Anthony Fauci (2)

FULL PDF : [HG00D0][GDrive]

Part 1 / Part 2 / Part 3 / Part 4 / Part 5 / Part 6 / Part 7 / Part 8

Mon , 24 Feb 2020 22:34:05 +0000Conrad, Patricia (NIH/NIAID) [ElFW: Re:Following up on NIH visitWhat is this?Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Jason Gale (BLOOMBERG/ NEWSROOM:) <j.gale@bloomberg.net>Sent : Monday, February 24, 2020 4:04 PM ------- --=~ To: Conrad, Patricia (NIH/NIA ID) [E) (b)( 6); Hoffman, Hillary (NIH/NIAID) [El(b) (6) >Cc: Fauci, Anthony (NIH/NIAID) [El- ------- (b)(6) Segre, Julie (NIH/NHGRI) [El (b )( 6)Subject: RE: Re:Following up on NIH visitDear Hillary ,Thanks for your email .I am in de ed l ooki ng forward t o my NIH v isi t on F r i day, a nd amst ill h opi ng I migh t ge t some t ime wi t h Dr . Fauc i, t h ough I ca napp re ciate he might be b usie r than either of us expected to beback when we firs t sc he du le d my in t er v iew wi t h him!Warm regards ,JasonJason Gale, MHlthSecSenior editor I Bloomberg NewsLevel 30, 120 Collins St., Melbourne VIC 3000NIH-001390Tel. (landline ) +61-3-9228-8783 I Mobile CbH6)@jwgale I Linkedin : http://www .linkedin .com/pub/jason-ga le/6/249/a56F r om: (b)(6) At : 02 / 2 5/20 06 : 47 : 17To ; Jaso n Ga l e (BLOOMBERG/ NEWSROOM; )Subjec t : RE: Re :F o ll owin g up on NIH v i s i tHi Jason ,Hope you have/had safe travels to DC this week ! I wanted to check in toconfirm that you're still planning on coming to visit us at NIH this Friday?Currently , Dr. Myles is holding 1 0am and Dr. Belkaid is holding 1 :30pm todiscuss their microbiome-related research with you. Dr. Fauci's schedulehas been very fluid lately due to the coronavirus outbreak-we 'll likely needto check in with his assistant Patty Conrad on Thursday to see how hisFriday calendar looks (unless you hear otherwise from Patty directly).Best,HillaryHillary Hoffman, Ph.D. , Writer/EditorOffice of Communications and Government Relations , NIAID, NIH5601 Fishers Lane #6G38Rockville , MD 20852(b)(6)(b)(6)From: Jason Gale (BLOOMBERG/ NEWSROOM:) <j.gale@b loombe rg.net>Sent: Tuesday , January 28, 2020 4:3-9- -P-M-- --=-:= To: Hoffman, Hillary (NIH/NIAID) [E] CbH6)>Subject: RE: Re:Following up on NIH visitSounds good . Many thanks.----- Original Message -----From: Hillary Hoffman ----------------- To: JASON GALEAt: 29-Jan-2020 08:38:46Sounds good - I'll ask Dr. Myles to hold 1 Oam, so you can chatwith him before you meet Dr. Fauci at 11. We can re-confirmtiming closer to the date. I'll tag along , and can make sure youget where you need to - you'll get to visit several differentbuildings, fortunately all close by!NIH-001391From: Jason Gale (BLOOMBERG/ NEWSROOM :)<j .gale@bloom berg .net>Sent: Tuesday, January 28, 2020 4:32- P-M- ---- -------= To: Hoffman, Hillary (NIH/NIAID) [E] (bH 6J>Subject: RE: Re:Following up on NIH visitHi HillaryLate night for me on 2019-nCoV ...Shall we say before DrFauci? Then I'll know better how to get tohim. ~Thanks a lot. Jason----- Original Message-------------~= From: Hillary Hoffman ,__ (b)( ________ _,To: JASON GALECC: (b)(6)At: 29-Jan-2020 06:34:55Hi Jason ,Great speaking with you last week. I wanted to followup to let you know that Yasmine Belkaid and IanMyles-whose work we discussed on host-microbeinteractions and developing a bacteria-basedtreatment for eczema, respectively-are willing tomeet with you on Feb. 28.Here are links to some background info:• Dr. Belkaid's lab page, and recent NIAID pressrelease about a skin microbiome study fromher lab• Dr. Myles' lab page, and NIAID press releaseabout findings from a Ph 1/2 trial assessing theR. mucosa treatment for eczemaDr. Belkaid is available at 1 :30pm (her building is nextto the Clinical Center, where you'll be meeting withJulie Segre I believe from 12-1ish). Dr. Myles'schedule is a bit more flexible, and he's currentlyavailable to meet either in the morning before youspeak with Dr. Fauci or later in the afternoon after Dr.Belkaid (Dr. Myles is in the Clinical Center, about a 5min walk from Dr. Fauci's building)- let me know ifyou have a timing preference. We can firm up times abit closer to the date, but wanted to give you anupdate.NIH-001392Best,HillaryHillary Hoffman , Ph.D., Writer/EditorOffice of Communications and Government Relations, NIAID ,NIH5601 Fishers Lane #6G38Rockville, MD 20852(b)( 6)(b)(6)From: Jason Gale (BLOOMBERG/ NEWSROOM :)<j .gale@bloomberg.net>Sent: Thursday , January 23, 2020 4:09 PMTo: Hoffman , Hillary (NIH/NIAID ) [E]<hillary.hoffman@ nih.gov>Cc: Routh, Jennifer (NIH/NIAID) [E]<jennife r.routh@nih.gov>Subject: RE: Re:Following up on NIH visitSorr y!! Get t ing on nowFrom : (b)(6) At: -------------- 01/ 24 /20 08 : 07 : 48To: J aso n Ga l e (BLOOMBERG/ NEWSROOM:Cc: ( Cb)(~Subject : RE: Re :Following up on NIHvisitHi Jason ,Wanted to check that you're still able tojoin us this afternoon/morning -- and thatyou aren't having issues calling into theconference line. Jen and I are both on.Thanks , and hope to talk soon!HillaryFrom: Jason Gale (BLOOMBERG/NEWSROOM :) <j.gale@bloomberg.net>Sent: Friday, January 17, 2020 3:02 PMTo: Hoffman, Hillary NIH/NIAID) [E](b)( 6)Cc: Routh, Jennifer (NIH/NIAID) [E]NIH-001393(b)(6 )>Subject: RE: Re:Following up on NIHvisitAwesome. Thanks a lot.----- Original Message----From:Hillary Hoffman(b)(6)To: JASON GALE cc (b) (6)At: 18-Jan-2020 01 :31 :40Hi Jason ,Yes, 4pm next Thursday (8amFriday for you) works for us. Iwill send out a calendarinvitation with call-ininformation later today.Enjoy your time off, and lookingforward to speaking with younext week!Best,HillaryFrom: Jason Gale(BLOOMBERG/NEWSROOM:)<j.gale@bloomberg.net>Sent: Thursday , January 16,2020 6:24 PMTo: Hoffman , Hillary(NIH/NIAID) [E](b)(6)>Cc: Routh, JenniferNIH/NIAID [E]'---,;- (b=H=6)>Subject: RE: Re:Following upon NIH visitDear Hillar y ,Than ks for your email .I am on vaca t ion Mon-NIH-001394Thursday next week .Woul d a 4 pm call onThur sday Jan . 23 (8 amFriday for me) work?I jus t saw ha p pened t osee this report , FYI :h ttp s : //med i ca l xpr ess . com/news/2020 - 01 - gu t bacteri a parkinson . h t ml ?fbc lid =IwAR20XNzDroX9za HhP 73A22pK2zOP 2 cRQ6 YJ j dQo icbKrNKr j oPrQ9Z0I t' s a good exam p le oft he growing awarenessthat the HumanMicro b iome Project ishel p ing t o p rovide ofthe complexint erac tions withvarious b iologicalprocesses that un derp inhealth and disease.Have a grea t weekend ,jasonFrom :(b)(6)At: 01/17/20 03 : 22 : 49To : Jaso n Gale(BLOOMBERG/ NEWSROOM:Cc :(b)(6)Subject: RE:Re:Following up on NIHvisitHi Jason,Great to hear ofyour interest inmicrobiomea nd fluresearch. Jen and Iwould be happy tochat about whatNIAID may be ableNIH-001395to offer in terms ofsubjec t matterexp erts andstorylines in thoseareas.Might you beavailable for a shortcall next weekbetween 4-5pmEST on eitherTues., Wed ., orThurs . afternoon -corresponding to 8-9am Melbournetime on Wed.,Thurs. , or Fri.morning (assumingI've got my timezones correct)? Ifwe can't find amutually convenienttime , happy tocontinuediscussions overemail.Best,Hilla ryHillary Hoffman, Ph.D.,Write r/EditorOffice ofCommunications andGovernment Relations,NIAID, NIH(b)(6)Media line: 301-402 -1663From: Jason Gale(BLOOMBERG /NEWSROOM :)<j .gale@bloom berg.net>Sent: Wednesday,NIH-001396January 15, 202011:56 PMTo: Rancourt , Anne(NIH/NIAID) [E](b)(6)Cc: Leitman , Laura(NIH/NIAID) [E])(6)Hoffman ,Hilla ry (NIH/NIAID)[E]; Routh,Jennifer(NIH/NIAID) [E](b)(6)(b)(6)Lave lle,Judi th (NIH/NIAID)[El(b)(6)Segre, Julie(NIH/NHGRI) [E])(6)Subject: RE:Re:Following up onNIH visitHi Anne,Thanks a lo tfor yo ur ema ila nd yoursugges t ions!After my lastvi sit to NIH( a nd mee t in gwith LisaPr octor andJ u l ie Segreyea r s ago }, wed i d t heattac he d s to r yon the gu tmic r obiome .We ' r e ve rykeen t o l oo kNIH-001397NIH-001398at do in g apodcast ser ieson themicrobiome(skin, gut ,otheranatomicalb i ts ) a nd howit ' s informingour views onhe a l t h,disease andthe way weprevent a ndtreatdiseases .It would becoo l t oworks ho p t hi stheme with youa nd yourco ll eaguesbefore myv i s i t , if youh ave somet ime?I cut my teethin medica lsc ien cewriting on(bird) fl u andwou l d beinterested inthe re searchJeffreyTaubenberger ' slab is doing ,but myun derstanding(and I couldbe wro ng) i st h at t he re ' sstill a lot ofwork to bedone inproducing auniversa l f l uNIH-001399s h ot . I f suc hvacc in ecandidates arest ill y e arsfro m en t e r in gclinicaltrials , weprobab l y wou l dp u sh thatlower down thelist .Hop e t h athelps , andthanks again !Jaso nHi Jaso n,Ahead of yo urvisit , hereare a f ew l absthat are doinginnovativework a nd maypresentinterestingbackgrou nds t obecome f u t u restories , orin for m yourreport in g . Forantimicrobialres i stancespec i f i ca ll y ,Dr . Fa u ci isyour bestsource . Butthe below areexci t in g areasof researc h atNIAID , and maybe a f i t forProg n os i s . Le tme know if anyof the belowp i que yourNIH-001400in t eres t a ndwe ca n s haremore detaila nd/or arrangetime .• Skinmicrobiome: NI AI Dresearc hersdeve l opeda t op i ca ltherap yforeczem athatin vo l vestr ea t in gskin with"goo d "bacter i a .If proveneffective, t hi sstrategyco ul doffer aninexpensivetr ea t men tthatreq u iresl essfrequen tapplication t h anmanyc urrenteczemamedica t i ons . APhase 1/2tr i a l atNIHin d i catedNIH-001401t hat t hisno ve ltherapyi s safe ,a nd mos tparticipantsexperiencedimp r ovements intheireczema .NI H hasexcl u sivelyl i ce n sedthetechnolo gy t oFo rteBiosciences t oadva ncethispote nt i a lne wtherapyt hroug hfur t he rclinicaldeve l opment .• Genetherapy:NI AI D isdeveloping a ndapp l y in ggenecorr e ct i ontechniq ues t otr ea t aNIH-001402var ie tyofg eneticimmuned i sord e rs. Forexample ,NI AI Dscientists co devel opedalentiviral genetherapyto treatinf a n tswith XSCID, arar e a ndfa ta lgeneticimmuned efi c ien cy . Inc l ini ca ltr i a l s ,the g enet he rapys uc cessfullyrestoredt heimmunesystemsofinfantsnewlyd i agnosedwith XSCID, aswe ll asolde rchildrena nd you ngadu l tswith theNIH-001403co n d i t i onwhoexperiencedcomp l exmedicalproblemsafterreceivingstandardt h erapy .Mu stangBio ish and l i ngcommercialdeve l opment of thelentiviral ge net h erapyfor XSCID.• Flu: Dr .JeffreyTaube nberger is a1918in f l ue n zaexpertwhosequencedthe 1918pandemicv i ra lge nomeu singarc hi va lautopsyspecimensfrom t h eArmedForcesI n stituteofNIH-001404Pa t holog ya ndfrozenl ungb io ps ie sfrom 1918fl uv i ct im sinterredinpermafrost .Lear ningabout1918pandemicf l u ca nhelp usbetterpreparefor a ndtargetfu t u repa ndem i cstrains .Dr .Taubenberge r ' s labi sdeve l op ing a so call eduniversa lfl uvaccinet h atincl udes4in act i vatedinfl u enzav i rusesand isexpectedtoundergoclinicalNIH-001405t es t in gsoo n.Also , Dr .Matt hewMemolil e adsNIAI D' sin f l ue n zachallengest u diesin whi c hhealthyvol u ntee rs arepu rp os e lyexposedt oinfl u enzain acarefu ll yco n t ro l l ede nv i ronmen t .Challengestud i esoffer au niq ueoppor t u nity t o askfoc u sedq ues t i onsregard in ginfl u enzavi r u spat h oge nesis andvaccinee ff i cacyin acont r ol led mann er .• Mosquitoes:NI AI D' sNIH-001406Laboratory ofMalariaa ndVectorResearchinvestigatesdisease transmittinginsectsand broadareas ofmalariabiologyandpathogenesis . Dr .Tov iLehmanst udiesmosqui t oeco l ogy,coveringbroadpopu l at ion biologyquestio n sre l evanttopatternsofmalariatransmission a ndvectorcontrol .Recent l y ,Dr .Le hmana ndcolleaguesin Malifoundt h at asingleNIH-001407mosqu i t oca ntra v el upt o 2 00mi l e s ina sin g leni g htwi t h t heri g htprevaili ng win dspeed .There s e a rc hinvolvedcollect ing f l y in gi n sectsu sings t i ckyne t s onh eli umfill edba ll oo n ss u spendeda tvary in gh e i g hts .• Eatingfor theimmunesystem:Dr .YasminBe l ka i di sresearc h ingco nne c t i onsb e t weent hemic r obiom~ ,nu t r i t i onNIH-001408, f a t ,a ndimmunity .Thi s workis e ar l ystage ,b utpot en t i a llyparadi gmshift ingas sheuncov ersco nnec t ionsbet weend ie t a ndimmunity ,withimp l i cat ions fo rus in gnu tr i t iont o boos timmunein t erven tion s ,includingvacc ine s .• RSV:Multipler ese arc hers areworkin gt odeve l opvaccinesaga in stresp i ratorysy ncyt i a lv i rus(RSV) -so met hin gmostNIH-001409pare nt shaveheard of ,bu t i sno tcoveredby media .RSVu s uallyca u sesmi l dcold - likesymptomsinhealthyad u lts ;h owever ,RSV canbes e r i ous ,part i cu l arly forin fa ntsa nd t heelderly .I t i s t hemos tcommoncause ofbro nc hi o litis andpneumon i ai nchildrenyo ungert h an 1 inthe US .Scientists h avespentdecadestry in g t odevelopanurge nt l yneededsafe andNIH-001410effec t i vevacci ne.Oneca nd i dateknown asDS- Cavldevelopedby Dr .BarneyGraham ' st eam atNIAID ' sVaccineResearc hCenterhas shownear l ypromisein aPh as e 1c li ni ca ltrial .I' m CCin g mypub li c affa i rscolleagues wholi aise wi t ht he se top i csin case therei s fo ll ow up .Look in gforward tohopef u llymee t in g youwhen youvisit .Thanks ,AnneFrom: JasonGale(BLOOMBERG/NEWSROOM: )<j . gale@bloomberg . ne t >Sent:Thursday ,December 19 ,20 19 4 : 24 PMTo: Ra ncourt ,Anne(NIH/NIAID )[ E]>Subject:)(6)Re : Followin gup on NIHvisitHi Anne ,Tha nks foryour ema il andoffer toass i st wi t ho t h erin t e rv ie ws .I 'm "oldsch ool ," ands ee mer i t inb u ildingrelationshipswi t hresearchersand hearin gabout t hei rwork wi t hou tt hee xpec tat i on ofn ecessar il yg ettin g asto r y .My interestsar e pr e ttyeclectic -froma nt imi crob i a lresistance toNIH-001411a nes t hesi a . I ft he r e ' s someinterestingstuffh appe nin g t h athasn ' t beenreported on inmuch d e ta ilthat speaks tot he futu re ofhe a l t h care(that co ul dwould fo r ou rProg nos i splatform) , I ' dbe keen t ohea r abo ut it .Ma ny t h a n ksaga in a ndhappyholidays,JasonUt01T l .( 1 . lJ.. ""l(b)(6)l_ J.. l . - ·.<.l l Ih t t p : //www . l i nkedin . com/p ub/jaso n gale/6/2 49/a56NIH-0014 12F rom :)(6)At :12 / 20 / 1902 : 54 : 30To : Jaso n Gal e(BLOOMBERG/NEWSROOM: )Subj e ct :Fo l low in g upon NIH visitHiJ ason ,Ihe a r dyou ' llbev i s i t ing usa t NIHonFeb .28 fo raninte r vi ewwi t hDr .Fa uci .Pleasele t meknowif Icanhe l pconnect youwitho t here xp er tswhil eyouareNIH-001413NIH-001414here .I 'd beh appytoarrange foryou t oseea nyl absorhe arfromexpertso nHIV orotherd ise ases -ju stlet mekno wwhatyou 'rein t ereste dinhe ar ing andseeingThanksLoo k ingforward t oi t.AnneAnneRancourt,MPSSec t ionChief ,OfficeofCommunications andGovernmentRelationsNat ionalIns t i tu t e ofAllergy andInfe c tiousDiseasesNat ionalInstitu t esofHea l t hPronouns :She/Her(b)(6)office(b)(6)mob ile(b)( 6)NIH-001415NIH-001416Madonna 's Secretfor Longevity SeenAiding BacteriaBoom: Health2012-05-0821 :34:07 .963 GMTBy KanekoMatsuyama andJason GaleMay 9 (Bloomberg)-- The secret toMadonna's stayingpowermay be surprisinglysimple: gardening.What the pop stardoes involves notrowel or soil.Thanksto dishes offermented soybeans, millet andbrown rice preparedby her personalchef, MayumiNishimura ,Madonna practicesa formof inner horticulture-- cultivating herintestinal flora in aburgeoningalternativeapproach to health.Studies of thetrillions of bacterialiving on and in thebody suggest theMaterial Girl, 53,may be ontosomething. Byeating foods rich infiber and laced withso-called goodNIH-001417bacteria , she maybe encouraginghelpful microbes toflourish inher bowel, aiding infood digestion andvitamin extractionandpossibly staving offdiseases fromasthma to coloncancer ."This diet thatMadonna isfollowing is verysensible, "says DavidTopping, chief foodnutritionresearcheratAustralia'sCommonwealthScientific andIndustrial ResearchOrganization inAdelaide, whostudied gut biologyfor 25 years ."The bacteria thatlive inside you arefulfilling veryimportantfunctions ."While scientists tryto understand theecology of thebacteria and theirinteractions withdiet and disease ,companiesare looking for waysto profit.The health benefitsof gut germs havespawned a globalmarket for productsNIH-001418that contain friendlybacteria , calledprobiotics , in theform of tablets orsupplements addedto foodsby companiesincluding Danone,Nestle SA, andYakult Honsha Co.The market forsupplemented dairyproducts such asDanone'sActivia yoghurtsand Yakult'sfermented drinks,worth $14.7billion six yearsago, will probablyexpand 32 percentto $33.5billion by 2016 ,EuromonitorInternationalestimated lastmonth.Quinoa, Not CoffeeStudies published inthe past year havelinked certainbowel-dwellingbacteria to astronger immunesystem , whileothers have beenassociated withautism and obesity.In onepaper published inthe journal Nature,scientists showedthat atype of white bloodNIH-001419cell that producesantibodies onlyacquiredits infection-fightingability afterspending time in thegut.Nishimura, who hascooked for cancerpatients beforebeinghired by Madonna ,serves quinoa andother whole grainsasstaples , along withvegetables and soysauce, she said in atelephone interviewfrom New York. Shealso tries to offerseaweed everysecond day -usuallysauteed orboiled."We eat foodprocessed as littleas possible ,"Nishimura,55 , says of herdietary approach ,known asmacrobiotic. Shedoesn't recommendmeat, dairy andcoffee. An agent forMadonnadidn't respond to arequest forcomment.Whole grains andfiber act as bothfood and fertilizer tothe bacteria in thebowel, according toMark Morrison , aNIH-001420microbiologist withAustralia's CSIROin Brisbanestudying waysto improve gutfunction and health.'Terrific Interest'There are 10 timesas many bacteria inthe human intestinaltract as there arecells in the body. Ascoordinator of theHuman MicrobiomeProject, Lita Proctoris helping toorganizecollaboration fromhundreds ofscientists aroundthe worldtrying to map andstudy microbialcommunities livingon the skin,in the mouth andbowel, and in otherparts of the body."It's extremelyheartening andhealthy to have somuchattention now paidto the diet ," saysProctor, who worksat theNational HumanGenome Institute inBethesda,Maryland .Even so, Proctorsays the research isstill in its infancy,and products basedNIH-001421on partialunderstanding maynot deliver whatthey promise ."That's not holdingup the industry ,"she says. "It's avery fluid , ill-definedarea, but with a lotof terrificinterest."Flowers and WeedsThe term probioticis vague and there'sno accepteddefinition for it.Measuring resultsmay be even moreof a greyarea and somesupplements aredestroyed bystomach acidbeforeentering the gut,according toProctor.Nishimura relies onfermented foodssuch as miso, soysauceand tempeh to playthe role ofprobiotics and saysthe benefitsof her diet can bequickly noticed."I feel better than Idid 20 years ago,"Madonna wrote ina preface to thecookbook her chefhad published in2010. "I amNIH-001422very grateful to youfor this."The garden analogyis helpful when itcomes to describingthe complexecology of thebacteria living onhumans, says JulieSegre, the leadinvestigator workingon the skinmicrobiome atthe National HumanGenome ResearchInstitute."There are someflowers that make iteasier for otherflowers to grow inthe same soil,"Segre says. Themostimportant thing is tokeep out theinvasive weeds, shesays.'Transpoosions 'When the weedstake over ,AustraliangastroenterologistThomas Borody hasa radical approachto reestablishing thebalance of intestinalflora in his patients:he transplantsfecal germs fromdisease-freeindividuals directlyinto theupper reach of thecolon , in a pouchNIH-001423known as thececum.His Sydney clinichas done 1,800 ofthe procedures ,whichhe jokingly dubs"transpoosions ,"over 25 years.Borody , 62,says the treatmenthas helped patientswith ailmentsrangingfrom autism topseudomembranous colitis, a resilientinfectionthat causesabdominal pain,loose bowelmovements andfever."The next day theirdiarrhea stops," thedoctor says.After the procedure ,he asks patients toavoid treatmentsthatmay damage theirgut flora. Threestudies presentedat theAmerican CollegeofGastroenterology 'smeeting in Octoberindicate fecaltransplants can helpwith bouts ofdiarrheaassociated with thebacteriumClostridium difficile.NIH-001424When Weeds TakeOverKeeping inner bugshealthy is crucialbecause otherwisethey risk taking overmore than thegarden . If intestinalbacteria aren't ableto survive on thefood their hostconsumes ,the germs will try tofeed on what theycan find -- "mucusaswell as anythingelse ," according toCSIRO's Topping.That maylead toinflammatory boweldisease, a painfulcondition that canevolve into coloncancer , he says .Staving off diseaseis one reasonpeople have turnedtoNishimura 's cookingin the past. Thechef, who preparedmealsfor cancer patientsin Boston, says thediet helps withconstipation,menstrual pain andbody odor. Whenshe firstchanged the wayshe ate, Nishimurasays she also foundthat herNIH-001425allergic skin rashimproved .'So Fresh'Typically, Nishimuratailors her mealseach day to suit theway her employerfeels , she says,adding thatMadonna prefersthe chef herself toshop foringredients. Populardishes includeseaweed in misosoup; hijiki -- a typeof brown seaweed -served with carrotsand onions andseasoned with soysauce; andcooked oats forbreakfast ,Nishimura says.Whole grainsdemand harderwork for bowelbacteria , whichhelp the bodyextract vitamins andnutrients from food,becausethe insoluble fiberthey contain is onlybroken down in thelower reaches ofthe digestive tract ina fermentationprocessthat deliversdifferent quantitiesand varieties ofinflammation -NIH-001426fighting short-chainfatty acids to thebody'scells.There is "solidevidence" thatmicrobes play a roleintuning the immunesystem , says IanLipkin, director oftheCenter for Infectionand Immunity atColumbiaUniversity 'sMailman School ofPublic Health,where scientistsshowed inJanuary thatchildren with autismand gastrointestinaldisturbances have abacterial speciesnot found in nonautisticchildren with tummyupsets.Madonna andothers makingsimilar diet choicesmay not knowthey're pushing thescience frontier.They may just feelbetter."When you cut outanimal products,white sugar andcoffeefor 10 days youstart to feel thedifference ,"Nishimura said."When I first beganNIH-001427this diet, Iremember how myhead becameclearer, I woke upearlier and felt sofresh in the morningthatI didn't want to stayin bed."Madonna herselfisn't lacking instamina . Her worldtour,which starts in TelAviv this month andends next March ,includes 75concerts in Europeand North America .Her previousworld tour was in2008 and 2009 ,when she alsopublished sixchildren's booksand directed orproduced twomovies.For Related Newsand Information:Most-read healthcarestories : MNIHEA <GO>Bloomberg 's tophealth stories:HTOP <GO>Bloomberg 's topstories on Japan:TOPY <GO>Bloomberg drugdatabase: BORG<GO>--Editors: MartheFourcade, RickSchine.To contact thereportersresponsible for thisstory:Kanoko Matsuyamain Tokyo at +81-3-3201-3490 orkmatsuyama2@bloom berg .net;Jason Gale inMelbourne at CbH6)orj .gale@bloomberg. netTo contact theeditor responsiblefor this story :Jason Gale at +65-6212-1579 orj.gale@bloomberg .net.NIH-001428From:Sent:To:Subject :NIAID inquiries, pleaseAnthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAID) [E)Mon, 24 Feb 2020 22:33:02 +0000Billet, Courtney (NIH/NIAID) [E]FW: Virus TransmissionNational Institute of Allergy and Infectious DiseasesBui lding 31, Room 7 A-0331 Center Driv e, MSC 2520National Institu tes of HealthBethesda , MD 20892-2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The informa tion in this e-ma il and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipie nt. If you have received this e-mail in eITorplease inform the sen der and delete it from your mai lbox or any other storage devices. The National Institute ofAllergy and Infe ctio us Diseases (NIAID) shall not accept liability for any statements made that are the send er's ownand not express ly made on behalf of the NIAID by one of its representatives.-----Original Message-----From : DANIEL GAGNON ---------(b-) (6) Sent: Monday , February 24 , 2020 3:49- P-M- ---~~ To: Fauci , Anthony (NlH/NlAID) [E] -------- (b)(6) > Subject: Virus TransmissionHi Dr. Fauci:1 have been a long time admire r of you in the field of modern medicine. This question l have relates to the currentCoronavirus circulating around the world. For many years r have informed people that the ways a virus can bepassed from person to person isn' t always by a sneeze, cough or by touching someones face with their hands. Hasanyone in your medical community though t that if someone were smoki ng and was an infec ted person that once theyexpel the smoke particles into the air that those micro smoke panicles may contain viruse s that were in therespiratory system ofan infected perso n. Everyone T mention this to don ' t believe that this is poss ible. Whal are yourthoughts on this matter? lfso why hasn' t tbe medica l comm unity warned the public about this possibility as T stayaway from all establis hments that allow smok ing on their prem ises .Thank you,Daniel Gagnon(b)(6)NIH-001429From:Sent :Fauci, Anthony (NIH/NIAIO) [E)Mon, 24 Feb 2020 19:55:2 1 +0000To:Subject:Conrad, Patricia (NIH/NIAID) [E);Barasch, Kimberly (NIH/NIAID) [C]FW: interv iew with Dr FauciHere is th e reason for t he conf usion .,Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b)(6lThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: RABIN, RONI <roni.rabin@nytimes.com>Sent : Monday, February 24, 2020 2:51 PM To: Fauci, Anthony (NIH/NIAID) [E)-- -----------~-~ Cb)( > Subject : Re: interv iew with Dr FauciI 'm sorry -- I thought you had canceled this time this morning when you said you needed to reschedule.I'm so sorry . I'm in the middle of a meeting with editors at the Times about coronavirus coverage.On Mon, Feb 24, 2020 at 2:42 PM Fauci, Anthony (NIH/NIAID) [E] -------- CbH6)>w rote:Hi Roni,We just tried calling you at !:::::==~ (=b)-~(:6-)for our 2:30pm ET interview with Dr. Fauci. Please give us acall as soon as possible at (b)(6) _Thank you,KimKim Bara sch [CJOffice of the Directo rNational Inst itu te of Allergy & Infe ct ious Diseases(b)(6)(b)(6)NIH-001433From: Conrad, Patricia (NIH/NIAID) [E]Sent: Friday, February 21, 2020 4:30 PMTo: (b)(6)Cc: Deatrick, Elizabeth (NIH/NIAID) (CJ- ---------- CbH ; Robinson, Whitney (NIH/N IAID) [CJ (b)(6)>Subject: interview wi th Dr FauciDr Fauci can be available for your interview as per below on Monday Feb 24th at 2:30 pm ET - 3:00pm ET. Please let us know asap if that time works. The number to call for the interview will be (b'll - (6) Thank you,-pattyRoni RabinNew York Times(b)(6)Roni.rabin@nyt imes.comSeeking: Phone interviewSubject: asymptomatic transmission of coronavirusPatricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNational Institute of Allergy and Infectious DiseasesThe Nationa l Inst itutes of Health31 Center Drive, MSC 2520- Room 7A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDiscla imer:The information in this e-mail and any of its attachments is confiden lial and may contain sensitive information. It should not beused by anyone who is not the original intended recip ient. If you have received this e-mail in error please inform the sender anddelete it from your mailbox or any other storage devices. National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of itsrepresentatives.Roni Caryn RabinNew York Ti mes Staff Writer(212) 556-8314NIH-001434Cell:- ----(b)(6)NIH-001435From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Mon, 24 Feb 2020 18:07:33 +0000Doepel, Laurie (NIH/NIAID) [E]Subject:Attachment s:FW: ASF ---- measles - aerosol / contact/ drople t1-s2.0-51879625717301773-main.pdfFrom: Folkers, Greg {NIH/N IAID) [El (b)(6)Se nt: Tuesday, September 4, 2018 3:15 PMTo: Fauci, Anthony (NIH/NIAID) [E]----- -=(b)""~'= >Cc: Conrad, Patricia (NIH/NIA ID) [El (b)( 6); Doepel, Laurie (NIH/NIAID) [ElCb)( ; Eisinger, Robert (NIH/NIAID) [E] CbH6J Folkers, Greg~-':'""'."'.'"'.""'."-":-:~ ;::::::==:::::.;_- .....;;.__-.;.-.--.=(NIH/NIAID) [E] (b)(6)>; Marston, Hilary (NIH/NIAID) [E] (b)(6)Subjec t: ASF ---- measles - aerosol /contact/ dropletAnd per CDC -- rrequ ires airbornes precautionshttp s://www .cdc.gov/infect ioncontrol/ba sics/tran smission-based-precaution s.htm lTable2Ovel'lliew of the evidence on trans mission routes of respiratory viruses based on experim ent al data and the transmi ssion route acco rdingto infec tion prevention guidelin esV1rus Virus family" Transmission routeMeasles virusParainfluenza virusHMPVRSVHCoVMERS-CoVSAAS,CoVRhinovlrusAdenovirusInfluenza virusParamyxoviridasParamyxovirfdasPnevmoviridaePnevmoviridaeCoronaviridaeCoronavlridaeCoronaviridaePicomaviridaeAd8novlrf<1aeOrthomyxovirldaeExpe-imental and observational dataAerosol [75-n ,78°,79"].Limited data, contact (by fom ite) [83,841 ".Limited data. contact (by fomite) " (30]Contact [89.88], ci'up let (88], aerosol[90,91"1-Umited data , contact (by fomite) [~6 7] 8,Contact (84) • [89) • [91 .. J. droplet (89] " .aerosol (917 .Contact [70 ) • [73,79, 101], drople t[73,78°,79•,1171, aerosol (76, 118] c (82) c.d,Contact [35.36.42 ]. aerosol [37 ,40 , 119).Contact [100] 0 [100,1011 droplet (1031,aerosol (102, 1031 .Droplet/aerosol [55,56,sr,59 ]a Taxonom y was based on [621 airtlorne transmission is seemingly linked to:Guidelines bContact [3,110) , droplet [3 ,109-111 ],aerosol (3, 109-111 ).Contact (3,109-111 ], droplet [3,109-111 ),aeroso l (3,109).Contact [3,110.111). droplet [3,110,111].Contact [3,109-111 ), droplet [3,109,110],aerosol (109, 111].Contact (3,110.11 i), droplet [3,110,111].Contact (111]. drop let [3,111]Contact [3,110,111 ), dropl et [3, 110,111),aerosol (3, 110,111).Contact [109-111 ], droplet [109,1 11).aerosol (109-111 ].Contact (3,109-111 ), droplet (3, 109,11 OJ,aerosol (110, 111].Contact (109-111 ], droplet [3, 109-111 ),aerosol (3, 109-111 ).b WIP [108], ' Blue Book ' (109), 'Red Book ' [110). CDC [3] and Up-To-D ate [111]. The conclusions on experimental data as presented in this tablereflect me conclusions from the auttlOrs.c Supersp reade r events.d Aerosol-genera 6ng proced ures On a nosooomial situation).• Conclusions were drawn based on stability expe riments.Disclaimer: Any third -part y mMerial in this email has been shared under fair use provisions of U.S.copyright law, without furth er verifi cation of its accura cy/veraci ty_ It do es not necessarily repre se nt myviews nor those ofNTAJD, NIT-I, HHS, or the U.S. government.NIH-001442From:Sent:To:Cc:Subject:Joha n:Fauci, Anthony {NIH/NIAID) [E]Mon, 24 Feb 2020 17:21:34 +0000Van Hoof, Johan [JRDBE];Erbelding , Emily (NIH/NIAID) [E)Stoffels, Paul [JJCUS)RE: as26 based COVID-19 vaccine candidateThanks for t he note . I enjoye d and learne d from your presentat ion thi smorn ing. The best way to keep in t ouch with NIAID would be t hrough Emily andBarney.Best regards,.TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The Nationa l Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Van Hoof, Johan [JRDBE] --------- (b)(6)Sent: Monday, February 24, 2020 11:58 AMTo: Erbelding, Emily (NIH/NIAID) [E),-------- (=b)~(= >Cc: Fauci, Anthony (NIH/NIAID) [E]- -------- (b)(6) Stoffels, Paul [JJCUS)- ------- (b)(6) Subject: as26 based COVID-19 vaccine candidateDear Emily,Dear Dr. Fauci,First of all, I want to thank NIAID and its team for spending time with us going through the Janssen plansfor Ad 26 COVID-19 vaccine development.In follow up of our call earl ier today, please find herewith the key action points I noted from ourdiscussion. I would welcome your perspectives/comments, as well as the best way to keep in touch withNIAID.Looking forward to your feedback,NIH-001443Best regards,JohanJohan Van Hoof, M.D.Managing Director , Janssen Vaccines and Prevention B.V.Global Therapeutic Area Head IDV, Vaccines, Janssen Pharmaceuticals R&DPhoneE-mailAssistantPhone(b)(6)(b)(6)(b) ( Fax : +32 14 60 2841(b)(6)************************************************************************************************************************ ************************Follow Up to Ad26 COVID-19 call with NIAID; February 24th 2020NIH-001444(b) (4)(b) (4)NIH-001445From :Sent :To:Subject:You are correct.Anthony S. Fauci , MDDirectorFauci, Anthony (NIH/NIAIO) [E)Mon, 24 Feb 2020 16:53:04 +0000Folkers, Greg (NIH/NIAID) [E]RE: ASF ------ - NEJM commentary -- change title?National Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)( 6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Folkers, Greg (NIH/NIA ID) [El ---------(b) (6)>Sent : Monday, February 24, 2020 11:51 AM -------::-::-=, To: Fauci, Anthony (NIH/NIAID) [E] (b)( (;)> ~=======~~ Cc: Eisinger, Robert (NIH/NIAID) [E) ________ CbH_, ; Folkers, Greg (NIH/NIAID) [E](b)(6)>Subject : ASF ------- NEJM commentary -- change title?(b)(5)Disclaim er: Any third -party mat erial in this email has been shared for intern al use under fair use pr ovisionsof U.S. copyri ght law, without furth er verific ation of its accurac y/veracit y. It does not necessarily re pre sentmy views n or those of NIAlD, NIH, HHS, or the U.S. govern ment.NIH-001446From:Sent :Fauci, Anthony (NIH/NIAIO) [E)Mon, 24 Feb 2020 16:51:09 +0000To: Faye LiCc: Billet, Courtney (NIH/NIAID) [E);Conrad, Patricia (NIH/NIAID) [E);Barasch,Kimberly (NIH/NIAID) [C]Subject: RE: Interview Request from ChinaFaye :Thank you for your note. Please send me you r questions by e-mail and I will tr yto answe r them by e-mail.Best regards,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From : Faye Li (b)(6)>Se nt: Monday, February 24, 2020 1-1-:4-1- A-M-- -, _...._..,= To: Fauci, Anthony (NIH/NIAID) [E)- -------- (b)(6) Subject: Interview Request from ChinaDear Dr. Fauci,I'm Faye Li, journalist from the Portrait, a national magazine in China. My beat is science and technology.Since the outbreak of the 2019 novel coronavirus (COVID-19) in China, I'm covering feature stories aboutthe outbreak, hoping to explain to readers what it is, especially since the virus is evolving daily at anunexpected high speed, and in so many confusing ways.Now in China we are getting conflicting information about the new virus and thus become confusedabout it. For example, we are seeing more and more cases that a patient with negative test results for 2non-continuous days, still infected with the virus and tested positive afterwards. It makes the treatmentreally difficult because it seems hard to determine whether the patient is fully cured or not. Since youare an experienced immunologist, I'm wondering if you could share your insights with the Chinesereaders and take an interview . The Interview could be via phone or email, whichever works fine for you.NIH-001447If possible, I'd love to send you the questions before we talk. Since we have time difference, I might notbe available dur ing the early afternoon (your time) but I could make it in the morning, noon and maybelate in the afternoon and evening (your time).I'm sorry for bothering you on this subject, but we face severe difficulty in understanding this new virusand taking measures properly. We have quite limited sources and perspectives for understanding thisnew virus. However, as a science reporter, I believe in a crisis of public health, the informat ion is the keyfor the public. They should have the opportunity to hear more perspectives from different specialists.Since you are experienced in fighting against so many viruses, especially SARS, I believe your opinionswi ll be inspiring to the readers.It would be of great help and great honor for us to invite you for an interview. A phone call interviewwould be preferred but if t ime doesn't work for you, is it possible for you to reply via email? I'll list allthe questions in deta il.I could be reached byBest wishes,FayeThe PortraitBeijing, China(b)(6) or ______ C_b)_C_6,) I'm looking forward to your reply.NIH-001448From :Sent :To:Subject :Cristina , please.Anthony S. Fauci , MDDirectorFauci, Anthony (NIH/NIAIO) [E)Mon, 24 Feb 2020 16:01:59 +0000Conrad, Patricia (NIH/NIAID) [ElRE: Call for Dr. FauciNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Conrad, Patricia (NIH/NIAID) [El ---------(b)(6)>Sent: Monday, February 24, 2020 10:46 AM -------::-::-=, To: Fauci, Anthony (NIH/NIAID) [El~ ---:::===(b=)((;=)> =!.,._~~ Cc: Barasch, Kimberly (NIH/NIAID) [C) ---------- (b)(6) >; Haskins, Me linda (NIH/NIAID) [El (b) ( >Subject: Fwd: Call for Dr. FauciIs this a friend or do u just want to pass to Cristina. Pis adviseSent from my iPhoneBegin forwarded message:From: "Haskins, Melinda (NIH/NIAID) [El"- --------(b) ( > 0 ate: February 24, 2020 at 10:40:37 AM ESTTo: "Conrad, Patricia (NIH/NIAID) [E]" --------=- (bc)(-= >Cc: "Harr is, Kara (NIH/NIAID) [El" --------- (b)(6)>Subject : FW: Call for Dr. FauciFrom: Harris, Kara (NIH/NIA ID) [El -------- (b)(6)>Sent: Monday, February 24, 2020 10:39 AMNIH-001449To: Barasch, Kimberly (NI H/N IAI D) [ C] Cb) (6J>Cc: Correa, Meylin (NIH/NIA ID) [C] (b)(6J>; Forde, Michae l (NIH/N IAID)[C] (b)(6J>; McCullough, Claire (NIH/NIAID) [E] ----------(b)(6J>; Haskins, Melinda (NIH/N IAID) [E] --------. (ab)(6") "S"'"7= Subject: RE; Call for Dr. FauciHi, Kim-I spoke to Dr. Jacobs directly . He said that Dr. Michael Lockshin is a good frie nd/fellowCornell graduate (Dr. Jacobs also noted he went to Cornell) and gave him Dr. Fauci'snumber.Dr. Jacobs and Dr. Alexander Tarakhovsky, a virologist at The Rockefe ller Institute, wouldlike to speak to Dr. Fauci about the coronavirus. They have a theory that there may beyeast invo lved because it is sticky and perhaps it came from the Chinese government.They want to share their ideas and perhaps start a U.S. government effort "similar to TheManhattan Project." They do not want funding.I thanked Dr. Jacobs for sharing his ideas and stated that I would pass along the message.Should Dr. Fauci wish to speak to them, Dr. Jacobs can be reached at the number belowand Dr. Tarakhovsky can be reached at (b)(6)Please let me know if you have any question s.Thanks,KaraFrom: McCullough, Claire (NIH/NIAID) [E] (b)(6)Sent: Monday, February 24, 2020 10:07 AM --------~~ To: Barasch, Kimber ly (NIH/NIAID) [C] CbH6J>Cc: Harris, Kara (NIH/NIAID) [E] (b)(6J>; Correa, Meylin (NIH/NIAID) [C]--------- (b)(6)>; Forde, Michae l (NIH/NIAID) [C] (b)(6)> Subject: Call for Dr. FauciHi, Kim--I got some additional information from Dr. Michael Jacobs office. He is adermatologist in New York City and said that Dr. Fauci is expecting his call. The secretaryprovided no further information.Dr. Michael Jacobs(b)(Thank you.Claire A. McCulloughLegislative Affairs and Correspondence Management BranchOffice of Communications and Government RelationsNational Institute of Allergy and Infectious DiseasesNational Institutes of Health5601 Fishers Lane, Rm. 6F27 - MSC 9806Bethesda, MD 20892Tel: (b)(6)The information in this e-mail and any of its attachments is confident ial and may contain sensitive information. Itshould not be used by anyone who is not the original intended recipient. If you have rece ived this e-mai l in errorplease inform the sender and delete it from your mailbox or any other storage devices. National Institute of AllergyNIH-001450NIH-001451and Infectious Diseases shall not accept liability for any statements made that are sender's own and not expresslymade on behalf of the NIAID.From:Sent :To:Cc:Subject:Attachme nts:proof.pdffyiAnthony S. Fauci , MDDirectorFauci, Anthony (NIH/NIAIO) [E)Mon , 24 Feb 2020 15:14:10 +0000Billet, Courtney (NIH/NIAID) [E]Eisinger, Robert (NIH/NIAID) [E]FW: New England Journal of Medicine 20-02387Fauci-20-02387-Text.docx, Embargo-Guidelines-5.13.pdf, Production-and-Nat ional Institute of Allergy and Tnfectious DiseasesBuild ing 31, Room 7A-0331 Center Drive , MSC 2520Nat ional Institutes of HealthBet hesda , MD 20892 -2520Phone: (b) (6)FAX: (30 I) 496-4409E-mail: (b)(6)The i11formation in this e-mail and any of its attachments is confiden tial and may contai n sensitive info1111ation. Itshould not be used by anyone who is not the original intended recipie nt. If you have receive d this e-mail in eITorplease inform the sender and delete it from your mailbox or any other storage de vices . The National Institu te ofAllergy and Infec tious Diseases (NlAlD) sha ll not accept liability for any statements made that are the sender's ownand not express ly made on behal f of the NIAID by one of its representa1ives.-----Orig ina l Message-----From: New England Journal of Medicine <onbehalfof @ma nuscriptcentral. com>Sent : Monday,Febrnary 24, 2020 10:0-0- A-M-- - "="'~ To : Fau ci, Anthony (NlH/NIAID) [E] _____ ...,Cb)( >; Lane, Cliff(NlH/NIAlD) [E]--------(b)(6) ; Redfield , Robert R. (CDC/OD) (b)(6) Subj ect: New England Journal of Medicine 20-02387Dear Dr. Fauci,Tha nk you for the aiiicle , "COVTD- 19: Nav igat ing the Unchartered," which the .Journal is plea sed to accept forpub) ication.Th is accept ance is made with the unde rstand ing that neither the artic le itself nor any part of its essentia l sub stance,tables or figures has been pub lished or will be subrni t1ed for publication elsew here before it appears in the Journal.The accepta nce is also made with the understanding that all the auth ors, the data, and its pres entation meet therequirements as desc,ibed in the Recomme nda tions for the Conduct, Reporting , Edi ting and Publication of ScholarlyWork in Medica l Journals (www .icmje.org).Please note that the acceptanc e of your comme nta ry should be considered confide ntial infonnation to be shared onlywith your coauthors until its final publication. To ensure that no news repo rts about the article appear prematurely inany fonn, do not speak to the media, hold press conferences, or issue news re leases about your paper before theweek of publication . You must receive an explicit commitment to withhold release of the information until theembargo is lifted at 5:00 p.m. (Eastern Time in lhe United States) on the day before. the date of publication. If thereare any questions about this policy, you shou ld discus s them with the Editor.We assume that financial relationships creating possible conflicts of interest for all authors have been fully disclo sedto the Editor , including (but not limited to) any relevant rela tionships listed in the Open Payments database atNIH-001452NIH-001453https://openpaymentsdata.cms. gov/search/physicians/by-name-and -location for physicians practicing in the UnitedStates. For information on what would qualify as a 'relevant' disclosure, please review tbe instructions on page l ofyour disclosure form.Authors are reminded that all material published in the Journal is copyrig hted by the Massach usetts Medical Society,that by agreeing to have their manuscript published in the Journa l they !:,>rantto the Society full right and authority tosecure copyright for the full tenn and any renewals or extensio ns thereof, and that pennission for reprinting must beobta ined in writing from the Journal.The Journal will edit your manuscript in accordance with its estab lished sty le. You will receive a proof of the ed itedmanusc1ipt by e-mail; the proof stage will be your next opportunity to make changes . For important info1mationabout production and proofs , see the attached document. In the meantime, please do not make any changes or sendany new material to us. Tbank you for your contribut ion to the Journal.Sincerely yours,Eric J. Rubin, MD, PhDEditor-in-ChiefNew England Journal of Medicine10 Shattuck StreetBoston, MA 02115(617) 734-9800Fax: (617) 739-9864http://W\vw.ne jm.orgFrom:Sent :To:Cc:Subjec t:Ming:Fauci, Anthony (NIH/NIAID) [E)Mon, 24 Feb 2020 14:22:21 +0000(b)(6)Barasch, Kimberly (NIH/NIAID) [Cl;Conrad, Patricia (NIH/NIAID) [ElRE: COVID-19 QuarantineThank you for your note and offer to help. I will ask my Staff Ass istant, Kim Barasc h, co set up a brief call for youto relate your impressions to me.Best regards ,TonyAnthony S. Fauci , MDDirectorNational Institu te of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Driv e, MSC 2520National Institutes of HealthBethe sda, MD 20892 -2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recip ient. If you have 1·eceived this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIAID by one of its representatives.-----Original Message-----~m 00~Sent: Sunday , February 23, 2020 7:52 -P-M- ----=-:-:-= TCoc:: Fauci, Anthon(by) (6()N lWNlAID) [El ..._ _____ C_b_H. >Subject: COVID-19 QuarantineDear Dr. Fauci ,My name is Ming Lei, a Division Director at the NIGMS . I am writing to you as a private citizen , to thank you foryour leade rship in yet anoth er public health eme rgency, and to make myself ava ilable to you if you have the time formy in-person observations oftbe COVID-19 caused quarantine in Hubei Province, China ; the evacuation ofAmc1icans; and the quarantine in the US.(b)(6)As the virus sti ll roams around , and a possibili tyof caus ing a pandemic , I want to let you know that I am willing to share with you my direct observations in casesuch information is of value in the developing of our responses going forward, which you will undoubtedly playinga critical role.l will send you a reminder through my NIH email account, in case this message is put into the junk mail folder.Sincerely ,NIH-001454NIH-001455From:Sent :To :Cc:(NIH/NIAID) [ElFauci, Anthony (NIH/NIAIO) [E)Mon , 24 Feb 2020 14:03:36 +0000Billet, Courtney (NIH/NIAID) [El;Marston, Hilary (NIH/NIAID) [ElFolkers, Greg (NIH/NIAID) [El;Conrad, Patri cia (NIH/NIAID) [El;Routh, JenniferSubject: RE: FOR YOUR REVIEW: Draft Rollout, All Staff, and Statement on Preparing forPotential Patients w/ COVID-19Looks fine to me.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It shou ld not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIA ID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Billet, Courtney (NIH/NIAID) [El (b)(6)>Sent : Monday, February 24, 2020 8:54 AM -------= = To : Fauci, Anthony (NIH/NIAID) [El <O. (b)( i>; Marston, Hilary (NIH/N IAID) [El(b)(6)>Cc : Folkers, Greg (NIH/NIAID) [E) (b)( >; Conrad, Patricia (NIH/NIAID) [E]________ Cb_H_6); Routh, Jennifer (NIH/NIAID) [El (b)(6)Subject: FW: FOR YOUR REVIEW: Draft Roi lout, All Staff, and Statement on Preparing for PotentialPat ients w/ COVID-19Renate is asking that I confirm that Dr. Collins' changes (tracked in attachments) sync with what we'vebeen saying. They look ok to me. What say you?From: Collins, Francis (NIH/OD) [El (b)(6)>Sent : Monday, February 24, 2020 6:45:07 AMTo : Myles, Renate (NIH/OD) [El (b)(6); Fauci, Anthony (NIH/NIAID) [E](b)(6); Tabak, Lawrence (NIH/OD ) [E] (b)( >; Gilman, James(NIH/CC/OD) [E] CbH6)>NIH-001456Cc : Burklow, John (NIH/OD) [El CbH6)>; Hallett, Adrienne (NIH/OD) [El(b)(6)1>; Allen-Gi fford, Patrice (NIH/OD) [E] (b)( >; Billet,Courtney (NIH/NIAID) [E] (b)(6); Davey, Richard (NIH/NIAID) [E](b)( >; Palmore, Tara (NIH/CC/OD) [E] CbH >; Cohen, Justin(NIH/CC/OD) [E] (b)(6)>Subject: RE: FOR YOUR REVIEW: Draft Rollout, All Staff, and Statement on Preparing for PotentialPatients w/ COVID-19Hi all,Nicely done, Renate. I made a few edits in two of the documents, see attached.FCFrom : Myles, Renate (NIH/OD) [E] (b)(Se nt: Sunday, February 23, 2020 8:56 PMTo: Fauci, Anthony (NIH/NIAID) [E]------ =(b=H=6) Collins, Francis (NIH/OD) [E](b)(6)>; Tabak, Lawrence {NIH/OD) [E] (b)(6)>; Gilman, James(NIH/CC/OD) [El CbH6)>Cc: Burklow, John (NIH/OD) [E] (b)(6)>; Hallett , Adrienne {NIH/OD) [E](b)(5)(b)(6)>; Allen-Gi fford, Patrice (NIH/OD) [El (b)( >; Billet,Courtney {NIH/NIAID) [E] (b)(6); Davey, Richard {NIH/N IAID) [E](b)(6)>; Palmore, Tara (NIH/CC/OD) (E] (b)(6)>; Cohen, Justin(NIH/CC/OD) [El (b)(6)>Subject : RE: FOR YOUR REVIEW: Draft Rollout, All Staff, and Statement on Preparing for PotentialPatients w/ COVID-19Thanks, all.Best,RenateLatest rollout, all staff and statement are attached .From : Fauci, Anthony (NIH/N IAID) [E] ______ C)b_C_6>)Sent : Sunday, February 23, 2020 8:15 PMTo: Myles, Renate (NIH/OD) [E] Cb)( >; Collins, Francis (NIH/OD) [E](b) (5)(b) (5)(b)(6J Tabak, Lawrence (NIH/OD) [El (b)(6)>; Gilman , James(NIH/CC/OD) [El --.-.~-== (=b)=(6~)>--~ =Cc: Burklow, John (NIH/OD) [E] (b)( >; Hallett, Adrienne (NIH/OD) [E]NIH-001457(b)(6) 1>; Allen -Gifford, Patrice (NIH/OD) [E] (b)(6) Billet ,Courtney (NIH/NIAID) [E) (b)(6)>; Davey, Richard (NIH/NIAID) [E](b)(6l; Palmore, Tara (NIH/CC/OD) [E] (b)(6); Cohen, Justin(NIH/CC/OD) [E) (b)(6) >Subject: RE; FOR YOUR REVIEW: Draft Rollout, All Staff, and Statement on Preparing for PotentialPatients w/ COVID-19Renate:The rollout plan looks fine except that I would include -------------- (b) (5)Thanks ,TonyFrom: Myles, Renate (NIH/OD) [E] (b)(6)>Sent: Sunday, February 23, 2020 7:23 PMTo: Collins, Francis (NIH/OD) [E]_ ____ _.,.(b..)._(=6. ); Tabak, Lawrence (NIH/OD) [E](b)(6)>; Fauci, Anthony (NIH/NIAID) [E] (b)(6)>; Gilman, James"(: N"-:-'IH--/-C:--C::--/-0:--:D:--:)- -[~:E]:-===..;__- ~ (bc)-(-=6c)>Cc : Burklow, John (NIH/OD) [E] CbH6)>; Hallett, Adrienne (NIH/OD) [E)(b)(6)>; Allen-Gi fford, Patr ice (NIH/OD) [E) (b)(6) ; Billet,Courtney (NIH/NIAID ) [E) (b)(6); Davey, Richard (NIH/NIAID) [E](b)(6)>; Palmore, Tara (NIH/CC/OD) [E) (b)( Cohen, Justin(NIH/CC/OD) [E] (b)(6)Subject: FOR YOUR REVIEW: Draft Rollout, All Staff, and Statement on Preparing for Potential Patientsw/ COVID-19Importance: HighGood evening :At tached for your review are draft materia ls to communicate NI H's preparation for potential receipt ofpatients with COVID-19 to the NIH Clinical Center (timing TBD), including:1. Rollout plan2. All staff emai l3. StatementThese materials were reviewed by Rick Davey, Tara Palmor e, and Courtney Billet. I am developing a listof potenti al Qs and will work with CC and NIAID folks to develop responses, but I wanted to get theseproducts into review in the interest of time.Best,RenateRenate Myles, MBADeputyDirectorfor Public AffairsOffice of Communications and Public LiaisonNational Institutes of HealthNIH-001458Tel: ----(-b)(6)NIH-001459From:Sent:To:Subject:LorenzoFauci, Anthony (NIH/NIAIO) [E)Mon , 24 Feb 2020 12:59:47 +0000Leggio, Lorenzo (NIH/NIDA) [E]RE: Question from the Italian Embassy in DC re: coronavirusThanks for the note. Unfortunately , I cannot be of any help to you since Imyself have no access to this equipment. The best person to contact would beDr . Robert Kadlec of ASPR at HHS.Best regards,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail r (b) (6YThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Leggio, Lorenzo (NIH/NIDA) [E] ---------- (b)(6)Sent: Monday, February 24, 2020 5:55 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)( >Cc: (b)(6)Subject: Question from the Italian Embassy in DC re: coronavirusDear Dr. Fauci,I apologize in advance if I write you directly to ask this question. I know you are super busy but I thoughtyou could provide some guidance on someone I could contact about this matter.(b) (5)NIH-001460I know this seems a very technical quest ion and I appre ciate you have many other things on your plate,so I hope you don't mind if I decided to reach you out. I do know that Filippo and his team will be verygrateful for any guidance that they could receive.Thanks in advanceLorenzoLorenzo Leggio, M.D., Ph.D.Senior Investigator (Clinical), NIDA IRP and NIAAA DICBRChief, Section on Clin ical Psychoneuroendocrino logy and Neuropsychopharmacology , NIDA IRP andNMA DICBRAssociate Director for Clinical Research, Medication Development Program, NIDA IRPSenior Medical Advisor to the Director, NIAAANationa l Institutes of Health10 Center Drive {l0CRC/15330) Room 1-5429Bethesda, MD 20892-1108251 Bayview Blvd, Room 01A844Baltimore, MD 21224Office Phone: (b)(6) (Bethesda); ____ (b)_C6) (Baltimore)Cell: (b)(6)E-mail: (b)(6) ---------(b) (5)Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of theintended recipient(s) and may contain confidential and privileged information. Any unauthorizedreview, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contactthe sender by reply e-mail and destroy all copies of the original message.NIH-001461From:Sent:To:Cc:Subject :Fauci, Anthony (NIH/NIAIO) [E)Mon, 24 Feb 2020 12:42:02 +0000STEWART SIMONSON____ (b_H_ (NIH/CC/BEP) [E]RE: Our story todayThanks, Stewart. We will do it again after Cliff returns from China and fin ishes his14 day self-quarantineAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the or iginal intended recipient. If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: STEWARTS IMONSON- ---------- (b) (6) > Sent: Monday, February 24, 2020 7:35 AM To: Fauci, Anthony (NIH/NIAID) [E- _-_-_-_-_- ~~ (b><_ >Subject: Re: Our story todayThank you-he is grateful for your help, Tony. He is in a unwindable situation but he is doing what isright and with integrity . (b)( . As doI (b)(6). I really appreciate it.sOn Feb 24, 2020, at 7:23 AM, Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6)wrote:Stewart:Here is another article in which I strongly support Tedros.TonyNIH-001462Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: Cb) (6)FAX: (301) 496-4409E-mail : (b)(6)The information in this e-mai l and any of its attachments is confidential and maycontain sensitive information . It should not be used by anyone who is not theoriginal intended recipient. If you have received this e-mail in error please inform thesender and delete it from your mailbox or any other storage devices . The NationalInstitute of Allergy and Infectious Diseases (NIAID) shall not accept liability for anystatements made that are the sender's own and not expressly made on behalf of theNIAID by one of its representatives .From: John Lauerman (BLOOMBERG/ NEWSROOM:) <jlauerman@bloombe rg.net>Sent: Mo nday, February 24, 2020 7-:0-4- A-M- ---=-<'"-=-> To: Fauci, Anthony (NIH/NIAID) [E) CbH6>JSubject: Our story todayHi Dr . Fauci: here ' s o u r story on Te d ros to d ay , in caseyou have n 't se en i t.h ttps:/ / www. b lo omberg . com/n ews/fea tu res / 20 20 - 02-23/ c or o nav iru s - ne ws - who - d ire ct or - g ener a l - r ac e s - a g a in st timeTh a n ks aga in for a ll your help wi t h t hi s o ne . Hop e weget a c hance t o ta l k aga in soo n .Re gards , J LJohn Lauerman , Bloomberg News(b)(6)3 Queen Victoria Street, London, UKtel. +44 (0) 2035 251028 cell --------- http://www . b Io om berg .comhttp://www .bloomberg .com/prognosisNIH-001463From:Sent :To:Fauci, Anthony (NIH/NIAIO) [ElMon , 24 Feb 2020 12:24:01 +0000John LauermanSubject :Thanks, John.Anthony S. Fauci , MDDirectorRE: Our story todayNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)( 6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: John Lauerman (BLOOMBERG/ NEWSROOM:) <j lauerm an@bloomberg.net>Sent: Monday, February 24, 2020 7:04 AM -------=-:-:= To: Fauci, Anthony (NIH/NIAID) [El (b)(6)Subject: Our story todayHi Dr . Fa uci : here ' s ou r sto r y on Te dr os to day , in cas e yo uh a v en ' t s ee n it .https : // www. bloombe r g . com/news/features/2020 - 02 - 23/co r onavi r us news - who - d ir ector - ge n era l - races - against - timeTh a n ks a ga in fo r a ll you r h e lp with thi s on e . Hope we g e t ac hance to ta l k a g a in soon .Re gards , JLJohn Lauerman, Bloomberg News3 Queen Victoria Street , Lond-o--n-, -U--K- -=-c-c-='I tel. +44 (0) 2035 25 1028 cell ______ C_b>_<6)http://www . bloomberg .comhttp://www .bloomberg .com/prognosisNIH-001464From:Sent:To:Cc:Fauci, Anthony (NIH/NIAIO) [E)Tue, 25 Feb 2020 11:07:01 +0000Cassetti, Cristina (NIH/NIAID) [E]Erbelding, Emily {NIH/NIAID) [E]Subject : FW: ACT Additional reading material and developmentsAttachments: About ACT.Global and its Premium Purity.pdf, ATTOOOOl.htm, ACT CleanCoatFebruary 2020.pdf, ATT00002.htm, ACT ECA System Februar 2020.pdf, ATT00003.htm, Dr.Brill andOr.Steinmann - ACT CleanCoat Viruzidie englisch EN 14476 08.01.2015 Logo Brill.pdf, ATT00004.htmCristina:Please se if we can engage this person (Richard Tubb) and see what he has to offer. He usedto be the White House physicianThanks,TonyFrom: Fauci, Anthony (NIH/NIAID) [E]Sent: Monday, February 24, 2020 10:42 PMTo: Biegun, Stephen E (b)( >Cc: Cassetti, Cristina (NIH/NIAID) [El (b)( ; Erbelding, Emily (NIH/NIAID) (El--------- (b)(6)>; Conrad, Patricia (NIH/NIAID) [E] (b)(6) Subject: FW: ACT Additional reading material and developmentsSteve:Thanks for the note. I do indeed know Dr. Tubb. He sent me similar material and I am goingto connect him with our program people here at NIAIO to see if we can help in any way.Best regards,TonyFrom: Biegun, Stephen E (b)(6)Sent: Monday, February 24, 2020 10:33 PM------~~ To: Fauci, Anthony {NIH/NIAID) [E]- -------- (b)(6)> Subject : Fwd: ACT Additional reading materia l and developmentsTony,I expect you know Or. Richard Tubb. He and I worked closely together in the White House 18 years ago. Ihave a lot of confidence in his judgment, and therefore am forwarding the materials he sent me for yourconsiderat ion.I know nothing about the technologies involved, but I know this is a time to write off no good options.Warm regards,NIH-001378SteveSent from my iPhoneBegin forwarded message:From: Richard Tubb (b)(6)>Date : February 24, 2020 at 8:47:23 PM ESTTo: "Biegun, Stephen E" (b)( , Robert Kadkec (b)(6),(b)(6)Subject: ACT Additional reading material and developmentsNIH-001379From:Sent :To:Subject:Attachment s:Let us discussAnthony S. Fauci , MDDirecto rFauci, Anthony (NIH/NIAIO) [E)Mon, 24 Feb 2020 20:22:42 +0000Marston, Hilary (NIH/NIAID) [E]FW: chloroquine in COVID-19chloroquine.pdfNational Institute of Allergy and Infectious DiseasesBui lding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e -mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Gatti, Philip (b)( >Sent : Monday, February 24, 2020 2:42 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E]- ------- (b)(6)> Subject: FW: chloroquine in COVID-19Dear Dr. Fauci,Is there any indication/data to substantiate this claim from China (attached publication) thatchloroquine/hydroxychloroquine can decrease COVID-19 infections and lung disease?Thank you,Philip Gatti, Ph.D.PharmacologistFDACDERONDSilver Spring, MD(b)(6)NIH-001430From:Sent :To:Subject:Attachment s:Let us discuss.Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAIO) [E)Mon, 24 Feb 2020 20:21:35 +0000Marston, Hilary (NIH/NIAID) [E]FW: chloroquine in COVID-19Chloroquine and SARS.pdfNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail (b)(6)The information in this e-mail and any of its attachments is confiden tial and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e -mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Gatti, Philip (b)(6)Sent : Monday, February 24, 2020 3:05 PM -------~= To: Fauci, Anthony (NIH/NIAID) [E]- -------- (b)(6) Subject: RE: chloroquine in COVID-19Tony ,Thanks for the quick response . There are data from 2005 showing inhibition of SARS infection andspread from 2005 . Please see attached .Regards ,PhilFrom: Fauci, Anthony (NIH/N IAID) [E) CbH >Se nt: Monday, February 24, 2020 3:00 PMTo: Gatti, Philip (b)( >Cc: Lane, Henry C (NIH) (b)(6)>; Cassetti, Cristina G (NIH) ---------- CbH6;J Erbelding, Emily J (NIH) (b)(6)>Subj ect : RE: chloroquine in COVID-19Phil:NIH-001431There are no data in this brief report and so I have no way of evaluating theirclaim. There are a lot of these types of claims going around. I would love to seetheir data.Best regards,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone : Cb()6 )FAX: (301) 496-4409E-mail Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Gatti, Philip (b)(6)Sent: Monday, February 24, 2020 2-:4-2- P-M- --:,,:,--== To: Fauci, Anthony (NIH/NIAID) [E]- ------- (b)(6) Subject: FW: chloroquine in COVID-19Dear Dr. Fauci,Is there any indication/data to substantiate this claim from China (attached publicat ion) t hatchloroquine/hydroxychloroquine can decre ase COVID-19 infections and lung disease?Thank you ,Philip Gatt i, Ph.D.PharmacologistFDACDERONOSilver Spring, MD(b)( 6)NIH-001432From:Sent :To:Subject:Anthony S. Fauci , MDDirectorFauci, Anthony (NIH/NIAIO) [ElWed, 26 Feb 2020 19:07:38 +0000Tabak, Lawrence (NIH/OD) [E)RE: URGENT- Need your inputNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail Cb()6 )(b) (5)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the or iginal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Tabak, Lawrence (NIH/OD) [E] (b)(6)Sent : Wednesday, February 26, 2020 2:06 PM ------ -== To: Fauci, Anthony (NIH/NIAID) [E] (b)( ; Hallett, Adrienne (NIH/OD) [E]________ C_bC>6); Conrad, Patricia (NIH/NIAID) [El (b)( >Subject : Re: URGENT-Need your inputYes- that was the main thing- but any other issues that you can think of in our space?ThanksGet Out look for iOSFrom: Fauci, Anthony (NIH/N IAID) [El (b)(6)Sent : Wednesday, February 26, 2020 2:04:38 PMTo: Tabak, Lawrence (NIH/OD) (E] CbH6J>H;a llett , Adrienne (NIH/OD) (El--------- (b)(6) 1>; Conrad, Patricia (NIH/NIAID) [E] (b)(6)> Subject: RE: URGENT-Need your inputNIH-001304(b) (5)Anthony S. Fauci, MDDirectorNational Insti tute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone : (b)(6)FAX : (301) 496-4409E-mail : Cb()6 )The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who Is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infect ious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From : Tabak, Lawrence (NIH/OD) [El (b)( >Sent: Wednesday, February 26, 2020 1:57 PM ------~= To: Fauci, Anthony (NIH/NIAID) [El Cb) (6)>; Hallett, Adrienne (NIH/OD) [El----------(b)(6); Conrad, Patricia (NIH/NIAID) [E] (b)(6) Subject: Fwd: URGENT-Need your inputI will join call- anything you want brought up?LarryGet Out look for iOSFrom: Pollard, Ashton (05/10S) (b)( >Sent: Wednesday, February 26, 2020 1:44:56 PMTo: Mango, Paul (HHS/10S) CbH6)>; Lenihan, Keagan (FDA/OC)Cb)( >; Tabak, Lawrence (NIH/OD) [E] (b)(6) ; McGowan,Robert (Kyle) (CDC/0D/OCS) (b)(6)>; Shuy, Bryan (OS/ASPR/10) -------- (b) (6). Zeb I e y, Kyle (HHS/0S/OGA) (b)(6)>; Charrow , Robert (HHS/OGC)Subject: RE: URGENT-Need your inputHi All,I am about to send this invite. Please confirm your attendance via email or by accepting the calendarinvite.Thank you,Ashton-----Original Message-----From: Mango, Paul (HHS/I OS) Cb) (6)Sent: Wednesday, February 26, 2-02-0- -I :-43- P-M- - ~= To: Lenihan, Keagan (FDA/OC) (b)(6) ; Tabak, Lawrence (NIH/OD) [E]---------(b)(6) ; McGowan, Robert (Kyle) (CDC/OD/OCS) CbH >; Shuy, BryanNIH-001305(OS/ASPR/10) Cb><; Zebley , Kyle (HHS/OS/OGA) (b)(Charrow, Rober t (HHS/OGC)Cc: Pollard, Ashton (OS/IOS)Subject: URGENT- Need your inputTeam- Urgen t, how prio rity request: '(b)( >(b)(6)(b) (5) ---------------------Ashton will invite you to a 230pm call to discuss. Plea se organize your responses into bullet points todiscuss with the group.Sent from my iPhoneNIH-001306From: Fauci, Anthony (NIH/NIAIO) [E)Sent: Wed, 26 Feb 2020 18:25:04 +0000To: Billet, Courtney (NIH/NIAID) [E]Cc: Folkers, Greg (NIH/NIAID) [E];Conrad, Patricia (NIH/NIAID) [E];Marston, Hilary(NIH/NIAID) [E];Routh, Jennifer (NIH/NIAID) [E];Stover, Kathy (NIH/NIAID) [E]Subject: RE: Sec. Azar press briefing remarksAtt achment s: 2 26 20 press briefing remarks - with Fauci edits .docxHere are my edit s.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It shou ld not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Billet, Courtney (NIH/NIAID) [E] -------- (b)( 6)> Sent : Wednesday, February 26, 202-0- 1-:1-2- P-M -:-::~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Cc: Folkers, Greg (NIH/NIA ID) [El (b)(6)>; Conrad, Patricia (NIH/NIAID) [El(b)( >; Marston, Hilary (NIH/NIAID) [El (b)(6) >; Routh, Jennifer -:--.-----:-:---:--:;:::::::==-...:....--_;,~(NIH/NIAID) [El (b)(6); Stover, Kathy (NIH/NIAID) [E] (b)( >Subject: ASF: Sec. Azar press briefing remarksThese are Sec Azar's remarks for press tonight . (Plan still evolving.)They are asking for our comments back by 2:45 pm. New content is highlighted to make it easier onreviewers .We're sending your talk ing points down there momentarily.From : Brennan, Patrick (05/ASPA) ---------- (b)(6)Sent: Wednesday, February 26, 2020 1:07 PM -------~~ To: Conrad, Patricia (NIH/NIAID) [E)~':":"":":"'.:-:-::-:-:=== (=b)=(6::)>....;;SB"=o'"n'.ds, Miche lle E. (CDC/00/0ADC)CbH6J>G;a latas, Kate (CDC/0D/OADC) CbH >; Billet, Courtney (NIH/NIAID) [E]=====--!_ Cb)(6):>M; ichael, Gretchen (OS/ASPR/OEA) Cb)(6):>J;a nik,Heather (FDA/OC) CbH6J>C; aliguiri, Laura (FDA/OC)NIH-001307(b)(6J>; Lepore, Loretta (CDC/00/0CS) (b)( ":"."":".-:-:-:;-:-:-:-:-:;:::======-~~(HHS/OGC) (b)(6J>; Arbes, Sarah (HHS/AS,L.) .:..!:=====(b)"( =>;= M~ors-e, Sara (HHS/ ASL) (b)(6J>; Pence, Laura (HHS/ASL) (b)(6)>; Moughalian, Jen(HHS/ASFR) (b)(6); Shuy, Cait rin (HHS/ASFR} (b)(6); Trueman,Laura (HHS/I EA) (b)(6J v>; Mango, Paul (HHS/105) (b)(6)>; Johnston,Darcie (HHS/IEA) (b)(6)>; Kane, EIieen (OS/ASPR/OEA) (b)((;);Shuy, Caitrin (HHS/ASFR) (b)(6)>; Zebley, Kyle (HHS/OS/OGA) (b)(6)Grigsby, Garrett (HHS/OS/OGA) (b)(6JCc : ASPA-Deputies (b)(6)>; Foster, Timothy (OS/ASPA) (b)(6)>;McGowan, Robert (Kyle) (CDC/00/0CS) (b)(6)>Subject: For review by 2:45 PM: Sec. Azar press briefing remarksHi all,Attached is a draft of the Secretary's remarks for this evening 's potential press briefing. Some of this isrote/ repeated from yesterday or this morning's testimony; I have put the new content in yellow toaccelerate review.Please let me know if you have edits to th is by 2:45 PM.Thank you !Best,PatrickNIH-001308From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Wed, 26 Feb 2020 15:18:25 +0000Billet, Courtney (NIH/NIAID) [E]Subject: RE: For review by 10:00 AM Weds: Peter Navarro coronavirus op-edI do not have time for thi s. Sorry.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6lThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Billet, Courtney (NIH/NIAID) [E] (b)(6)Sent : Tuesday, February 25, 2020 10:08 PM -------=-=-~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6l>; Marston, Hilary (NIH/N IAID) [E](b)(6)>Cc: Folkers, Greg (NIH/NIAID) [E] (b)(6)>; Conrad , Patricia (NIH/NIAID) [E]"':'--.-----:-:---:-:::(:b:)=(6=); =Ro~u-th_, _J:e~nn~if er (NIH/NIAID) [E] (b)(6lf>; Stover, Kathy (NIH/NIAID) [E) (b)(6)Subject: Fwd: For review by 10:00 AM Weds: Peter Navarro coronavirus op-edThis is an oped for Peter Navarro . We are asked for comments by 10am Weds.(Complicating things a little, he was apparently just on with Tucker Carlson stating parts of it verbat im.So, hopefully th is is accurate!)From: "Brennan, Patrick (OS/ASPA)" (b)(6)>Date : Tuesday, February 25, 2020 at 8:27:03 PM --------=c--,=, To: "Conrad, Patricia (NIH/N IAID) [E]" (b)(6)>, "Bonds, Michelle E. (CDC/0D/OADC)"(b)(6)>, "Galatas, Kate (CDC/0D/OADC)" (b)(6)> , "Billet, Courtney (NIH/NIAID)[E]" (b)(6)>, "Michae l, Gretchen (OS/ASPR/OEA)" (b)(6) , "Janik,_H_eat_h_er_(:FD.A../_:O_C.:).'..'. .=!:~~------- Cb_><_6)>, "Caliguiri, Laura (FDA/OC)"CbH6J>",L epore, Loretta (CDC/00/0CS) " CbH6J",S timson, Brian"':'-~::-:-::-::-::.======:...:...-~=(HHS/OGC)" ---------(b)(6), "Arbes, Sarah (HHS/ASL)" Cb)( >, "Morse, SaraNIH-001325(HHS/ASL)" (b)(6J>, "Pence, Laura {HHS/ASL)"Jen {HHS/ASFR)" (b)(6)>, "Shuy, Caitrin {HHS/ASFR)"(b)(6)>, "Moughalian,(b)(6)>,"Trueman, Laura {HHS/IEA)" (b)(6) v >, "Mango, Paul {HHS/10S)"(b)(6), "Johnston, Darcie {HHS/IEA)" (b)(6), "Kane, EIieen(OS/ASPR/OEA)" .""".":"~(=b)(6)=>, =="Sh =uy,= Ca~itrin (HHS/ASFR)" (b)(6)>, "Zebley, Kyle {HHS/0S/OGA)" (b)(6)>, "Grigsby, Garrett (HHS/0S/OGA)"(b)(Cc: "ASPA-Deputies" <ASPA-Deput ies@hhs.gov>, "Foster, Timothy (OS/ ASPA)"---------- (b)(6), "McGowan, Robert (Kyle) (CDC/OD/OCS)"------=- (b")"("=6' ) Subject: For review by 10:00 AM Weds: Peter Navarro coronavirus op-edHi all,Attached is a draft op-ed from the WH's Peter Navarro regarding the administration's coronavirusresponse - covering PPE, vaccines, therapeutics, and diagnostics.There is a lot going on here so we'd like to have edit s/ recommendati ons/ affirmativ e clearance fromFDA, CDC, NIAID, ASFR, and ASPR.Please send edits to me and Tim Foster by 10:00 AM tomorrow {Wednesday}. Thank you!Best,PatrickNIH-001326From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Wed, 26 Feb 2020 02 :19:38 +0000Tabak, Lawrence (NIH/OD) [E)Subject : RE: LHHS appropriators coronavirus supplemental brief 3:30p WednesdayThan.ks, Lany !-----Original Message -----From: Tabak , Lawrence (NIH/OD) [E] (b) (6)Sent: Tuesday, February 25, 2020 9:0 l- -P-M- -~~= To: Fauci, Anthony (NIH/NIAID) [E] (b)( >Subject: FW: LHHS appropriators coronav irus supp lemental brief3:30p WednesdayTony,l will be able to do this . hopefully we can move this back in the correct direction.LarryOn 2/25/20, 9:00 PM, "Cochran , Norris (HHS/ASFR)" ------------ (b)( wrote:Correc tion, ---(-b) (5). Thank you in advance.Norris> On Feb 25, 2020, at 8:55 PM, Cochran, Non-is (HHS/ASFR) --------- (b)(6) > wrote: >> Dr. Tabak , Neil - would you be available to brie (b)(5)(b) (5)We would have CDC on the line as well. ASPRby phone or in person. We will be in person. Please let me know either way. Thank you in advance.>> Norr isNIH-001343From:Sent :To:Cc:Subject:Travis AFBRick/Tara:Fauci, Anthony (NIH/NIAIO) [ElTue, 25 Feb 2020 03:46:47 +0000Davey, Richard (NIH/NIAID) [El;Palmore, Tara (NIH/CC/OD) [E]------- (b)( ;Conrad, Patricia (NIH/NIAID) [El FW: 4 Additional COVID-19 Asymptomatic Positive Indiv iduals Identified atPlease give me a call (b)(5Ji. If during business hours, please call-----=~-::;---:---:-----:-:----:-:-my office at (b)(6) If in the evening/night call my cell phone at (b)(6). Myhome phone is (b)(6).Thanks,TonyFrom: Tabak, Lawrence (NIH/OD) [El --------- (b)(6)>Sent: Monday, February 24, 2020 10:40 PM --------=-c-= To: Kadlec, Robert (OS/ASPR/10)- ------- (b)( >; Stecker, Judy (OS/10S) (b )( 6) >Cc: Harrison, Brian (HHS/10S) (b)(6); Fauci, Anthony {NIH/N IAID) [El(b)(6)>; Palmore, Tara (NIH/CC/OD) [El CbH6l>; Yeskey, Kevin(OS/ASPR/10) (b)(6); Greene, Jonathan (OS/ASPR/EMMO)________ Cb _>C6); Lee, Scott (OS/ASPR/EMMO) (b)(6)>Subject : Re: 4 Additional COVI0-19 Asymptomatic Positive Individuals Identified at Travis AFBthanksFrom: "Kad lec, Robert (OS/ASPR/ 10)" --------- (b)(6)>Date: Monday, Februa ry 24, 2020 at 10:37 PM ---------:a = To: "Tabak, Lawrence (NIH/OD) [E)" --------- CbH6J>",S tecker, Judy (OS/10S) " (b)(6)>Cc: "Harrison, Brian (HHS/10S)" (b)(6) Anthony Fauci---------- CbH6)"Palmore, Tara (NIH/CC/OD) (E]" CbH6)>," Yeskey, Kevin (OS/ASPR/10)" <Kevin.Yeskey@hhs.gov >, "Greene, Jonathan (OS/ASPR/EM MO)"---------- Cb)( ·>, "Lee, Scott (OS/ASPR/EMMO)" (b)(6) Subject: RE: 4 Additional COVID-19 Asymptomatic Positive Individuals Identified at Travis AFBLarry would be ------------------- (b)(5J. Best BobFrom: Tabak, Lawrence (NIH/OD) [El --------- (b)( > Sent : Monday, February 24, 2020 10:28 PM ------~~ To: Kadlec, Robert (OS/ASPR/IO) _______ Cb_H_6)>; Stecker, Judy (OS/10S)(b)(6)>Cc: Harrison, Brian (HHS/10S) CbH6)F; auci, Anthony (NIH/N IAID) [El---------- (b)(6) Palmore, Tara (NIH/CC/OD) [El CbH6JY; eskey, KevinNIH-001380(OS/ASPR/I0) CbH6)> ; Greene , Jonathan (OS/ASPR/EMMO)~..;.__..;._...;....!==~ (b:);(::5"'">-; L:-e--e-, S:-c-ott ( OS/ ASPR/EM MO) Cb)( 6)>Subject: Re: 4 Additional COVID-19 Asymptomatic Positive Individuals Identified at Travis AFB-Any idea on t iming? - please let me know --------------------- (b)(S ) ThanksLarryFrom: "Kad lec, Robe rt (OS/ASPR/ 10)" (b)(6)Date: Monday, February 24, 2020 at 10:26 PMTo: "Stecker, Judy (OS/ 10S)" CbH6)>Cc: "Harrison, Brian (HHS/10S)" CbH6)>, Anthony FauciCbH6)>, "Tabak, Lawrence (NI H/OD) [E]" (b)(6) "Pa lmore,Tara (N IH/CC/OD) [E]" CbH6)> , "Yeskey, Kevin (OS/ASPR/ 10)" --------~~ --------- CbH6)>, "Greene, Jonathan (OS/ASPR/EMMO)" CbH6)>, "Lee, Scott (OS/ASPR/EMMO)" CbH6)1Subject: FW: 4 Additional COVID-19 Asymptomatic Posit ive Individuals Identified at Travis AFB(b) (5)From : Kadlec, Robert (OS/ASPR/I0 )Se nt: Monday, February 24, 2020 10:19 PMTo: Harrison, Brian (HHS/I0S) (b)(6)>; Stecker, Judy (OS/10S)=======~(b~)(6) > ; Mango, Paul (HHS/10S) (b)( >; Murphy, Ryan {OS/ASPA) "'.""'"'---:'"'"""".'""".'.""'.-:"(.'b.":) .(::6-):=:;:= ..A= rb_e.s..,~;S=arah (HHS/ASL) (b)(6)>; Fauci, Anthony(NIH/NIAID) [E) (b)(6)>; Tabak, Lawrence (NIH/OD) (E] (b)(6)>;Redfield , Robert R. (CDC/OD) (b)(6); McGowan , Robert (Kyle) (CDC/OD/OCS)(b)(6)>; Trueman, Laura (HHS/I EA) (b)( ; Mougha lian, Jen (HHS/ ASFR)(b)(6)>; Johnston, Darcie (HHS/IEA) (b)(6)> --------- Cc: Lee, Scott {05/ASPR/EMMO) (b)(6)>; Yeskey, Kevin (OS/ASPR/I0)-~-~~===t.(b.).(6.).1>:; .W..a.te-r~s, ~Cic ely (OS/ASPR/OEA) (b)(6)>; Shuy, Bryan (OS/ASPR/I0) (b)(6)>; Greene, Jonathan {OS/ASPR/EMMO ) ---------= ~ CbH >; Imbria le, Samuel (OS/ASPR/SIIM) (b)(6)>; Austin,Meredith (uscg.mil) (b)(6) 1>; Herrmann, Jack {HHS/ASPR/OPP)========~-:;;---:--:-------:-(-b)-(6)- :F-e:rr'o:,- P"h il J. EOP/N SC ---------- CbH6)>; Ruggiero, Anthony J. EOP/NSC CbH6)>; Cavanaugh, Brian J. EOP/NSC (b)(6)>Subject : 4 Additional COVID-19 Asymptomatic Positive Individuals Identified at Travis AFBImportance : HighThis evening, we were advised by the State of California that 4 passengers from the Diamond Princesstested positive by the CDC for COVID-19.NIH-001381One individua l who tested positive by the CDC had been tested positive in Japan and is already inhospital in CA.We are developing the following possible Courses of Action as the State of CA cannot absorb these 3addit ional asymptomatic ind ividuals..:_ _ ________________________ ("b"~'"('"S") 'NIH-001382From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Mon, 24 Feb 2020 18:46:26 +0000Moughalian, Jen (HHS/ ASFR)Subject: RE: Close Hold Review - Send comments by 1:40 pmJen :I had changed th e --------------- (b) (5) Thanks,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBu ilding 31 , Room 7A-0331 Center Drive , MSC 2520Nat ional Institutes of HealthBethesda MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may conta in sensitiveinformat ion . It shou ld not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) sha ll notaccept liability for any statements made t hat are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Moughalian, Jen (HHS/ASFR-) -------- (b) (6>r> Sent : Monday, February 24, 2020 1:43 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [El (b)( ; McGowan, Robert (Kyle) (CDC/0D/OCS)(b) (6)>; Shuy, Bryan (os·~; A".S"~"P.-R::-/:1'-.0::'):" =:===~- ("b")'"("-='"; Kadlec, Robert (OS/A SPR/10)(b)(6) •>; Grigsby, Garrett {HHS/0S/OGA) (b)(6); Zebley, Kyle~---::---:--'"""'":'-==-~(HHS/0S/OGA) (b)(6) Lenihan, Keagan (FDA/OC) (b)(6)>;Redfield, Robert R. (CDC/OD) (b)(6)>Cc: Cochran, Norris (HHS/ASFR) (b)(6)>; Cabezas, Miriam (HHS/ASFR)(b)( >; Hittle, Taylor (HHS/ASFR) (b)(6) --------- Subject: RE: Close Hold Review - Send comments by 1:40 pmThanks for the quick response!From : Fauci, Anthony {NIH/N IAID) [ElSe nt: Monday, February 24, 2020 1:42 PM(b) ( >---------=-:--:= To: Moughalian, Jen {HHS/ASFR) (b)(6)>; McGowan, Robert (Kyle) (CDC/0D/OCS)(b)(6)>; Shuy, Bryan (O ~S:-/::A--:S:--P:: -R::/-::1-0::-): =-====-~ (b")'""(C -=>"; IKadI e c, Robert (0 5/ ASP R/1 0)(b)( >; Grigsby, Garrett {HHS/0S/OGA) (b)(6) Zebley, Kyle":"""."~:-:-:-:-:-":""'."'':'-::===~..:.........:::__;:;.,..,=(HHS/OS/OGA)_ _____ C_>bC6;) Lenihan, Keagan {FDA/OC) CbH6)>;NIH-001439Redfield, Robert R. (CDC/OD) (b)(6)Cc: Cochran, Norris (HHS/ASFR) (b)(6)> ; Cabezas, Miriam (HHS/ASFR)(b)(6)>; Hittle, Taylor (HHS/ASFR) (b)(6)> --------- Subject: RE: Close Hold Review - Send comments by 1:40 pmJen:See my sugges ted edits in red.Thanks,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone Cb) (6)FAX: (301) 496-4409E-mail -------- (b)(6)The information in this e-ma il and any of its attachments is confidential and may contain sensitiveinformat ion . It shou ld not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) sha ll notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Moughalian , Jen (HHS/ASFR)Sent : Monday, February 24, 2020 1:18 PMTo: McGowan , Robert (Kyle) (CDC/O0/OCS)(b)(6)(b)(6)>; Shuy, Bryan (OS/ASPR/IO)(b)( >; Kadlec, Robert (OS/ASPR/1O)(HHS/OS/OGA)_~~==== (b=)(:6)~>;_Z=ebley, Kyle (HHS/OS/OGA)(b)(6) Grigsby, Garrett------- (b) ( >; Fauci, Anthony (NIH/NIAID) [E) (b)(6)>; Lenihan, Keagan (FDA/OC)----------- >; Redfield, Robert R. (CDC/OD) (b)(6) Cc: Cochran, Norris {HHS/ASFR) (b)(6); Cabezas, Miriam {HHS/ASFR)(b)(6)>; Hittle, Taylor (HHS/ASFR) (b)(6)> --------- Subject: Close Hold Review - Send comments by 1:40 pmImportance: HighClose hold . Please see below draft 0MB language for a possible emergency supplemental request. Dueto the fast moving nature of this process, please send comments by 1:40 PM. Numbers are still underdiscussion, and we will share more info in the daily update.NIH-001440Jen MoughalianAssistant Secretary for Financial Resources (ASFR)US Department of Health and Human Services-----(b)(6) (Office) -----(b)(6) (Cell)NIH-001441(b) (5)From: Fauci, Anthony (NIH/NIAID) [E)Sent: Mon, 24 Feb 2020 02:00:10 +0000To: Myles, Renate {NIH/OD) [ElSubject: RE: FOR YOUR REVIEW: Draft Rollout, All Staff, and Statement on Preparing forPotential Patients w/ COVID-19----------------------- (b)(5) Thanks.From: Myles , Renate (NIH/OD) [E] (b)(6)Sent: Sunday, February 23, 2020 8:56 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [El (b)(6)>; Collins, Francis (NIH/OD) [E](b)(6)>; Tabak, Lawrence {NIH/OD) [E] (b)(6)>; Gilman, James{NIH/CC/OD) [El (b)(6)1Cc: Burklow, John (NIH/OD) [El (b)(6); Hallett, Adrienne {NIH/OD) [El(b)(6)>; Allen-Gifford, Patrice {NIH/OD) [El (b)( >; Billet,Courtney (NIH/NIAID) [E) (b)( ; Davey, Richard {NIH/NIAID) [El(b)( >; Palmore, Tara (NIH/CC/OD) [El (b)(6)>; Cohen, Justin"{: N'"- IH- /':C"'-C::'-/':0"'-0::'--): -[~:E: ]:-=~ (b)(6) >Subject: RE: FOR YOUR REVIEW: Draft Rollout, All Staff, and Statement on Preparing for Potent ialPatients w/ COVID-19Best,RenateLatest rollout, all staff and statement are attached.From: Fauci, Anthony {NIH/NIAID) [E] <afauci@niaid.nih .gov>Sent: Sunday, February 23, 2020 8:15 PMTo: Myles, Renate (NIH/OD) [E] <mylesr@mail.nih.gov >; Collins, Francis (NIH/OD) [E]<collinsf@od .nih.gov >; Tabak, Lawrence {NIH/OD) [E) <lawrence.tabak@nih .gov>; Gilman, James(NIH/CC/OD) [El <james .gilman@n ih.gov>Cc: Burklow, John (NIH/OD) [E) <burklowj@od .nih .gov>; Hallett , Adrienne (NIH/OD) [E)<adrienne.hallett@nih .gov>; Allen-Gifford, Patr ice (NIH/OD) [El <patr ice.allen -giffor d@nih.gov >; Billet,Courtney (NIH/NIAID) [E) <billetc@nia id.nih .gov>; Davey, Richard {NIH/NIAID) [E]<rdavey@ niaid.n ih.gov>; Palmore, Tara (NIH/CC/OD) (E] <t palmore @cc.nih.gov >; Cohen, Justin{NIH/CC/OD) [El <justin .cohen@nih .gov>Subject: RE: FOR YOUR REVIEW: Draft Rollout, All Staff, and Statement on Preparing for Potent ialPatients w/ COVID-19Renate :The rollout plan looks fine except that I would includeThanks,NIH-001603(b)(6)TonyFrom: Myles, Renate (NIH/OD) [E] (b)(6)>Sent: Sunday, February 23, 2020 7:23 PM ------~~ To: Collins, Francis (NIH/OD) [E] (b)(6); Tabak, Lawrence (NIH/OD) [E]----:-~---:-:==Cb=H6!)>.; -F_.a. u_:c.i_,. A._.n~ t:h_o n~y (NIH/NIAID) [El CbH6)>; Gilman, James (NIH/CC/OD) [El CbH6)>Cc: Burklow, John (NIH/OD) [El (b)(6); Hallett, Adrienne (NIH/OD) [El(b)(6) 1>; Allen-Gi fford, Patrice (NIH/OD) [El (b)(6); Billet,Courtney (NIH/NIAID) [E) (b)(6); Davey, Richard (NIH/NIAID) [El(b)(6); Palmore, Tara (NIH/CC/OD) [E] (b)(6J>; Cohen, Justin{NIH/CC/OD) [E] (b)(6)>Subject : FOR YOUR REVIEW: Draft Rollout, All Staff, and Statement on Preparing for Potential Patientsw/ COVID-19Importance: HighGood evening:Atta ched for your review are draft materia ls to commun icate NI H's preparation for potential receipt ofpatients with COVID-19 to the NIH Clinical Center (timing TBD), including:1. Rollout plan2. All staff emai l3. StatementThese materials were reviewed by Rick Davey, Tara Palmore, and Courtney Billet. I am developing a listof potential Qs and will work with CC and NIAID folks to develop responses, but I wanted to get theseproducts into review in the interest of time.Best,RenateRenate Myles, MBADeputy Director for Public AffairsOffice of Communications and Public LiaisonNational Institutes of HealthTel: (b) (6)NIH-001604From:Sent :To:Subject :Please handle.From:Fauci, Anthony (NIH/NIAID) [ElSun, 23 Feb 2020 23:14:18 +0000Cassetti, Cristina (NIH/NIAID) [ElFW: Important regarding CoronaVir us(b) (6) > ---------------- Sent : Sunday, February 23, 2020 6:10 PM To: Fauci, Anthony {NIH/NIAID) [E] -----------~-~-- (b)(6)>; Fauci, Anthony (NIH/N IAID) [E] (b )( 6)Subject: Important regarding CoronaVirusRespected Dr. AnthonyIt was great to know about you and your institution, for efforts in combating any emerging infectiousdisease.I am writing this email regarding our preliminary observation about the coronav irus genome .I wish to share with you we have found 12 mirro r DNA sequence wit hin the genome of Coronavirus . Wehave named it (MRl to MR12) . we are highly interested in MR2 as this mirror DNA sequence is absentin the human genome. (b)(4)I wish to add here there are few studies which state that mirror DNA has the potentiality to fo rm H-DNAand later has a potent iality to induce mutations. We strongly believe a future study on mirror DNA cananswer " Why some virus mutates faster? " "Can we stop them from mutating? (b)(4)(b) (4)I will be than kful to you, If you can give me your valuabletime to discuss telephonically or through skype our ideas. I can be reached at (b)( .I look forward to hearing from you.with regards and Best wishesDr Vikash Bhardwaj (PhD JNU India)Asst Professor BiotechnologyStarex University Gurugram India.NIH-001605From:Sent :To:Cc:Subject:Fauci, Anthony (NIH/NIAID) [ElSun, 23 Feb 2020 23:11:59 +0000Lerner, Andrea (NIH/NIAID) [ElConrad, Patricia (NIH/NIAID) [ElRE: COVID-19 clinical care teaml am totally aware of all of this and have been directly involved in sening it up. You have my OK to partic ipa te tothe extent that you desire.-----Original Mcssage-----From: Lerner, Andrea (NTH/NJAJD)[ E] _______ (_b)_(_6)>Sent: Sunday, February 23, 2020 5:39 PMTo: Fauci , Anthony (NIH/NIAlD) [E) _____ _, ("b")"'"(=' >Subject: COVID-19 clinical care teamDear Dr. Fauci ,l got a call a few minute s ago from Veronique Nussenblatt , Chie f of the Clinica l Center ID Consult Service,regarding me being a part of the clinical care team of COVID-19 patients if they come to the NIH.She did not have any definitive infonnation but said there was a chance patients could be coming from Californiathis week - this is the first J had heard of that, and l'm guessing you may know more about it than 1 do.The work would include either day or night shifts, likely a couple a week. People on the clinical care team are notinstrncted to separate themselves from others and will be per tested for the virus daily when working clinically.l wanted to ask for your OK to do this clinical work- of course I will maintain my responsibilities in the officewhile doing so. Please let me know and happy to discuss further if you'd like.Sincere ly,AndreaSent from my iPhoneNIH-001606From:Sent:To:Chase (NIH/NIAID) [ElFauci, Anthony (NIH/NIAIO) [E)Sun, 23 Feb 2020 21:35:02 +0000Haskins, Melinda (NIH/NIAID) [E];Selgrade, Sara (NIH/NIAID) [E];Crawford,Cc: Marston, Hilary (NIH/NIAID) [E];Eisinger, Robert (NIH/NIAID) [E];Lerner, Andrea(NIH/NIAID) [El;Conrad, Patricia (NIH/NIAID) [ElSubject: Flip CardsI have gone over the Flip cards. I note that we have only 2 cards forCoronavirus. I want to have a separate flip fo lder for coronavirus with a ful l setof cards for the specific coronavirus hearings that are coming up. You should sitdown with me and also work with Hilary to prepare this set of cards. They shouldcontain all the current epi as well as the dollar numbers for the proposedsupplemental budget that we are putting together- I will get asked about thatand I have clearance from the department to talk about it. Also, I want a set ofcards for what we are doing in the area of research, i.e. basic research (eg animalmodels, etc.), diagnostics, therapeutics (remdesivir trials in China, Japan, andNebraska), and the whole menu of vaccines. In other words, I want an entire setof cards for coronavirus. That is what I am going to get asked in both thecoronavirus hearings as well as in the NIH Appropriations hearing s.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone : (b)(6)FAX : (301 496-4409E-mail Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notac cept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .NIH-001607From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Sun, 23 Feb 2020 21:22:40 +0000Jon LaPookSubject : RE: Coronavirus reality checkHow about a pastrami sandwich on rye and a potato knish?Anthony S. Fauci, MDDirectorNational Institu te of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Driv e, MSC 2520National Institu tes of HealthBethe sda , MD 20892 -2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The informa tion in this e-ma il and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipie nt. lf you have received this e-mail in eITorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infe ctio us Diseases (NIAID) shall not accept liability for any statements made that are the send er's ownand not express ly made on behalf of the NlAID by one of its representatives.-----Original Message-----From : Jon LaPook ,,;:;-----~ (b~)~(6=)Sent: Sunday , February 23, 2020 4:16 P-M- ----~~ To: Fauci , Anthon y (NlH/NlAID) [E] (b)( ·Subject: Re: Coronav irus reality checkThanks , Tony.1 would love you to cons ider my request to "tag along" with you some day - not to join you for meeti ngs (I wouldwait outside unless invited in) or listen in on conference calls but to chat with you in between to give people aninside look at how serio usly the gove rnment is taking the outbreak. And T could bring down a shmear from Barn eyGreengrass for lunch. How could you pass that up???JonJonathan LaPook, M.D.Chief Medical Correspondent, CBS NewsProfessor of Medicin eNYU Langone HealthTwitter @DrLaPookOn Feb 23, 2020, at 4:05 PM, Fauci, Anthony (NIH/NIAID) [E] .__ _____ Cb _H __ > wrote:Jon:The current appearance of community transmissions in Japan , South Korea , Italy and Iran is troublesome . As Ihave repeatedly said over the past couple of weeks , if and when (looks more like when now) a numbe r of othercountries besides China have sustained human to human transmissions , then we will be on the briJJk of a pandemic,NIH-001608if not already there. The reason to say this is that when several countries have widespread transmissions, then spilloverto other countries is inevitable since one cannot shut out the rest of the world and so you can expect increasingworld-wide transmissions among progressively more countries. In esse nce, you will be expe1iencing a pandemic.We are not quite there yet, but we are getting disturb ingly close. It will soon be a matter of se mantics regardingwho would be willing to call it since it is not a mathematically precbe definition. I am not so sure that WHO willhave the will to declare this a "pandemic" before a number ofrespected epidemiologists around the world startrcfciTing publicly to it as a pandemic regardle ss of what WHO docs or does not declare. WHO will likely be behindthe curve here and will wait until it is patently obviou s what we are dealing with.Hope that this is helpful.Best,TonyAnthony S. Fauci, MDDirectorNational lnstitute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive , MSC 2520National lostitutes of HealthBethe sda, MD 20892-2520Phone: ------ (b)(6)FAX: (301) 496-4409E-mail: -------- (b)(6)The information in this e-ma il and any of its attachments is confidential and may contain sensitive i11fom1ation. Itshould not be used by anyone who is not the original intended recip ient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NlAID by one of its representatives.-----Original Message-----From:J on LaPook ,.:::;...----. (~b)~(6=)Sent: Sunday , February 23, 2020 3:47 P-M- ------,;;..=,. ...,. To: Fauci, Anthony (NIH/NIAJD) [E] (b)(Subject: Coronavims reality checkHi Tony,Why do I not think that this is a relaxing S1mday for you?NIH-001609NIH-001610This definitely feels like an inflection point in the coronavirus outbreak - both in the unsurprising way it's spreadingand the equally unsurprising misinfom1ation and public alann/panic we are seeing. Unsurprising but here we are.Can you give me a quick brain dump on where you think we are and how r can best inform the pub lic?Thanks,JonP.S. please let me know whenever I can report that the outbreak is officially being called a pandemic.Jonathan LaPook , M.D.Chief Medical Correspondent , CBS NewsProfessor of MedicineNYU Langone HealthTwitter @DrLaPookFrom:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Sun, 23 Feb 2020 20:01:51 +0000Richard Allen JohnsonSubject: RE: 2020.02.23 SundayDick:Transmission is definitely by respiratory droplet. Still unclear about aerosoltransmission although there are anecdotal reports that this occurs similar to whatwe saw in individual episodes with SARS back in 2002-2003. Almost certainlycontact transmission occurs with hand to mucosa (mouth, eyes, nasal mucosa).Unclear about fomites, doorknobs, etc. Virus can live for a couple of hours oncertain inanimate objects. Virus definite ly isolated from stool and urine, but notsure of role in transmission. No information about Transmission to fetus.Children have very low rate of infection . No good serologic test at this pointalthough they are rapidly being developed .Best,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520Nation al Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the or iginal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Richard Allen Johnson --------- CbH > Sent: Sunday, February 23, 2020 2:32 PMTo: Fauci, Anthony (NIH/NIAID) [E]-------.. (b.). .(= 6>l>R; ichard Allen Johnson(b)( >Subject: Re: 2020.02.23 SundayThanks, Tony. Please continue communication with me by email. But rest your voice for a short whlle.I am having tro uble understanding the exact mode of transmission of COVID-19.NIH-001611-Sneeze or cough produces respiratory droplet or aerosolized respiratory secretion which make contractwith upper or lower respiratory mucosa, which results in infection of human cells. Seems most likely.- What about contact transmission, contaminated hand to conjunctivae, nasal mucosa, or mouth- Fecal/oral- transmission to fetus-What are the diagnostic tests to confirm diagnosis of novel coronavirus? PCR of secretions? Who in theworld has these test kit; who manufactures kit.-Are follow up serologies begin done?Interest ing questions to us and to Shelly Wolf if he were with us.Thanks, Tony. My voice is also a little raspy.Best,DickOn Sun, Feb 23, 2020 at 10:46 AM Fauci, Anthony (NIH/NIAID) [ElDick:-------- (b)(6) wrote:My voice is hoarse since I have been giving so many Congressional and White Housebriefings and TV and radio interviews. I just need to shut up for a while .Best,TonyFrom: Richard Allen Johnson (b)( ----------- Sent: Sunday, February 23, 2020 5:25 AM To: Fauci, Anthony (NIH/NIAID) [E] -_-__-_- --~~ Cb_)C_6)>Subject: 2020 .02.23 SundayHi, TonyI continue to follow the Cobid-19 epidemic .What is the problem with your voice. It crackles like mine. I attribute mine to 'postnasal drip.'WHO and Dr. Tedros are looking much better on TV. He has the WHO logo in the background . His tieshow be tighter . His slouch is better . He still puts his elbows on the table in front of him.Looking forward to lunch with you.Best,DickNIH-0016 12From: Fauci, Anthony (NIH/NIAIO) [E)Sent: Sun, 23 Feb 2020 15:56:48 +0000To: Margolis, Leonid (NIH/NICHD) [E]Cc: Cassetti , Cristina (NIH/NIAID) [E];Erbelding, Emily (NIH/NIA ID) [E];Conrad,Patricia (NIH/NIAID) [E]Subject: RE: Coronavirus tissue test system: a suggestionThanks , Leonid. I will pass this on to appropriate associates.Best regards,TonyFrom: Margolis, Leon id (NIH/N ICHD) [E] -------- (b)(6)>Sent: Sunday, February 23, 2020 5:50 AM To: Fauci, Anthony (NIH/NIAID) [E] -----------~-~-- (b)(6) Subject: Coronavirus tissue test system: a suggestionImportance: HighDear Tony,As you may know, for many years we study HIV pathogenesis in human tissues ex vivo.(Among my many papers, there is one, may be not the best, but that I am most proud of. This iswhere my co-author is Dr. Fauci ©)Regards,LeonidLeonid Margolis, Ph.D.Head,Section of lntercellular InteractionsEunice Kennedy -Shriver National Institute of Child Health and Human DevelopmentBuilding 29B, Room 1H16D29 Lincoln DriveBethesda, MD 20892Phone: (b)(6)Fax: 301-480-0857e-mail: (b)(6) ---------NIH-001613(b)(5)From:Sent :To:Subject:John:Fauci, Anthony (NIH/NIAID) [E)Sun, 23 Feb 2020 15:53:48 +0000john wonRE: KAMAThank you very much for your kind note . I hope that all is well with you.Best regards,TonyFrom: john won (b) (6) >Sent: Sunday, February 23, 2020 9:06 AM ------ ..-.-,= To: Fauci, Anthony (NIH/NIAID) [E]- ------- (b)(6)> Subject: Re: KAMADear Dr. Fauci,I hope you are doing well . Your participation during our Washington DC 20 17 convent ion was one of themost memorable events of our organization's history.United States and the world now turns to you for your help as Coronavirus crisis is becoming pandemic.All of us here at KAMA are thinking about you and all those affected . Thank you very much for all yourcontributions.Warm regards,John WonOn Oct 24, 2017, at 10:42 AM, Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6)wrote:John:Thank you for your kind note. It was a pleasure to be with you.Best regards,TonyFrom: john won (b)(6)Sent: Tuesday, October 24, 20 17 10:12 AMTo: Fauci, Anthony (NIH/NIAID) [E) _____ __.(.,b_).(.=6)>Subje ct: KAMANIH-0016 14NIH-001615Dear Dr. Fauci,Thank you very much for speaking to us at the 43rd Annual KAMA Convention . It was atremendous privilege for all of us. You were also so kind to stay afterwards to take pictureswith all those who asked.To be honest, having you there was very surreal. You symbolize the best of Americanmedicine. I grew up idolizing your accomplishments as college and medical student. Yousaved and touched the lives of so many around the world . It is still hard to believe that Ihad this special opportunity to welcome you.We will continue to do our best to serve the public and mentor medical studen t s. I hopeyou can speak to us again in the near future . Thank you very much. I hope you continue inyour position for another 40 years.Warmest regards,John H. WonFrom:Sent:To:Subject:Julia:Fauci, Anthony (NIH/NIAID) [E)Sun, 23 Feb 2020 15:52:06 +0000Julia BelluzRE: Comment?The appearance of community transmissions in Japan, South Korea, Italy and Iran istroublesome. As I have repeatedly said over the past coup le of weeks, if and when (looks morelike when now) a number of other countries besides China have sustained human to humantransm issions, then we are on the brink of a pandemic, if not already there. The reason to sayth is is that when several countries have widespread transmission, then spill-over to othercountries is inev itable since one cannot shut out the rest of the world and so you can expectincreasing world-wide t ran smissions . Hence, you will be experiencing a pandemic. We are notquite there yet, but we are getting disturbingly close.I hope that this is helpful.Best,TonyFrom: Julia Belluz <julia.belluz@vox.com>Sent : Sunday, February 23, 2020 4:13 AM ------ -=~ To: Fauci, Anthony {NIH/NIAID) [E] (b)(6J>Cc: julia.belluz@voxmedia.com; Conrad, Patricia {NIH/NIAID) [E]- -------- (b)(6J>; Barasch, Kimber I y {NIH/NIAID) [CJ (b)(6)Subject : Comment?Dear Dr. Fauci,Just over a week ago we talked for th is story about how the outbreak is likely larger than we know now:https://www .goog le .com/amp/s/www .vox.com/p latform/amp/2020/2/ 14/2113 4473/coronavirus outbreak-singapore-us-symptoms-pandemicGiven the developments in Singapore, Iran, Italy, and on the Diamond Princess cruise ship, I'm justwondering how your opinion about the possibility of containment and how fast we are approaching apandemic has changed. Do these developments suggest we've entered a new phase in the outbreak?If you have a few minutes to chat or email today, let me know. We'll be aiming to run a story on thistoday.Thank you for considering.JuliaNIH-001616On Feb 15, 2020, at 12:10 AM, Julia Belluz <julia.belluz@vox.com> wrote:Thank you so much for making the t ime to comment at what I know is a crushingly busytime . As usual don't hesitate to ping if you have any further comments or questions ! Juliahttps :ljwww .vox.com/2020/2/14/21134473/coronav irus-outbreak -singapore-ussymptoms-pandemicSent from my iPhoneOn Feb 14, 2020, at 1:21 PM, Fauci, Anthon y (NIH/NIAID) [E]---------(b)(6) wrote:Julia:I just called you now {7:20 AM Washington , DC time) andgot mvoice mail in German that I could not understand. Youcan call me at CbHThanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidentialand may contain sensitive information . It should not be used by anyonewho is not the original intended recipient. If you have received this emailin error please inform the sender and delete it from your mailbox orany other storage devices . The National Institute of Allergy andInfectious Diseases (NIAID) shall not accept liability for any statementsmade that are the sender 's own and not expressly made on behalf of theNIAID by one of its representativ es.NIH-001617From:Sent:To:Subject:Ted:Fauci, Anthony (NIH/NIAID) [E)Sun, 23 Feb 2020 14:26:22 +0000Theodore LiRE: Covid-19 questionThanks for the note. Since she is 22 days out of Singapore she would be well beyond the 14day quarantine used for people who are coming out of risk zones. And so although her risk isnever zero, it is really very low . If she were coming from Japan or South Korea, which areexperiencing an emerging outbreak, I might feel a litt le different, but Singapore has goodinfection control despite the number of cases in that country Given her history of recentShingrix vaccination, I would wait another day to see if her fever breaks. I agree that I wouldkeep her at home for now. I do not think it would come to that, but if you want to get testingdone, it still would have to go to the CDC via the Virginia department of health . Bottom line isthat I wou ld sit tight fo r now and see how she does over the next day or so. If things change,do not hesitate to call or e-mail me.Best,TonyFrom: Theodore Li (b)(6)>Sent: Sunday, February 23, 2020 9:11 AMTo: Fauci,A nthony (NIH/NIAID)[ E)------ -(-b"=)"(-="6")Subjec t: Covid-19 questionHi Tony,The wife of one of my patients received the Shingrix vaccine on Thursday 2/20 and developedfever to 101.4 the following day with malaise, headache, mild nausea (no respiratorysymptoms). She's taken ibuprofen with transient temperature reduction; the fever andsymptoms are the same today.BUT ... she and her daughter were in Singapore (b)(6) where they stayed at the ;....~========---=-=-:-= ------ (b)(6), visited (b)(6) and the (b)(6). They then flew to Colombo, Sri Lanka before returning via Europe last (b)(6) to (b)(6). So herfever began 3 weeks plus 1 day after being in Singapore.I've to ld her to keep treating the fever and symptoms but to stay at home for now. The feverafter Shingrix usually resolves after 2-3 days so I'd expect it to abate today or tomorrow. Myquestion is whether there's enough of a concern, viz. the time in Singapore, for her to be testedfor covid-19 . If so, what's the best way to conduct the testing? Or is it okay to see if her feverbreaks by tomorrow?(You must be getting lots of these questions).Best,TedNIH-0016 18From:Sent:To:Cc:[ElSubject:Larry:Fauci, Anthony (NIH/NIAIO) [E)Sun, 23 Feb 2020 04:27:10 +0000Tabak, Lawrence (NIH/OD) [E-l- -----=-:-=, Colli ns, Francis {NIH/OD) [El ------- (b)(6) ;Conrad, Patricia (NIH/NIAID)Heads UpI need to speak with you tomorrow (Sunday) about a request that we (NIH) will get fromASPR (Kadlec) regarding the housing of asymptomatic coronavirus positive individuals. I amcopy ing Francis since the discussion will ultimately get to him.Best,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .NIH-001619From:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Sat, 22 Feb 2020 21:06:45 +0000Cassetti, Cristina (NIH/NIAID) [E]FW: CoronavirusPlease han dle. Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail (b) (6lThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: OB Roberts Cb)~ >Sent : Saturday, February 22, 2020 4:03 PM To: Fauci, Anthony (NIH/NIAID) [E)-- -----------~-~ Cb)( > Subject : CoronavirusTo: Dr. FauciFM: Oliver B Roberts(b)(6)Dr. Fauci; I attended a small water seminar, put on by local (Seventh Day Adventist) medical professionals,in the mid 1970's at Elms Haven, California .This seminar taught the participants how to eliminate the flu with the use of water treatments, ie(steam baths, etc).I have now for these past 40 some-odd years, been taking two treatment 's; one in the evening andanother in the middle of the night, whenever I have contacted the flu: AND have had the facilities to doso; and each time I was well the next morning. No temperature, no symptoms whatsoever.With the high rate that this Coronavirus is spreading, one can see what a great tool these treatmentscan be for medical professionals. To have those who are sick with the flu, complete ly free of allsymptoms after two treatments would greatly ease the burden on Dr's and other medical professiona lsAND each facility.NIH-001627NIH-001628Dr. I am asking for a few minutes of your time to explain this. I would like to share this with you andothers. I just want to help by sharing what I learned and have been doing all these years. I feel so guilty,knowing this and not having a way to get this information to those needing it, when there so many outthere sick and dying.Note: I have been trying to reach out, hoping someone wi ll hear me. Alas I do not have the education,pedigree nor the contacts: But you Dr. have all three! I ask not that you believe in me, but that youbelieve in these treatments.Thank You for your time, please feel free to contact me via email or by phone or text or even havesomeone up here talk with me.Sincerely;OB Roberts{Ben)From:Sent :To:Cc:Fauci, Anthony (NIH/NIAIO) [E)Sat, 22 Feb 2020 21:04:58 +0000Conrad, Patricia (NIH/NIAID) [E)Barasch, Kimberly (NIH/NIAID) [C)Subject: FW: Congratulations and time to speak: Researchers Are Racing to Make aCoronavirus Vaccine. Will It Help? - The New York TimesPlease set up a call with HannahAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301) 496-4409E-mail : (b)(6lThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Valant ine, Hannah (NIH/OD) [El -----------(b)(6) Se nt: Tuesday, February 18, 2020 1-0-:0-5 -A-M- --, .....,....,= To: Fauci, Anthony (NIH/NIAID) [E) --------- (b)(6) Subject: Congratulations and time to speak: Researchers Are Racing to Make a Coronavirus Vaccine. WillIt Help?- The New York TimesImport ance: HighHi Tony,I have been following this terrific work by NIAID scientists in the VRC- congratulations!htt ps://www .nyt imes.com/2 020/ 01/28/he alth/c oronavirus-vaccine.htm lAs you can imagine I am delighted see Dr. Kizzmekia Corbett playing a leading role in these activities .Most importantly she is delighted with the mentorship, sponsorship and opportunity she has received atNIH, particularly from Barney Graham. (b)(6), (b)(S)Please let me know when you might be availab le to speak with me.Best,HannahNIH-001629From:Sent:To:Fauci, Anthony (NIH/NIAIO) [ElSat, 22 Feb 2020 20:53:35 +0000NIAIDODAMSubject: FW: CUGH Annual MeetingLet bus discuss.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Thomas Quinn (b)(6)Sent: Thursday, February 20, 2020 3:56 PM -------=-=--== To: Fauci, Anthony (NIH/NIAID) [El (b)((;)>Cc: Folkers, Greg (NIH/NIAID) [E] (b)(6); Conrad , Patricia (NIH/NIAID) [E]-----:-~::===(b)=(6J>=;~ =B=a-ra -sch, Kimberly (NIH/NIAID) [CJ (b)(6)>; Judith Wasserhei t Cb)< >Subject: CUGH Annual MeetingHi Tony,I know how busy you are but I wanted to give you a brief update on the AnnualConference of the Consortium of Universities for Global Health (CUGH) based inWashington, DC. Here is the link to the overall CUGH meeting which provides anoverview of the whole conference https ://www .cugh2020 .org/program . As wediscussed months ago you agreed to be in the opening day plenary session onApril 18th , entitled "Emerging Infectious Diseases and their Impact on GlobalHealth Security". The details and other speakers are listed below. I may try toorganize a call of all speakers in a month to coordinate talks/topics as the sessionis 90 minutes with 5 speakers, and a lot of ground to cover, especially with theCOVID19 outbreak.NIH-001630NIH-001631Judy Wasserheit, copied here, would also like to invite you to a special session sheis organizing on the coronavirus epidemic at the same CUGH conference in a latebreakersession on Sunday, April 19 (the second day of the conference) from8:4Sam-10:1Sam at the Washington Hilton Hotel (Monroe Room). This talk wouldbe slightly different from the plenary session and you could expand on COVID19research prior ities and update on progress. We realize your schedule is verybusy but your insights and knowledge on both of these topic s is unparalleled. Ifyou cannot speak at the second session we would appreciate yourrecommendation as to an alternative who could address this latter topic.Thanks and all the best,TomPlenary Session Details:Session Day: Saturday, April 18, 2020Session Time : 11:30am-1:00pmLocation: Washington Hilton Hotel, International BallroomPanel Title: "Emerging Infectious Diseases and their Impact on Global HealthSecurity"Short Panel Description: This Plenary Panel will highlight the continual threats ofemerging and re-emerging infectiou s diseases, and their impact on global securityfor surveillance, detection, treatment and prevention of these diseases. Overrecent decades, multiple epidemic events have underscored how highlyvulnerable we are to viral threat s. Our world is globally connected-and an"emerging threat" in one part of the world can pose a threat everywhere and toeveryone. About 75 percent of new human diseases are caused by microbes thatoriginate in animals. These include HIV, influenza (including pandemic HlNl,HSNl , and H7N9), Severe Acute Respiratory Syndrome (SARS), Middle EastRespiratory Syndrome-Coronavirus (MERS-CoV), Ebola, Marburg, and Nipah. Therecent emergence of COVID from China clearly illustrates the magnitude , rapidityNIH-001632and impact that a new infectious agent can have on global health security. Thispanel of leading experts will discuss the emergence of these microbial threats,and our ability to detect, respond and prevent future epidemics of thesepathogens .Moderator(s) Info: Tom Quinn, Chief, NIAID, International HIV /STD Section andMan Charurat, Director, Division of Epidemiology and Prevention, Institute ofHuman Virology (IHV)Speaker(s) Info:1. Anthony Fauci, Director, NIAID2. Chikwe lhekweazu, Director General, Nigeria CDC3. Peter Hotez, Dean, National School of Tropical Medicine, Baylor College ofMedicine4. Jonna Mazet, Executive Director, One Health Institute, and Pl, PREDICT project,UC Davis5. Jennifer Nuzzo, Senior Scholar, Center for Health Security, Johns HopkinsUniversityFrom:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Sat, 22 Feb 2020 20:51:00 +0000Stover, Kathy (NIH/N IAID) [ElCc: Billet, Courtney (NIH/NIAID) [El;Conrad, Patricia (NIH/NIAID) [El;Folkers, Greg(NIH/NIAID) [ElSubject: RE: FOR ASF REVIEW: Draft PR re: launch of remdesivir COVID-19 trialAttachments :edits.docxNIAID press release COVID-19 treatment trial FOG - with fauci trackedSee my minor tracked edits. Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Stover, Kathy (NIH/NIAID) [El (b)(6)Sent: Friday, February 21, 2020 3:55 PM ------~= To: Fauci, Anthony (NIH/NIAID) [E) (b)(6)>Cc: Billet, Courtney (NIH/NIAID) [E] (b)(6); Conrad, Patricia (NIH/NIA ID) [El_______ (b) C_ >; Folkers, Greg (NIH/NIAID) [El (b)(6)>Subject: FOR ASF REVIEW: Draft PR re: launch of remdesivir COVID-19 trialHi Dr. Fauci,Please find attached for your review a draft press release to announce the launch of theremdesivir COVID-19 treatment trial, which enrolled its first patient today. It's been reviewedby the following individuals/groups:• FOG• OCGR (Kathy Stover, Courtney Billet)• DMID: Emily Erbelding, John Beige!• OCR: Cliff Lane, Libby Higgs• U Nebraska {Christop her Kratochvil, Andre Kalil, comms dept)• Awaiting comments from Gilead and WHO.NIH-001633For ease of reference, the following is the quote we have drafted for your use:Thanks much,KathyKathy StoverBranch ChiefNews and Science Writing BranchOffice of Communications and Government RelationsNational Institute of Allergy and Infectious DiseasesNational Institutes of Health31 Center Drive, Room 7A17FBethesda, MD 20892(b)(6)Media line: (301) 402-1663NIH-001634(b) (5)From:Sent:To:Cc:Fauci, Anthony (NIH/NIAIO) [E)Sat, 22 Feb 2020 20:38:12 +0000Conrad, Patricia (NIH/NIAID) [ElRouth, Jennifer {NIH/NIAID) [ElSubject : RE: interview request: draft responses for Greek newspaperGood job! See my minor edits in red. Thanks.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Conrad, Patricia (NIH/NIAID) [E] ---------- (b)( Sent: Friday, February 21, 2020 4:57 PM -------~~ To: Fauci, Anthony (NIH/NIAID) [El (b)(6) --------- Subject: FW: interview request: draft responses for Greek newspaperDo you want to edit these .. greek paper/pring?Patric ia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNation al Institute of Allergy and Infectious DiseasesThe National Inst itutes of Health31 Center Drive, MSC 2520- Room 7A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaimer:The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be usedby anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itNIH-001635from your mailbox or any other storage devices . National Institute of Allergy and Infectious Diseases (NIAID) shall not acceptliability for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.From: Routh, Jennifer (NIH/NIAID) [E) CbH6J>Sent : Friday, February 21, 2020 4:52 PM ------~~ To: Conrad, Patricia (NIH/NIA ID) [E) (b)(6)>; NIAID FOG <fog@niaid.nih.gov >Cc: NIAID COGCORE <COGCORE@mail.nih.gov>; NIAID Media Inquir ies <mediainqu iries@niai d.nih .gov>Subject : int erview request : d raft responses for Greek newspaperReporter: Theodora TsoliOrganization : Greek newspaper To VIMA (www.tovima .gr)Phone #(s): CbH6), thtsoli@tovima .grSubject: COVID-19Deadline: Monday 2/24The reporter emailed questions for ASF. I have drafted proposed responses for hisreview , also attached.1. Do you believe that SARS-COV2 is capable of causing a pandemic? Areyou expecting many secondary transmissions of the virus outside China?A pandemic is generally defined as sustained transmission of a new pathogen inmultiple regions of the world. COVID-19 does not yet meet that definition , and Ihope that China and other countries in Asia with some transmission are able tocontain the outbreak. However , it is possible that COVID-19 could become apandemic. It would not be surprising to see additional secondary transmissions ofthe virus outside of China.2. Chinese authorities are reporting a decline of new cases. Could we say thatthe virus has peaked and maybe it will slow down? When are you expectingto have a clearer picture about the evolution of this epidemic?Although the number of daily cases in China appears to have gone down , it istoo early to tell if this is really a decline in the outbreak.3. Could the virus become endemic and give seasonal outbreaks?If China is not able to contain the outbreak, it is possible COVID-19 couldbecome endemic and lead to seasonal outbreaks. However, it is too early toknow the likelihood of this scenario.4. What about its transmissibility? Some experts say that WHO isunderestimating it's transmissibility. Could the reality be different maybebecause, among other things, many cases stay undetected?Because of the many unknowns about SARS-CoV-2 , it is difficult to make anyfirm conclusions regarding overall transmissibili ty and severity. However , itappears to be much more transmissible than SARS. Also , there are likelyasymptomatic COVID-19 infections that are not getting counted because peopledo not go to the doctor for testing or treatment if they are not sick.NIH-001636NIH-001637s. Do you believe that the measures taken by China and countries around theworld are adequate to stop SARS-COV2 spread? There is a lot ofdiscussion about thermal cameras and travel restrictions for example.China has taken extreme measures to control the outbreak. Restricting themovement of 50 million people is unprecedented. However, it might ultimatelyhave an effect on slowing transmission. Precautions implemented in the U.S. arenot intended to detect every person with COVID-19 entering the country.However, our approach has allowed us time to better plan and prepare our healthsystem .6. What is the key to stop the worldwide spread of the virus?Though we have mobilized a rapid research response to quickly developeffective countermea sures, right now, the outbreak response remains focused onthe proven public health practices of identifying cases , isolating patients andtracing contacts.7. In the northern hemisphere we have a flu outbreak - in Greece as well.Some experts say that this is the real danger and not the coronavirus. Whatis your view?I am always concerned about influenza . Every flu season , millions of people areat risk of getting very sick or dying. Currently people in the U.S. and mostcountries in the northern hemisphere are at a much higher risk of being exposedto influenza than SARS-CoV-2. However , the COVID-19 outbreak is an evolvingsituation and we are treating it as a very serious public health threat.8. Many efforts are being in process for the development of a vaccine for thenew coronavirus . Are you coordinating any of them and which ones? Arethere any efforts more promising than others? Which platforms of vaccinedevelopment are more promising? When do you believe that we could havea vaccine available for clinical trials and then for human use?NIAID is exp loring multiple candidates and is on track to test an experimentalmessenger RNA (mRNA) vaccine in a Phase 1 clinical trial this spring. This firstphase of clinical testing will involve giving the vaccine to healthy adults in theUnited States to see if it is safe and if it can induce an immune response inrecipients. It is important to realize that the development of investigationalvaccines and the clinical testing to establish their safety and effectiveness takestime. A vaccine against the novel coronavirus will likely not be widely availablefor more than a year.9. What about therapies? Dozens are being tried - from plasma to herbalmedicines in China. Which are the most promising?NIAID is pursuing the development of antivirals and monoclonal antibodies forpotential use against COVID-19. NIAID is preparing protocols for in vitro and invivo studies of the antivi ral remdesivir, which has shown promise against othercoronaviruses in animal models . NIAID also plans to evaluate Kaletra(lopinavir/ritonavir) and interferon-beta for their activity against SARS-CoV-2 . Inaddition, NIAID scientists are working to identify monoclonal antibodies withtherapeutic potential from stored SARS patient samples as well as COVID-19patient samples .10. Are the things we know about this new virus more than the ones we don'tknow? Which are the main questions about it that remain to be answered?New data are published about SARS-CoV-2 every day. However, we still have alot to learn. For example, we do not know why there are so few cases amongchildren, which is uncommon for a respiratory virus.11. How worried should people outside China be about SARS-COV2? What isthe biggest danger from this virus?. The risk to the general American public remains low at this time ; however, thiscould change and that is why we are treating the emergence of a novelcoronavirus as a very serious public health threat. We understand thatpeople may be worried . We ask that people not let fear or panic guide theiractions.12. Which are the protective measures anyone should take against the newvirus? Do masks work?The vast majority of people outside of China do not need to wear a mask. Amask is more appropriate for someone who is infected than for people trying toprotect against infection.Jennifer Routh [E]News and Science Writing BranchOffice of Communicatio ns and Government RelationsNational Institute of Allergy and Infectious Diseases (NIAID)NIH/HHS31 Center Drive Room 7A17CBethesda , MD 20892Direct: CbC)Disclaimer : The information in this e-mail and any of its attachments is confidential and may contain sensitive informati on. It should not beused by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage dev ices. The National Institu te of Allergy and Infectious Diseases shall not accept liab ility for anysta tements made that are sender's own and not express ly made on behalf of the NIAID by one of its representat ives.NIH-001638From :Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Sat, 22 Feb 2020 19:41:48 +0000Cassetti, Cristina (NIH/NIAID) [ElSubj ect : RE: HHS Engages Sanofi's Recombinant Technology for 2019 Novel CoronavirusVaccineThanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBui lding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Cassett i, Cristina (NIH/NIAID) [El (b)(6)> --------- Sent : Saturday, February 22, 2020 2:26 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [El (b)(6)> Cc: Erbelding, Emily (NIH/NIAID) [E~l --=-=--=--=--=-== ~Cb=H > Subject : Fwd: HHS Engages Sanofi's Recombinant Technology for 2019 Novel Coronavirus VaccineThis is the press release from ASPR, in case you need more information on the Sanofi CoV effortsCristinaBegin forwa rded message:From: "Folke rs, Greg (NIH/NIAID) [E]" ---------(b)(6)0 at e: February 18, 2020 at 3:07 :21 PM ESTSubject : HHS Engages Sanofi' s Recombinant Techn ology for 2019 Novel Coronav irusVaccineFORI MMEDIATER ELEASEFebruary 18, 2020Conta ct: ASPR Press Offic e202 -205 -8117asprmedia@hhs.govNIH-001639NIH-001640HHS Engages Sanofi's RecombinantTechnology for 2019 Novel CoronavirusVaccineRacing to develop a vaccine against the 2019 novel coronavirus, the U.S. Department ofHealth and Human Services' Office of the Assistant Secretary for Preparedness andResponse has engaged Sanofi Pasteur, the vaccines global business unit of Sanofi.The Biomedical Advanced Research and Development Author ity (BARDA), a component ofASPR, will provide expertise and reallocated funds to support the vaccine's development .Sanofi will use its egg-free, recombinant DNA platform to produce a recombinant 2019novel coronavirus vaccine candidate.The technology produces an exact genetic match to proteins of the virus . The protein'sDNA will be combined with DNA from a virus harmless to humans, and used to rapidlyproduce large quantities of antigen which stimulate the immune system to protect againstthe virus . The antigens will be separated and collected from these cells and purified tocreate working stocks of vaccine for advanced development."Flexibility and scalability are cornerstones of rapid response to an emerging infectiousdisease," said BARDA Director Rick A. Bright, Ph.D. "Using this proven technology, we canpivot immediately to address this new global health threat. Our goal is a licensed vaccineto provide long-term health security against this latest virus and prevent futurecoronavirus outbreaks ."BARDA has worked with Sanofi since 2004 and in 2009 began collaborating with ProteinSciences of Meridian , Connecticut, now owned by Sanofi, to develop a recombinanttechnology with the flexib il ity to make millions of doses of vaccine quickly in an influenzapandemic. In 2016, BARDA added this vaccine to the U.S. National Pre-pandemic InfluenzaVaccine Stockpile. When Sanofi purchased the company and its technology in 2017, BARDAcontinued working with Sanofi on pandemic vaccine development , and in December 2019the partners began focusing on increasing manufactu ring capacity for recombinantinfluenza vaccine in the United States, in accordance with a president ial execut ive order toenhance national security and the public health by modernizing influenza vaccines andtechnologies .This expanded collaboration with Sanofi is BARDA's second program to focus ondeveloping a novel coronavirus vaccine candidate in the past few weeks. There is currentlyno approved vaccine, treatment, or diagnostic for novel coronavirus infections; however,the U.S. Food and Drug Administration has issued an emergency use authorization (EUA) toenable emergency use of a diagnostic test developed by the Centers for Disease Controland Prevention.BARDA also is working with counterparts across the government, including within HHS andwith the Department of Defense. The team is reviewing potential vaccines, treatments anddiagnostics from across the public and private sectors, particularly products indevelopment for Middle East Respiratory Syndrome (MERS) or Severe Acute RespiratorySyndrome (SARS), to identify promising candidates for development and licensure todetect, protect against or treat novel coronavirus infections.To obtain information about any potential products in development in the private sectorthat could be used in responding to the novel coronavirus outbreak, the U.S. governmentNIH-001641launched a single point-of -entry website for innovators and product developers to submitbrief descriptions of their diagnostics, therapeutics, vaccines, and other products ortechnologies relevant to this new virus.Federal agencies are particularly interested in identifying products and technologies thathave progressed into or beyond non-clinical studies, have established large-scalecommercial Good Manufacturing Practices (cGMP) manufacturing capability, and/or haveutilized a platform already approved by the U.S. Food and Drug Administration (FDA).BARDA also opened an easy broad agency announcement, an EZ-BAA, specific todiagnostics that utilize platforms already cleared by the FDA, with a viable plan to meetrequirements for the FDA to consider Emergency Use Authorization (EUA) within 12 weeksof an award.About HHS, ASPR, and BARDAHHS works to enhance and protect the health and well-being of all Americans, providingfor effective health and human services and fostering advances in medicine. public health,and social services. The mission of ASPR is to save lives and protect Americans from 21stcentury health security threats . Within ASPR, BARDA invests in innovation , advancedresearch and development , acquisition, and manufacturing of medical countermeasures -vaccines, drugs, therapeutics, diagnostic tools , and non-pharmaceutical products neededto combat health security threats . To date, 54 BARDA-supported products have achievedregulat ory approval, licensure or clearance. BARDA DRIVe brings together the best ideasfrom the medical and scientific communities, together with government and venturecapital investment, to drive innovation that will strengthen our nation's health security . Tolearn more about preparing for and responding to publ ic health emergencies, from newinfectious diseases to natural disasters and bioterrorism, by visiting the HHS public healthemergency website, www .phe.gov. For more information on partnering with BARDA ondeveloping medical countermeasures , visit www .medicalcount ermeasures.gov, and formore on DRIVe, visit dr ive.hhs.gov.###Note: All HHS press releases, fact sheets and other news materials are available athttps://www .hhs.gov/news .Like HHS on Facebook@, follow HHS on Twitter @HHSgov@, and sign up for HHS EmailUpdates.Last revised: February 18, 2020Disclaimer: Any thfrd-party material in this email has been shared for internal use under fairuse provisions of U.S. copyright law, without further verification of its accuracy/veracity . Itdoes not necessarily represent my views nor those ofNIAID , NIH, HHS, or the U.S.govern ment.From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Sat, 22 Feb 2020 19:41:42 +0000David WillmanSubject : FW: HHS Engages Sanofi's Recombinant Technology for 2019 Novel CoronavirusVaccineDavid:See press release below regarding BARDA and Sanof i.Best,TonyAntho ny S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone Cb) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who Is not the original Intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Cassetti , Cristina (NIH/NIAID) (E]- --------- (b)(6) Sent : Saturday, February 22, 2020 2:26 PMTo: Fauci, Anthony (NIH/NIAID) [E]_ _____ ('"b'~..-(.6=) >Cc: Erbelding, Emily (NIH/NIAID) [E)- ---------(b)(6) Subject : Fwd: HHS Engages Sanofi's Recombinant Technology for 2019 Novel Coronavirus VaccineThis is the press release from ASPR, in case you need more information on the Sanofi CoV effortsCristinaBegin forwarded message:From: "Folkers, Greg (NIH/NIAID) [E]" (b)(6)>Date: February 18, 2020 at 3:07:21 PM ESTSubject : HHS Engages Sanofi's Recombinant Technology for 2019 Novel Coronav irusVaccineNIH-001642NIH-001643FOR IMMEDIATE RELEASEFebruary 18, 2020Contact: ASPR Press Off ice202-205 -8117asprmedi a@hh s.govHHS Engages Sanofi's RecombinantTechnology for 2019 Novel CoronavirusVaccineRacing to develop a vaccine against the 2019 novel coronavirus, the U.S. Department ofHealth and Human Services' Office of the Assistant Secretary for Preparedness andResponse has engaged Sanofi Pasteur, the vaccines global business unit of Sanofi.The Biomedical Advanced Research and Development Author ity (BARDA), a component ofASPR, will provide expertise and reallocated funds to support the vaccine's development .Sanofi will use its egg-free, recombinant DNA platform to produce a recombinant 2019novel coronavirus vaccine candidate.The technology produces an exact genetic match to proteins of the virus . The protein 'sDNA will be combined with DNA from a virus harmless to humans, and used to rapidlyproduce large quantities of antigen which stimulate the immune system to protect againstthe virus. The antigens will be separated and collected from these cells and purified tocreate working stocks of vaccine for advanced development."Flexibility and scalability are cornerstones of rapid response to an emerging infectiousdisease," said BARDA Director Rick A. Bright, Ph.D. "Using this proven technology, we canpivot immediate ly to address this new global health threat. Our goal is a licensed vaccineto provide long-term health security against this latest virus and prevent futurecoronavirus outbreaks. "BARDA has worked with Sanofi since 2004 and in 2009 began collaborating with ProteinSciences of Meridian , Connecticut, now owned by Sanofi, to develop a recombinanttechnology with the flexibility to make millions of doses of vaccine quickly in an influenzapandemic . In 2016, BARDA added this vaccine to the U.S. National Pre-pandemic InfluenzaVaccine Stockpile . When Sanofi purchased the company and its technology in 2017, BARDAcontinued working with Sanofi on pandemic vaccine development, and in December 2019the partners began focusing on increasing manufact uring capacity for recombinantinfluenza vaccine in the United States, in accordance with a president ial execut ive order toenhance national security and the public health by modernizing influenza vaccines andtechnologies .This expanded collaboration with Sanofi is BARDA's second program to focus ondeveloping a novel coronavirus vaccine candidate in the past few weeks. There is currentlyno approved vaccine, treatment , or diagnostic for novel coronavirus infect ions; however,the U.S. Food and Drug Administration has issued an emergency use authorization (EUA) toenable emergency use of a diagnostic test developed by the Centers for Disease Controland Prevention.BARDA also is working with counterparts across the government, including within HHS andwith the Department of Defense. The team is reviewing potential vaccines, treatments anddiagnostics from across the public and private sectors, particularly products inNIH-001644development for Middle East Respiratory Syndrome (MERS) or Severe Acute RespiratorySyndrome (SARS), to identify promising candidates for development and licensure todetect , protect against or treat novel coronavirus infections .To obtain information about any potential products in development in the private sectorthat could be used in responding to the novel coronavirus outbreak, the U.S. governmentlaunched a single point-of-entry website for innovators and product developers to submitbrief descriptions of their diagnostics, therapeutics, vaccines, and other products ortechnologies relevant to this new virus.Federal agencies are particularly interested in identifying products and technologies thathave progressed into or beyond non-clinical studies, have established large-scalecommercial Good Manufacturing Practices (cGMP) manufacturing capability, and/or haveutilized a platform already approved by the U.S. Food and Drug Administration (FDA).BARDA also opened an easy broad agency announcement, an EZ-BAA, specific todiagnostics that utilize platforms already cleared by the FDA, with a viable plan to meetrequirements for the FDA to consider Emergency Use Authorization (EUA) within 12 weeksof an award.About HHS, ASPR, and BARDAHHS works to enhance and protect the health and well-being of all Americans, providingfor effective health and human services and fostering advances in medicine, public health,and social services. The mission of ASPR is to save lives and protect Americans from 21stcentury health security threats. Within ASPR, BARDA invests in innovation, advancedresearch and development , acquisition , and manufacturing of medical countermeasures -vaccines, drugs, therapeutics, diagnostic tools, and non-pharmaceutical products neededto combat health security threats. To date, 54 BARDA-supported products have achievedregulatory approval, licensure or clearance. BARDA DRIVe brings together the best ideasfrom the medical and scientific communities, together with government and venturecapital investment, to drive innovation that will strengthen our nat ion's health security . Tolearn more about preparing for and responding to publ ic health emergencies, from newinfectious diseases to natural disasters and bioterrorism, by visiting the HHS public healthemergency website, www .phe.gov. For more information on partnering with BARDA ondeveloping medical countermeasures, visit www .medicalcountermeasures .gov, and formore on DRIVe, visit drive .hhs.gov.###Note : All HHS press releases, fact sheets and other news materials are available athttps://www.hhs .gov/news .Like HHS on Facebook@, fo llow HHS on Twitter @HHSgov@, and sign up for HHS EmailUpdates.Last revised: February 18, 2020Disclaimer: Any third-party material in this email has been shared for internal use under fairuse provisions of U.S. copyright law, without further verification of its accuracy/veracity . 1tdoes not necessarily represent my views nor those of N.lAJD, NIH, HHS, or the U.S.government .From:Sent :To:Fauci, Anthony (NIH/NIAIO) [ElSat, 22 Feb 2020 19:39:17 +0000Kevin ThurmSubject: RE: ThanksKevin:Many t hanks for yo ur kind note. Mu ch appreciated. I hope that all is well withyo u.Best rega rds,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Kevin Thurm Cb()6 ) >Sent : Saturday, February 22, 2020 -12-:4-5- P-M- -=-c-s-= To: Fauci, Anthony (NIH/NIAID) [El CbH >; Fauci, Anthony (NIH/NIAID) [ElSubject: ThanksTonyGood afternoon.-------- (b) ( >Just wanted to write and say how much I deeply appreciate your on-going public service; you've madeextraordinary contributions over the course of your career and, as I've watched you on TV in the contextof the current public health threat of the coronavirus , I know you're continuing to do so ...No need to respond; you have a lot going on.From one citizen and a former colleague, extending my thanks and deep appreciation.Best wishes.NIH-001645NIH-001646Kevin ThurmFrom:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Sat, 22 Feb 2020 19:36:40 +0000Folkers, Greg (NIH/NIAID) [E]Subject: RE: For review: ASM presentation for 26Feb2020Attachments:26Feb2020 .pptxASM Public and Scientific Affairs Committee Meeti ng 2nd FINAL forI mistaken ly put it into my Documents. Here it is, and I will put it into the ODnowAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Folkers, Greg (NIH/NIA ID) [E) (b)(6)>Sent: Saturday, February 22, 2020 2:25 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject: RE: For review : ASM presentation for 26Feb2020I don't see it in ODFrom: Fauci, Anthony (NIH/N IAID) [E] -------- (b)(6)>Sent: Saturday, February 22, 2020 1:49 PM -------~= To: Schneider, Johanna (NIH/NIAID) [E] (b)(6)>Cc: Folkers, Greg (NIH/NIAID) [E] ,.;...;;.....:.....====::a: (b~) ;~; ;;>--; -c=-on_r_a~d, Patricia (NIH/NIAID) [E](b) (6)>Subject: RE: For review : ASM presentation for 26Feb2020This is now "2 nd FINAL" in the OD folder. You just need to remove the instructionslides and do the required updates on several of the slides and then it is ready togo. Thanks.NIH-001647Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBui lding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the or iginal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) sha ll notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Schneider, Johanna (NIH/NIAID) [El- ---------(b)(6) Se nt: Friday, February 21, 2020 4:05 PMTo: Fauci, Anthony (NIH/NIAID) [El ------~~..:.::=======:~~ Cc: Folkers, Greg (NIH/NIAID) [El --------- >; Conrad, Patricia (NIH/NIAID) [El (b)(6)Subject: For review: ASM presentation for 26Feb2020Dr. Fauci,Attached is the presentation to the American Society for Microb iology (ASM) Public and Scientific AffairsCommittee on Wednesday Feb 26th.The top ics they have expressed interest in are:• NIAID Budget Request FY2021• Novel Coronavirus• Progress on a Universal Flu VaccineThe talk is 30 minutes plus 15-20 for discussion.I've scheduled 30 minutes Monday morning at 10AM to review the slides with you as well.The presentation has been uploaded to the shared dr ive. As indicated we wil l update the necessaryslides on Monday afternoon before sending them to ASM on Tuesday.Thanks,JohannaNIH-001648From:Sent:To:Subject:Thanks.Anthony S. Fauci , MDDirectorFauci, Anthony (NIH/NIAID) [E)Sat, 22 Feb 2020 19:33:57 +0000Cassetti, Cristina (NIH/NIAID) [E]RE: QuestionNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Cassetti, Cristina (NIH/NIAID) [El ---------(b)(6)> Sent: Saturday, February 22, 2020 2:22 PM -------=-,-:-= To: Fauci, Anthony {NIH/NIAID) [El (b)(6) ~=======~ Cc: Erbelding , Emily (NIH/NIAID) [E)_ ______ Cb>_C_6.>lSubject: Re: Questio nHi Dr. Fauci,This effort is completely driven by BARDA. DMID is not involved.Crist inaOn Feb 22, 2020, at 2:18 PM, Fauci, Anthony (NIH/NIAID) [E)wrote:Cristina:(b)( >What is the relationship that we (DMID/NIAID) has with Sanofi in thedevelopment of a coronavirus vaccine? Are we funding them? Do weNIH-001649have any agreement with them to develop a coronavirus vaccine, or isit BARDA who is dealing w ith them?Thanks,TonyAnthony S. Fauci, MODirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MO 20892-2520Phone: Cb()6 )FAX: (301) 496-4409E-mail: Cb) (6)The information in this e-mail and any of its attachments is confidential and maycontain sensitive information . It should not be used by anyone who is not theoriginal intended recipient. If you have received this e-mail in error please inform thesender and delete it from your mailbox or any other storage devices. The Nationa lInstitute of Allergy and Infectious Diseases (NIAID) shall not accept liability for anystatements made that are the sender's own and not expressly made on behalf of theNIAID by one of its representatives.NIH-001650From:Sent:To:Cc:Subject:Attachments:Bob:Fauci, Anthony (NIH/NIAIO) [E)Sat, 22 Feb 2020 18:32:37 +0000Eisinger, Robert (NIH/NIAID) [ElConrad, Patricia (NIH/NIAID) [ElNabel NAS nom ination(b)(6) 2020 NAS Nomination - Section 44 - 02-22-2020.docxHere is CbH6) NAS nomination. Let us touch bases on Monday to get ituploaded to the website.Thanks,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .NIH-001652From:Sent :To:Cc:Fauci, Anthony (NIH/NIAID) [E)Sat, 22 Feb 2020 14:08: 16 +0000Marlene ColucciDavid Rubenstein;Ginni Rometty;Donahoe, JohnSubject : RE: Business Council - Dr. Anthony Fauci "fireside chat" with David Rubenstein -Thank you !Marlene : Thanks for the note. It was my pleasure, and I never miss an opportun ity to interactwith David. He is an incomparable interviewer.Best,TonyFrom: Marlene Colucci <mcolucci@businesscouncil.com>Sent : Friday, February 21, 2020 2:40 PMTo: Fauci, Anthony (NIH/NIAID) [E]_ ____ __(b_)._-.(,=6)>Cc: David Rubenstein (b) (6); Ginni RomettyDonahoe, John __________ (b) (_6), >(b)( >;Subject : Business Council - Dr. Anthony Fauci "fireside chat" with David Rubenstein - Thank you!Dr. Fauci,We wanted to send a quick note to thank you for join ing us today. Your discussion with David was sointeresting and well received .The coronavirus alone was on the minds of so many CEOs as it impacts thei r supply chain.David, it goes w ithout saying that you are the best interviewer! You make everything substanti ve andenterta ining .Wish ing everyone an enjoyable weekend!Warmest regards,MarleneMarlene ColucciEXECUTIVEDIRECTORNIH-001653'I BUSl 1ESS~ (. <. L \,( l LT: 202-298-7650C: (b)(6)F: 202-785-0296NIH-001654From:Sent:To:Subject :Please hsandle.-----Original Message -----Fauci, Anthony (NIH/N IAID) [ElSat, 22 Feb 2020 14:06:21 +0000Cassetti, Cristina (NIH/NIAID) [ElFW: CoVid-19 In InfantsFrom: JF K (b) (6)Sent : Friday , February 21, 2020 2 :44 P-M-- ---~~ To: Fauci, Anthony (NIH/NIAID) [E]..._ ____ (b) <.. ..Subject: CoVid-19 In Infan tsDr. Fauc i,Infants and children infected with CoVid-19 seem to be an anomaly. Could it be as simp le as childhoodvaccinations? Are Chinese childr en vaccinated with anti malarial drugs such as Chloroqu ine phosphate , which isproving effective in older patients for CoVid-19?If infants and children are not getting severe infections, why?Jonathan F. KingNIH-001655From:Sent :To:Fauci, Anthony (NIH/NIAIO) [ElSat, 22 Feb 2020 14:00:30 +0000Marston, Hilary (NIH/NIAID) [E]Cc:Subject:Conrad, Patricia (NIH/NIAID) [E];Greg Folkers (GFOLKERS@niaid.nih.gov)FW: Session Planning fo r COVID-19 at CROI; Tuesday March 10, at 12:10 PMEastern Daylight TimefyiFrom: Kevin Bowen <kbowen@iasusa .org>Se nt: Friday, February 21, 2020 6:31 PMTo: Donna Jacobsen <djacobsen@iasusa .org>; Zunyou Wu -'."";:::=====(b)(=6); ~B~roo ks, John T. {CDC/DDID/NCHHSTP/DHPSE) (b)(6) Fauci, Anthony(NIH/NIAID) [E]'""""":-:-:-.:::=====::.....----------------- (-b..).""(6=' )El-Sadr, Wafaa M. (b)(6) >; Schooley, Robert========""'"(b');(' "·; ~Sc;h-oo' ley, Chip (b)(6)>; Eron, Joseph J Jr ==========(b!)(.6).>.; ;.G.e~ne sis Regalado (b)( >; Barie, Toni C ------------ (b)(6); Conrad, Patricia (NIH/NIAID) [E) (b)(6)> Subject : RE: Session Planning for COVID-19 at CROI; Tuesday March 10, at 12:10 PM Eastern DaylightTimeDear CROI Speakers and Moderators:We would like to schedule a planning call for next week to COVID-19 session at the 2020 Conference onRetroviruses and Oppor t unistic Infections (CROI). Please submit your availability using the poll athttp://whenisgood.net/ksy42az . The poll should automatically adjust to your local time zone, but youcan adjust the setting using the "Select your location" dropdown if needed.We will confirm the call as soon as possible.Regards,Kevin BowenProgram DirectorCROI Scientific Program and IAS-USA ProductionFrom: Donna JacobsenSent : Friday, February 21, 2020 1:37 PMTo: Zunyou Wu (b)( >; John T. Brooks MD ~=======~:;;-(-b)-(6-)>; Barie, Ra Ip h S >; Fauci, Anthony (NIH/NIAID) [El (b)( ,>Cc: Sharon Hillier PhDEl-Sadr, Wafaa M.<kbowen@iasusa.org >; Schooley, Robert(b)(6)(b)(6)>; Kevin Bowen(b)(6) 'RobertT. Schooley, MD---------------- (b)(6)>; Eron, Joseph J J ,. (b)(6)>; Kevin ________ __ Bowen <kbowen@iasusa.org >; Genesis Regalado <gregalado@iasusa .org>; Barie, Toni CNIH-001658-------------- Cb)( >; Conrad, Patricia (NIH/NIAID) [E] CbH6J> Subject: Session Planning for COVID-19 at CROI; Tuesday March 10, at 12 :10 PM Eastern Daylight TimeImport ance: HighDear Drs Wu, Brooks, Barie, and Fauci:It is more than incredibly imp ressive at how all of you, in just the past few days, have rearranged yourschedules and agreed to participate in this special session in only about 2 weeks. We are all verygrateful , and know t his will be tremendously impactful for the CROI audience.Below is the final list of present ations , although the order and titles may well change. We are hoping tohave a conference call with the session liaisons and speakers next week if possible, to go over each ofthe talks to address the overall plan and discuss any overlap. Shortly we will send out a poll foravailabi lity for early morning in China, early-mid afte rnoon in the US West Coast, and late afternooneveningin the US East Coast. If you can respond to the poll by Monday we would greatly apprec iate it;things are moving quick ly.Many thanks again,All of us at CROI!SPECIALU NCHllllES ESSIONO NC XMJ 19Tue. 3/ 10: 12:10 PM -1 :20 PM EASTE~ DAYLIGHT TIMEAuditoriumPreliminary Session Agenda {Order and talk. titles to be confirmed)1, FOCUSO N THE EPIDEMIOLOGYO F COVDI -19AND EFFORTSI N CHINAa. zY.Jrt.Wquy,. C hni eseC enter for OiseaseC onrto~ China1.5-minute live video (Skyll" or Zoom)updote from Ch'no2. FOCUS ON THE GLOBAL EPIDEM IOLOGY OF COVI0 -19 AND EFFORTS TO CONTROL THE OVT6REA,C:a. John Brooks, VS Cente<s for Disease Control, USA15-minute update3. FOCUS ON TliE VIROLOGY OF COROII OVlWSES OVERAL~ MOLECULAR ASPECTS OF TRANSMISSION TO HUMANS, PATHOGENESIS IN MICE MODELS IINO PAI\ALLElS tNIHUMANS, ETCa. Ralph Saric, University of North carolina, USA25-m invte lecture4, FOCUS ON NIAID/HIH EFFORTS TO STUDY NOVEL CORONOVIRVSESAND DEVELOP DIAGNOSTI CS. THERAPEI/TICS, ANO VACCINESa. Anthony Fautt, National lnstttuteof AJ! ergyand 1nfecuouso1seases, Nat1onal Institutes of Hea!th, USAl ~ inute recorded vpdateNIH-001659From:Sent:To:Subject :Let us discuss. Likely no.-----Original Message -----Fauci, Anthony (NIH/NIAID) [E)Sat, 22 Feb 2020 12:13:45 +0000Conrad, Patricia (NIH/NIAID) [E)FW: Triple E letterFrom: Br idbord, Ken (NJH/FIC) [VJ (b) (6):>Sent: Friday, February 21, 2020 3:56 PM- ----~ ~= To: Fauci, Anthony (NIH/NIAID) [E] (b)( >Cc: Marietta Ethier (b) (t6 Emily Lane <ELane@.:. ____ (_b)_(_6.>;>; Fauci, Anthony(NIH/NIAID) [E] (b)(6)Subject: Re: Triple E letterTony, my condominium community has established a program in which prominent members of the Washington areaare invited to make presentations on subjects of great public interest. Shown in the email below is a description ofthis program. In this regard I have been asked to contact you to see, recognizing your incredibly busy schedule, ifyou would be interested and able to provide an update on the Corona virus situation to our residents. Most likely you_____________________ __C.,,b)...(.6..), If you have a potential interest in sharing yourgreat expenise on this subject with our residents could you please have your staff contact Emily Lane who is copiedon this email to explore possible dates and limes thal would work for you . Thank you so much for yourconsideration of this request. KenOn 2/2 1/20, 3:36 PM, "Emily Lane" <ELane@.t.,_ ____ C_)b@... wrote:Dear Ken,The (b) (6) . Committee greatly appreciates your willingness to approach Dr. Anthony Fauci on ourbehalf, asking him to address the residents of the----,---, (b) (6) on the Coronavirus. It would perhaps behel ful to Dr.Fauci, to ex lain who we are and what we do. (b) ( ,(b)(6)The (b) ( Committee was ormed recently to create and orgamze events to e ucate, enlighten andentertain members of the Somerset community. A few weeks ago (b)(6) spoke to a sold out crowd onimpeachment. We've featured authors on a variety of topics; invited doctors with specialties of interest to ourcommunity organized trips to the Kennedy Center and theaters for attendance at ballets and plays and sponsoredvisits, led by experts, to various museums and the Library of Congress to view special exhibitions. An example ofthe latter is a tour of the Folger Library (b) (6). Apresentation by Dr. Fauci on the coronavirus would be of great interest to our constituency who keep informed byreading both national and international journals. We are flexible on the date for such an appearance needing only afew days' notice to inform our residents.I need not tell you that it would our great honor to welcome Dr. Fauci to the (b) (6):.NIH-001660Sincerely(b)(6)NIH-001661From:Sent:To:Cc:Fauci, Anthony (NIH/NIAID) [E)Sat, 22 Feb 2020 12:08:24 +0000Conrad, Patricia (NIH/NIAID) [E);Folkers, Greg (NIH/NIAID) [E)Marston, Hilary (NIH/NIAID) [E);Barasch, Kimber ly (NIH/NIAID) [CJSubject : RE: Session Planning for COVID-19 at CROI; Tuesday March 10, at 12:10 PMEastern Daylight TimeI totally agree. I do not want to be on a "session planning" call. Please have Hilary do this assuggested by Patty since she is preparing the talk . Thanks.From: Conrad, Patricia (NIH/NIAID) [E) --------- (b)(6)Sent: Friday, February 21, 2020 4:44 PM To: Folkers, Greg (NIH/NIAID) [E] -------------~--~- (b)(6Jr>;F auci, Anthony (NIH/NIAID) [El (b )( 6)Subject : FW: Session Planning for COVID-19 at CROI; Tuesday March 10, at 12:10 PM Eastern DaylightTimeImport ance: HighSince this is a taping fo r his remark s - can hi lary do thi s call since she is doing theslides? hate to waste ASF t ime on this with all our other moving parts .... ju st athought.Patricia L. ConradPublic Healt h Analyst andSpecial Assistant to the DirectorNational Institute of Alle rgy and Infectious DiseasesThe Nationa l Institutes of Health31 Center Drive, MSC 2520 - Room 7A03Bethesda, Maryland 20892(b)(6)30 1-496-4409 faxDisclaime r:The information in this e-mail and any of its attachments is confidential and may contain sensitive info rmation. It should not be usedby anyone who is not the original intended recipient. If you have rece ived this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices . National Institute of Allergy and Infectious Diseases (NiAID ) shall not acceptliabi lity for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives .From: Donna Jacobsen <djacobsen@iasusa .org>Sent: Friday, February 21, 2020 4:37 PMTo: Zunyou Wu (b)( >; Brooks, John T. (CDC/DDID/NCHHSTP/DHPSE)~=====(b)(~6)>~; Barie, Ralph (b)(6)>; Fauci, Anthony (NIH/NIA ID) [El (b) ( >Cc: Sharon Hillier PhD (b) (6] . ---------------------------NIH-001662(b)(~ EI-Sadr, Wafaa M. (b)(6J>; Kevin Bowen ========-~;5""-:--'.~-:--.(b) (6); Schooley, Robert (b) (6); Schooley, Chip; Eron, Joseph J Jr ";::::=======-~.~._.-.K;=.e v-in Bowen; Genesis Regalado (b) (6)> ; Barie, Toni C ---------~~ = CbH6));C onrad, Patricia (NI H/NIAID) [E] (b)(6) ______________ _,Subject: Session Planning for COVID-19 at CROI; Tuesday March 10, at 12:10 PM Eastern Daylight TimeImportance : HighDear Ors Wu, Brooks, Barie, and Fauci:It is more than incredibly imp ressive at how all of you, in just the past few days, have rearranged yourschedules and agreed to participate in th is special session in only about 2 weeks. We are all verygrateful , and know this will be tremendously impactful for the CROI audience.Below is the final list of presentations, although the order and titles may well change. We are hoping tohave a conference call with the session liaisons and speakers next week if possible, to go over each ofthe talks to address the overall plan and discuss any overlap. Shortly we will send out a poll foravailabi lity for early morning in China, early-mid afternoon in the US West Coast, and late afternooneveningin the US East Coast. If you can respond to the poll by Monday we would greatly appreciate it;things are moving quick ly.Many thanks again,All of us at CROI!SPECIAWLN CH111S\EE SSIOONN C OV[) 19Tue, 3/10: 12:10 PM - 1:20 PM EASTE~ DAYLIGHT TIMEAuditoriumPreliminory Sc>:.ion Agendo (Orde1 1md tol k. title, to be con firmed)1. FOCU~O N TliE EPIDEMIOLOGYO F COVID-19AND EFFORTSI N CHINAa. ?uoxouW u, ChineseC enter for OiseaseC ontro~C hina15-minvte livev ideo (Skypeo r Z.oom)vpdatefr om Ch:fl(I2. FOCUSO N fHE GLOBAiE. PIDEMIOLOGOYF C OI/ID-19 AND EFFORTTSO CONTROL THE OIJT6REA~a. John Ofo<>k!I, VS Cent~o fo,- Di)C~ C<.mt,d,. USA15-minute update3. FOCUSO N rHE VIROLOGY OF COROtlOVIWS6 OVERAL~M OLECULARA SPECST OF TRANSMISSION TO HUMANS. PATHOGENEIS IN MICE MODELStl NO PARALLlES INIHUMANS,E TCa. Ralph Saric. University of North carolina, USA25-minute lecture4, FOCUS ON NfAI0/HIH EFFORTS TO STUDY NOVEL CORONOV IRVSESAN O OEVElO P DIAGNOSTICS. TH ERAPEUTICS, ANO VACCINESa. Anthony Fauti, National Institute of AJlergyandIn fectiousD iseasesN,.a tional Instituteso JHea!th, USA15-minute recorded updateNIH-001663From:Sent :To:Subject :Please handle.Fauci, Anthony (NIH/NIAID) [ElSat, 22 Feb 2020 12:06:10 +0000Cassetti, Cristina (NIH/NIAID) [ElFW: DEAR TONY: CORONAVIRUSFrom: Dr. Michael Jacobs (b)(6)> ---------- Sent: Friday, February 21, 2020 6:14 PM To: Fauci, Anthony (NIH/NIA_ID.). :[E..]- ..-:.-..-.-:.-!:-===(b=)~(6=)1 >= ==;= Cc: Alexander Tarakhovsky (b)(6); Lockshin, Michael MD(b)(6); Dr. Michael Jacobs (b)(6) > -------- ---------- Subject: DEAR TONY: CORONAVIRUSdear tony:i am a cornell medical school cum~ raduate. i am associate professor of dermato logy at wei ll- -----------------------=-~ cornell in private practice. ---.---.---:====~~-~-~----~-.----- (b)(6) a Ie xa nd er tarakhovsky is ------ (b)( and a professor at rockefeller university. he is a virologist.we have been fo llowing the corona virus pandemic closely, and a few days ago became alarmed at thenews that the chinese government is sterilizing their paper money from hube i province .we th ink that there is a possibility that the virus was released from a lab in wuhan, thebiotech area of china. we also th ink that the vi rus might be complexed with another organism, such as ayeast or fungus, to make it more sticky.we would like to discuss this with you further. we feel that immediate action must be taken by unitedstates scientists to try to neutralize this threat .please contact alexander and me at your earliest convenience at above emails or my mobile-----(b)(6) or office (b)(6) michael lockshin gave me you r email.with kind regardsmichael jacobsNIH-001664From:Sent :To:Subject:Attachments :Fauci, Anthony (NIH/NIAID) [ElSat, 22 Feb 2020 11:49:36 +0000Cassetti, Cristina (NIH/NIAID) [ElFW: coronavirusCai & Garen 1995.pdf, Cai & Garen 1996 .pdf, Cai & Garen 1997.pdfPlease handle. Thanks .From: Garen, Alan (b)( >Sent: Friday, February 21, 2020 7:46 PMTo: Fauci, Anthony (NIH/NIAID) [E]------ (=b)"("=6' )>Cc: Garen, Alan (b)(6)>Subject: coronavirusDear D. Fauci,I want to suggest that NIAID arrange to collect serum samp les from Coronavirus patients whohave survived a major infection and probably have genera ted antiviral antibod ies. Mylaboratory showed in the attached papers that such antibodies could be cloned from sera usinga powerfu l technology called Phage Display. The project cou ld be initiated in this country withas few as 2 patients.Sincerely, Afan Garen, Yale Univers ityNIH-001665From:Sent:To:Cc:Subject :Fauci, Anthony (NIH/NIAIO) [E)Sat, 22 Feb 2020 11:39:57 +0000Antoniak, Cynthia (NBCUniversal, MSNBC)Goldner, Shannah (NBCUniversal);Conrad, Patricia (NIH/NIAID) [E]RE: MSNBC ReconfirmingNo problem . See you then.From: Antoniak, Cynthia {NBCUniversal, MSNBC) <Cynth ia.Antoniak@MSNBC.COM>Sent: Saturday, February 22, 2020 6:39 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Cc: Goldner, Shannah (NBCUniversal) <shannah.goldner@nbcuni.com>; Conrad, Patricia (NIH/NIAID) [El(b)(6)Subject : RE: MSNBC ReconfirmingIf you could get there by 7:3Oam ... that would be great!From: Fauci, Anthony (NIH/NIAID) [El (b)( >Sent : Saturday, February 22, 2020 6:38 AMTo: Antoniak, Cynthia (NBCUniversal, MSNBC) <Cynthia .Anton iak@MSNBC.COM>Cc: Goldner, Shannah (NBCUniversal) <shannah .goldner@nbcun i.com >; Conrad, Patricia (NIH/NIAID) [El(b)(6)>Subject: [EXTERNAL) RE: MSNBC ReconfirmingI have received this e-mail and confirm 7 :45 AM hit . What time do you want me at the studio?From: Antoniak, Cynthia (NBCUniversal, MSNBC) <Cynth ia.Antoniak@MSNBC.COM>Sent : Saturday, February 22, 2020 5:49 AM ------~= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6J>Cc: Goldner, Shannah (NBCUniversal) <shannah .goldner@nbcun i.com >; Conrad, Patricia (NIH/NIAID) [El(b)(6)Subject : MSNBC ReconfirmingGood Morning Dr . Fauci,I am just reconfirming you for your segment on MSNBC this morning with Kendis Gibson and CoriCoffin .You ore hitting at 7:45am from the NBC News Bureau at 4001 Nebraska Avenue.Topics:-Coronavirus-infected Americans flown home against CDC adviceht tps://w ww.washingt onpost .com/h ealt h/ coro navirus- diamond-princess-cru iseamericans/2020/02/20/b6f 54cae-52 79-11ea-b119-4faabac66 7 4f st or y.ht ml-Decision to quarant ine cruise ship-was that a misstep?-Long term effects of decision to bring U.S. passengers backNIH-001666Please reply that you got this .Thank you!CyndiFrom: Goldner, Shannah (NBCUniversal) <shannah.goldner@nbcuni.com >Sent: Friday, February 21, 2020 3:09- P-M- -----=--:-~ To: Conrad, Patricia (NIH/NIA ID) [E) (b)(6)>Cc: Antoniak, Cynthia (NBCUniversal, MSNBC} <Cynthia.Antoniak@MSNBC.COM>; Fauci, Anthony{NIH/NIAID) [E] (b)(6)Subject: RE: contact at the studio tomorrow/MSNBC intvWe absolutely will do. Thank you so much and thank you for your patience. We will be in touch firstthing in the morning .From: Conrad, Patricia {NIH/NIAID) [E] (b)((;)Sent: Friday, February 21, 2020 3:04 PMTo: Goldner, Shannah (NBCUniversal) <shannah .goldner@nbcuni.com>Cc: Antoniak, Cynthia (NBCUniversal, MSNBC} <Cynthia.Antoniak@MSNBC.COM>; Fauci, Anthony(NIH/NIAID) [E] (b)(6)Subject: [EXTERNAL] RE: contact at the studio tomorrow/MSNBC intvOk- I am adding Dr Fauci to this email - please confirm to both of us in themorning. Thank youPatricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNat ional Institute of Allergy and Infectious DiseasesThe National Institutes of Health31 Center Drive, MSC 2520- Room 7A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaimer:The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be usedby anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices . National Institute of Allergy and Infectious Diseases (NIAID) shall not acceptliability for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.From: Goldner, Shannah (NBCUniversal) <shannah.goldner@nbcuni .com>Sent: Friday, February 21, 2020 2:55 PM ---------=-c-c-= To: Conrad, Patricia (NIH/NIA ID) [E) (b)(6)Cc: Antoniak, Cynthia (NBCUniversal, MSNBC) <Cynthia.Antoni ak@MSNBC.COM>Subject: RE: contact at the studio tomorrow/MSNBC intvNIH-001667We won't have an exact hit time until the morn ing BUT as of now, it's 7:30am . It might be 7:35am butthat is the hit time.Cyndi wi ll send it to you by Sam tomorrow.From: Conrad, Patricia (NIH/NIAID) [E] --------- (b)(6)> Sent : Friday, February 21, 2020 2:48 PMTo: Goldner, Shannah (NBCUniversal) <shannah.goldner@nbcuni.com >Cc: Antoniak, Cynthia (NBCUniversal, MSNBC) <Cynthia.Anton iak@MSNBC.COM>Subject : [EXTERNAL] RE: cont act at the studio tomorrow/MSNBC intvWill you or Cyndi send exact hit tim e toni ght? What is the approx . t ime we will getthat?Patricia L. ConradPub lic Health Analyst andSpeci al Assist ant to the Direc torNatio nal Institute of Allergy and Infect ious DiseasesThe Nationa l Instit utes of Health31 Center Drive, MSC 2520- Room 7A03Bethesda, Mary land 20892(b)(6)301-496-4409 faxDisclaime r:The information in this e-mail and any of its attachments is confidential and may contain sensitive information . It should not be usedby anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices . National Institute of Allergy and Infectious Diseases (NIAID) shall not acceptliability for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives .From: Goldner, Shannah (NBCUniversal) <shannah.goldner@nbcuni.com>Sent : Friday, February 21, 2020 10:42 AM -------- == To: Conrad, Patricia (NIH/NIAID) [E) ~-========(b)(:6=) ..~~ Cc: Robinson, Whitney (NIH/ NIAID) [C] (b)(6) Deatrick, Elizabeth (NIH/NIAID) [C]----------- (b)(6); Lavelle, Judith (NIH/NIAID) [E] --------- (b)(6)> Subject : RE: contact at the studio tomorrow/MSNBC intvThank you so muchFrom: Conrad, Patricia (NIH/NIAID) [E] (b)(6)Sent : Friday, February 21, 2020 10:35 AMTo: Goldner, Shannah (NBCUniversal) <shannah.goldner@nbcuni.com>Cc: Robinson, Whitney (NIH/NIAID) [C] (b)(6)>; Deatrick, Elizabeth (NIH/NIAID) [C]----------- (b)(6); Lavelle, Judith (NIH/NIAID) [E] CbH6J> Subject: [EXTERNAL] RE: contact at the studio tomorrow/MSNBC intvNIH-001668Great - t hanks.Please j ust let us know the exact him t ime and we will have him arr ive 20 minspri or.His cell is CbH6a) nd mine isPatricia L. ConradPublic Health Analyst andSpecial Assistant to the Directo rNational Institute of Allergy and Infectious DiseasesThe National Institutes of Health31 Center Drive, MSC 2520- Room 7A03Bethesda, Mary land 20892(b)(6)301-496-4409 faxDisclaimer:(b)(6)The informat ion in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be usedby anyone who Is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices . National Institute of Allergy and Infectious Diseases (NIAID) shall not acceptliability for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.From: Goldner, Shannah (NBCUniversal) <shannah .goldner@nbcun i.com>Sent: Friday, February 21, 2020 10:29 AM --------= = To: Conrad, Patricia (NIH/NIA ID) [E) (b)(6J>Cc: Robinson, Whitney (NIH/NIAID) [CJ (b)(6) Deatrick, Elizabeth (NIH/NIAID) [CJ(b)(6J>; Lavelle, Judith (NIH/NIAID) [E] (b)(6)> __________ _, -----------Subject: contact at the studio tomorrow/MSNBC intvImportance: HighPatricia, hi,The contact at the studio in the morning is Natalia Abrams. The number at the office is 202-885-4800.Also, Cyndi Antoniak will be in touch wit h you in the morning and send you an email about the segmentand just to touch base. If you need to reach Cyndi before she reaches you, her numbe r is 212-664 - 1450and her email is Cynthia .antoniak@nbcuni.com .Thank you so much for making the interview work out, we appreciate it.ShannahFrom : Conrad, Patricia (NIH/NIAID) [E] (b)(6)>Sent: Friday, February 21, 2020 9:06 AMTo: Goldner, Shannah (NBCUniversal) <shannah.goldne r@nbcuni.com >Cc: Robinson, Whitney {NIH/NIAID) [CJ CbH6)>D; eatrick, Elizabeth {NIH/NIAID) [C]NIH-001669---------- CbH6J>L; avelle, Jud ith (NIH/NIAID) [E] CbH6J> Subject : [EXTERNAL) RE: hi and request for Dr. Fauci this weekend on MSNBCHi ShannahSat urday Morning betw een 7:30 am ET - 8 am ET is best for Dr Fauci and wi llneed to be from the NBC Studi o at 4001 Nebraska Ave NW st udio. He has a hardstop no later th an 8:15 am. Please send us the onsite contact name and numb erand firm hit time wh en you can.Thanks,-pattyPatricia L. ConradPublic Health Analyst andSpecial Assistant to the Directo rNational Institute of Allergy and Infectious DiseasesThe Nat iona l Institutes of Hea lth31 Center Drive, MSC 2520 - Room 7 A03Bethesda, Maryland 20892(b)(6)30 1-496-4409 faxDisclaime r:The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be usedby anyone who is not the original intended recipient. If you have received !his e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices. National Institute of Alle rgy and Infectious Diseases (NIAID) shall not acceptliability for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.From: Goldner, Shannah (NBCUniversal) <shannah .goldner@nbcuni.com >Sent : Thursday, February 20, 2020 4:17 PM --------=-c--c= To: Conrad, Patricia (NIH/NIAID) [E) (b)(6)>Cc: Barasch, Kimberly (NIH/N IAID) [CJ (b)(6J>; Deatrick, Elizabeth (NIH/N IAID) [C](b)(6)Subject : RE: hi and request for Dr. Fauci this weekend on MSNBCThat's terr ific and yes, that studio is best if he can join us. Thank you so much. ShannahFrom : Conrad, Patricia (NIH/NIAID) [E) ---------- (b)(Sent : Thursday, February 20, 2020 4 :16 PMTo: Goldner, Shannah (NBCUniversal) <shannah .goldner@nbcuni.com >Cc: Barasch, Kimberly (NIH/N IAID) (CJ (b)(6)>; Oeatrick, Elizabeth (NIH/N IAID) [CJ(b)(6)Subject : [EXTERNAL] RE: hi and request for Dr. Fauci this weekend on MSNBCNIH-001670I am sure we can make one of these work - will let you know tomorrow .We would do from the NBC Nebraska Ave NW Studio.thxPatricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNational Institute of Allergy and Infectious DiseasesThe Nat ion al Institutes of Health31 Center Drive, MSC 2520 - Room 7 A03Bethesda, Maryl and 20892(b)(6)301-496-4409 faxDisclaime r:The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be usedby anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices. National Institute of Allergy and Infectious Diseases (NIAID) shall not acceptliability for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.From: Goldner, Shannah (NBCUniversal) <shannah.goldner@nbcuni .com>Sent: Thursday, February 20, 2020 4:12 PM To: Conrad, Patricia (NIH/NIAID) [E)~-=-=-==-=-=-= -- (~b=)(==6):>:,~ =Cc: Barasch, Kimberly (NIH/NIAID) [C]_ _______ Cb<)_ Deatrick, Elizabeth (NIH/NIAID) [C](b)(6)Subject : hi and request for Dr. Fauci this weekend on MSNBCImportance: HighPatricia, hi, I hope all is well with you.Is Dr. Fauci available this weekend to be on MS NBC to discuss the latest re Corona virus -https ://www .washingtonpost.com/ health/co ronavirus-diamond -princess-cruiseamericans/2020/02/20/b6 f54cae-5279- l lea -bl 19-4faabac667 4f story . htm IWe'd like him on either on Saturday, in the 7:30am to 8am half hour, with Kendis Gibson/Cori Coffin, oron Sunday in the 12pm or 1pm hour with Alex Witt. Whatever day/hour that is good for him, we'll makework.Thank you so much for your help in this matter.All the best,ShannahNIH-001671Shannah GoldnerMSNBCW: 212 -664-1289C: Cb) (6)NIH-001672From:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [ElSat, 22 Feb 2020 11:39:06 +0000Conrad, Patricia (NIH/NIAID) [E)RE: MSNBC ReconfirmingI just did reconfirm with a copy to you. Did you not get it?From: Conrad, Patricia (NIH/NIAID) [E) --------- (b)(6)> Se nt: Saturday, February 22, 2020 6:38 AMTo: Fauci, Anthony (NIH/NIAID) [E] -------=- (be)(-= >Subject: Fwd: MSNBC ReconfirmingYou need to respond to this . It's in your on boxSent from my iPhoneBegin forwarded message:From: "Antoniak, Cynthia (NBCUniversal, MSNBC)" <Cynt hia.Anton iak@MSNBC.COM>Date: February 22, 2020 at 5:49:00 AM EST ------~~ To: "Fauci, Anthony (NIH/NIAID) [E)" CbH6)>Cc: "Goldner, Shannah (NBCUniversal)" <shannah.goldne r@nbcuni.com>, "Conrad, Patricia{NIH/NIAID) (E]" (b)(6)Subject: MSNBC ReconfirmingGood Morning Dr. Fauci,I am just reconfirming you for your segment on MS NBC this morning wit h Ken disGibson and Cori Coffin .You are hitting at 7:45am from the NBC News Bureau at 4001 Nebraska Avenue.Topics:-Coronavirus-infected Americans f lown home against CDC adviceht tps:/ /www .washingtonpost .com/healt h/ coronavirus-diamond-princess-cr uiseamericans/2020/02/20/ b6f 54cae-5279 -11ea-b119-4faabac66 7 4f story .html-Decision to quaranti ne cruise ship-was t hat a misst ep?-Long term effects of decision to bring U.S. passengers backPlease reply that you got this.Thank you!CyndiFrom: Goldner, Shannah (NBCUniversal) <shannah.goldner@n bcuni.com>Sent: Friday, February 21, 2020 3:09 PM -------~~ To: Conrad, Patricia (NIH/NIAID) [El CbH6)NIH-001673Cc: Antoniak, Cynthia (NBCUniversal, MSNBC) <Cynthia.Antonia k@MSNBC.COM>; Fauci,Anthony (NIH/NIAID) [E] (b)(6)Subject: RE: contact at the studio tomorrow/MSNBC intvWe absolutely will do. Thank you so much and thank you for your pat ience. We will be intouch first thing in the morning .From: Conrad, Patricia (NIH/NIAID) [E] (b)(6)Sent: Friday, February 21, 2020 3:04 PMTo: Goldner, Shannah (N BCUniversal) <shannah.goldner@nbcun i.com>Cc: Antoniak, Cynthia (NBCUniversal, MSNBC) <Cynthia.Anto niak@MSNBC.COM>; Fauci,Anthony (NIH/NIAID) [E] (b)( >Subject : [EXTERNAL] RE: contact at the studio tomorrow/MSNBC intvOk- I am adding Dr Fauci to this email - please confirm to both of us inthe morn ing. Thank youPatricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNat ional Inst itute of Allergy and Infectious DiseasesThe Nat ional Institutes of Heal th31 Center Drive , MSC 2520 - Room 7 A03Bethesda, Mary land 20892(b)(6)301-496-4409 faxDisclaimer :The information in this e-mail and any of its attachments is confidential and may contain sensitive information . Itshould not be used by anyone who is not the original intended recipient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. National Institute or Allergyand Infectious Diseases (NIAID } shall not accept liability for any statement made that are sender's own and notexpressly made on behalf of the NIAID by one of its represent atives.From: Goldner, Shannah (NBCUniversal) <shannah.go ldner@nbcun i.com>Sent: Friday, February 21, 2020 2:55 PM --------~= To: Conrad, Patricia (NIH/NIAID) [E] (b)( >Cc: Antoniak, Cynthia (NBCUniversal, MSNBC) <Cynthia.Antonia k@MSNBC.COM>Subject: RE: contact at the studio tomorrow/MSNBC intvWe won't have an exact hit time until the morning BUT as of now, it's 7:30am. It might be7:35am but that is the hit time.Cyndi will send it to you by Sam tomorrow .From: Conrad, Patricia (NIH/NIAID) [E] ---------- (b)(6)Sent: Friday, February 21, 2020 2:48 PMNIH-001674To: Goldner, Shannah (NBCUniversal) <shannah .goldner@nbcun i.com>Cc: Antoniak, Cynthia (NBCUniversal, MSNBC) <Cynthia.Anton iak@MSNBC.COM>Subject: [EXTERNAL] RE: contact at the studio tomorrow/MSNBC intvWill you or Cyndi send exact hit time tonight? What is the approx. timewe will get t hat?Patricia L. Con radPublic Health Analyst andSpecial Assistant to the DirectorNational Institute of Allergy and Infectious DiseasesThe National Institutes of Health31 Center Drive, MSC 2520 - Room 7 A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaimer:The info rmation in this e-mail and any of its attachments is confidential and may contai n sensitive information. Itshould not be used by anyone who is not the origina l intended recipient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergyand Infectious Diseases (NIAID} shall not accept liability for any statement made that are sender's own and notexpressly made on behalf of the NIAID by one of its representatives.From: Goldner, Shannah (NBCUniversal) <shannah.go ldner@nbcun i.com>Sent: Friday, February 21, 2020 10:42 AMTo: Conrad, Patricia (NIH/NIAID) [E] ______ "C""Hb'"=" >Cc: Robinson, Whitney (NIH/NIAID) [CJ (b)(6)>; Deatrick, Elizabeth(NIH/NIAID) [CJ (b)(6); Lavelle, Judith (NIH/NIAID) [E],;__;_ _ ___;_,.;_;,_::::~(b);(:::6::):.;-:------Subject: RE: contact at the studio tomorrow/MSNBC intvThank you so muchFrom: Conrad, Patricia (NIH/NIAID) [E] ---------- (b)(6)Sent: Friday, February 21, 2020 10 :35 AMTo: Goldner , Shannah (NBCUniversal) <shannah.go ldner@nbcun i.com>Cc: Robinson, Whitney (NIH/NIAID) [C] (b)( Deatrick, Elizabeth(NIH/NIAID) [C) (b)(6) Lavelle, Judith (NIH/NIAID) [E](b)(6)Subject: [EXTERNAL] RE: contact at the studio tomorrow/MSNBC intvGreat -thanks.NIH-001675Please just let us know the exact him time and we will have him arrive20 mins prior.His cell is (b)(6) and mine is (b)(6) ------- -------Patricia L. Con radPublic Health Analyst andSpecial Assistant to the DirectorNational Institute of Allergy and Infectious DiseasesThe National Institutes of Health31 Center Drive, MSC 2520 - Room 7 A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaimer:The information in this e-mail and any of its attachments is confident ial and may contain sensitive information. Itshould not be used by anyone who is not the original intended recipient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergyand Infect ious Diseases (NIAID) shall not accept liabil ity for any statement made that are sender's own and notexpress ly made on behalf of the NIAID by one of its representat ives .From: Goldner, Shannah (NBCUniversal) <shannah.go ldner@nbcun i.com>Sent: Friday, February 21, 2020 10:29 AM --------~= To: Conrad, Patricia (NIH/NIAID) [El (b)( > ~-========:::::..-:;;;-;,-=, Cc: Robinson, Whitney (NIH/NIAID) [C] (b)(6J>; Deatrick, Elizabeth(NIH/NIAID) [C) (b)(6); Lavelle, Judith (NIH/NIAID) [El,;_ ___ ;_;_..;..==-(b~) :~; ,;;>;-----------Subject: contact at the studio tomorrow/MSNBC intvImportance : HighPatricia, hi,The contact at the studio in the morning is Natalia Abrams. The numbe r at the office is202-885-4800.Also, Cyndi Antoniak will be in touch with you in the morning and send you an email aboutthe segment and just to touch base. If you need to reach Cyndi before she reaches you, hernumber is 212-664- 1450 and her email is Cynthia.anton iak@nbcun i.com .Thank you so much for making the interview work out, we appreciate it.ShannahFrom: Conrad, Patricia (NIH/NIAID) [El (b)(6)Sent: Friday, February 21, 2020 9:06 AMTo: Goldner, Shannah (NBCUniversal) <shannah.goldner@nbcun i.com>Cc: Robinson, Whitney (NIH/NIAID) [CJ CbH6J>D; eatrick, Elizabeth{NIH/NIAID) [C) (b)(6)>; Lavelle, Judith {NIH/NIAID) [E]NIH-001676(b)(6)Subject: [EXTERNAL] RE: hi and request for Dr. Fauci th is weekend on MSNBCHi ShannahSaturd ay Morning betw een 7:30 am ET - 8 am ET is best for Dr Fauciand will need to be from the NBC Studi o at 4001 Nebraska Ave NWstudi o. He has a hard stop no later th an 8:15 am. Please send us theonsite conta ct name and numb er and firm hit tim e when you can.Thanks,-pattyPatricia L. Con radPublic Health Analyst andSpecia l Assistant to the DirectorNational Institute of Allergy and Infectious DiseasesThe National Institutes of Health31 Cente r Dr ive, M SC 2520 - Room 7 A03Bethesda, Maryland 20892(b)(6)30 1-496- 4409 faxDisclaimer:The information in this e-mai l and any of its attachments is confidential and may conta in sensitive information . Itshould not be used by anyone who is not the original intended recipient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergyand Infectious Diseases (NIAID) shall not accept liability for any statement made that are sender's own and notexpress ly made on behalf of the NIAID by one of its representatives.From: Goldner, Shannah (NBCUniversal) <shannah .goldner@nbcun i.com>Sent: Thursday, February 20, 2020 4:17 PM To: Conrad, Patricia (NIH/NIA ID) [E] --------~= (b)(6)Cc: Barasch, Kimber ly (NIH/NIA ID) [C] (b)(6)>; Deatrick, Elizabeth(NIH/N IAID) [C) (b)(6)Subject: RE: hi and request for Dr. Fauci this weekend on MSNBCThat's te rrific and yes, that st udio is best if he can jo in us. Thank you so much. ShannahFrom: Conrad, Patricia (NIH/NIA ID) [E] (b)(6)Sent: Thursday, February 20, 2020 4:16 PMTo: Goldner , Shannah (NBCUniversal) <shannah.goldner@nbcun i.com>Cc: Barasch, Kimber ly (NIH/NIAID ) [CJ (b)(6) ; Deatrick, ElizabethNIH-001677(NIH/NIAID) [C) (b)(6)Subject: [EXTERNAL] RE: hi and request for Dr. Fauci this weekend on MSNBCI am sure we can make one of these work - will let you knowtomorrow.We would do from the NBC Nebra ska Ave NW Studio.thxPatricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNational Institute of Allergy and Infectious DiseasesThe National Institutes of Health31 Center Drive, MSC 2520 - Room 7 A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaimer:The information in this e-mai l and any of its attachments is confidential and may contain sensitive information . Itshould not be used by anyone who is not the original intended recipient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergyand Infectious Diseases (NIAID) shall not accept liabil ity for any statement made that are sender's own and notexpress ly made on behalf of the NIAID by one of its representatives .From: Goldner, Shannah (NBCUniversal) <shannah.go ldner@nbcun i.com>Sent: Thursday, February 20, 2020 4:12 PMTo: Conrad, Patricia (NIH/NIAID) [E] ---------=- (b")('"=6")Cc: Barasch, Kimber ly (NIH/NIAID ) [C] (b)(6)>; Deatrick, Elizabeth{NIH/NIAID) [C] (b)(6)>Subject: hi and request for Dr. Fauci this weekend on MSNBCImportance : HighPatricia, hi, I hope all is well with you.Is Dr. Fauci available this weekend to be on MSNBC to discuss the latest re Corona virus -https://www .washingtonpost.com/health/coronavirus -diamond-princess-cruiseamerica ns/2020/02/20/b6 f54cae-5279-l le a-b 119-4faa bac667 4 f story.htm lWe'd like him on either on Saturday, in the 7:30am to 8am half hour, with KendisGibson/Cori Coffin, or on Sunday in the 12pm or 1pm hour with Alex Witt. Whateverday/hour that is good for him, we'll make work.Thank you so much for your help in this matter.NIH-001678All the best,ShannahShannah GoldnerMSNBCW: 212-664-1289C: (b)(6)NIH-001679From:Sent:To:Fauci, Anthony (NIH/NIAID) [ElSat, 22 Feb 2020 02:39:22 +0000Morens, David (NIH/NIAID) [ElSubject : FW: So what do you guys think? (I no it 's not influenza, but a lot of your 2007conclusions seem very valid now ... )David:Please respond to this person.Thanks,Tony-----Original Message -----From: 00( Sent: F-rid-ay ,- Fe-bru-ary- 21-, 20-20- 9:3-2 P-M- -- ---------------~~ To: Fauci, Anthony (NTH/NIAlD) [E] (b)(6)Subject: So what do you guys think ? (T no it's not influenza, but a lot of your 2007 conclusions seem very val idnow ... )Dear David Morens, dear Anthony Fauci,J realise it is not an influenza virus, but the outlook of your 2007 paper ("The 1918 lntluenza Pandemic: Insights forthe 21st Century") seems to me to be very valid for the current coronavirus outbreak. Or put differently - yourstatements and concerns from then mostly coincide with my thinking and wonies now ... :( .So a question - what is your thinking now? Are the hospitals you're affiliated with hiring additiona l staff (yet)? Anypersonal preparations?Good luck to you and all the best for those close to you, kind regards , Sean SchererP.S. I guess part of the the reason I'm asking is, because I (a non-institutionally affiliated biologist), am in touch withthe university-hospital here (b) ( Germany), but my concerns are so far falling on deaf ears ... But also justreading the paper and seeing others come to the same conclus ions - albeit on more theore tical grounds and multip leyears ago - made me want to reach out. Plu5 I guess I'm simp ly curious about what you think !NIH-001681From:Sent :To:Cc:(b)(6)Fri, 21 Feb 2020 14:38:56 -0500Billet, Courtney (NIH/NIAID) [E]Subject:Conrad, Patricia (NIH/NIAID) [E];Folkers, Greg (NIH/NIAID) [E]Re: Work related questionYou are correct. No chance that I would accept. ThanksOn Feb 21, 2020, at 2:23 PM, Billet, Courtney (NIH/NIAID) [E]Cb) (6) wrote:In the interest of fu ll disclosure: Stephanie Cb) (6) used to work here at HHS and isnow a VP with the American College of Preventive Medicine . For the life of me I couldn'tsee you saying yes to a weekend trip to Denver in May, and I wou ld hate to have themwaste their time sending an invite when they could be pursuing someone more likely toaccept. Hope this is OK.From : Billet, Courtney (NIH/NIAID) [E]Sent: Friday, February 21, 2020 2:18 PM To: Stephanie Marshall -------------------~-~- -- (b)( > Subject : RE: Work related questionHi -good to hear from you! I hesitate to speak definitively for him and his scheduler, butto be perfectly honest I think it's really unlikely that'd he'd be able to accept a speakinginvite for Denver. The schedule is insane for the foreseeable future and isn't letting up onthe weekends. He's turning invitations down left and right, unfortunately - especiallythose involving travel!From: Stephanie Marshall ------------- (b)(6) Sent: Friday, February 21, 2020 1:51 PMTo: Billet, Courtney (NIH/NIAID) [E] ______ (-b=)'-"=("6=' ) >Subject: Work related questionHi Courtney,I hope you're doing well despite the ongoing craziness whether it's coronavirus orpolitics. Yikes, these are unsett led t imes.I have a quick question for you. Our annua l meeting is May 14 - 17 in Denver. Manyof the sessions are in place but there's talk about doing a session aroundNIH-001682NIH-001683coronavirus and invit ing Dr. Fauci as the speaker. The meeting is a Thursdaythrough Sunday and they 're look ing at inviting him to speak potentially on Sundaymorning. Is this something he would even consider and would he commit this farout given everything that's going on? Any quick thoughts you might have would behelpful.Thank you, thank you! Have a great weekend.StephanieFrom:Sent :To:Cc:(b)(6)Fri, 21 Feb 2020 10:40:17 -0500Collins, Francis (NIH/OD) [E]Subject:Hallett , Adrienne (NIH/OD) [E];Tabak, Lawrence (NIH/OD) [ElRe: FYI on Senate staff visitThanks, Francis.On Feb 21, 2020 , at 10:30 AM, Collins, Francis (NIH/OD) [E](b)(6)Hi Tony,I got asked by Alex Keenan what the NIH needs for the coro navirus response. I said thatthis had been looked at with great care by you and your staff . If you are asking me fortechnical assistance, I said, we need about (b)(5)for FY20-21, and more in the long run.ASFR was in the room but did not have a visible seizure.Just thought you'd want to know before you meet with the staffers later today.FCNIH-001684From:Sent:To:Cc:Fauci, Anthony (NIH/NIAIO) [E)Fri, 21 Feb 2020 14:31:08 +0000Donna JacobsenConrad, Patricia (NIH/NIAID) [E);Greg Folkers _-_-_-_-_-_-_- ~= C_)bC_6.);Marston, Hilary (NIH/NIAID) [E)Subject: RE: CROI COVID 19 Session; Tuesday March 10 lunchDonna:Thanks for the note . I will be able to provide a 15 minute video with slides thatdiscusses the NIH/NIAID efforts to study the novel coronavirus and to developcountermeasures in the form of diagnostics, therapeutics, and vaccines. Yourteam can work with Patty Conrad, Hilary Marston and Greg Folkers on thelogistics. In the meantime, we will prepare the video.Best regards,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : Cb()6 )FAX: (301 496-4409E-mail Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The Nationa l Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statem ents made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Donna Jacobsen <djacobsen@iasusa.org>Sent: Thursday, February 20, 2020 8:53 PM ------~= To: Fauci, Anthony (NIH/NIAID) [E) (b)(6)>Cc: Conrad, Patricia (NIH/NIAID) [E] CbHSubject: RE: CROI COVID 19 Session; Tuesday March 10 lunchImportance: HighDear Dr Fauci:We've had a lot of discussion around our COVID-19 session today. An idea t hat came up was possiblyhaving you do something remotely. Either a live feed in from your office at approximately 1:05 PM to1:20 PM EDT on Tuesday, March 10 if you have that time available, or have you send in a video recordedpresent ation a day or 2 before that we can show at the session. Having some way to commun icate theNIH-001685high priority NIH/NIAID has on developing a vaccine and treatment would help bring the contenttogethe r.We know this is like ly not possible, with the very short notice and your even more tremendously busyschedule around all of this. But it's worth the ask.Please let me know if you think either of these is possible. And Patty, sorry for butchering your emailaddress earlier.Best,DonnaDonna M. JacobsenExecutive Director /PresidentInternational Antiviral (formerly AIDS) Society-USAExecutice Manager, CROI131 Steuart St, Ste 500San Francisco, CA 94105415-544-9400https://www .iasusa.orgAbout IAS- USA : Established in 1992, the IAS-USA is a not-for-profit, professional educationorganization. The mission of the IAS-USA is to improve the prevention , treatment , care, and quality of lifefor people with or at risk of HIV, hepatitis C virus, or other viral infections through high-quality, relevant,balanced, and needs-orien ted education and information for practitioners who are actively involved inmedical care. The organization's educational activities are particular ly intended to bridge clinical researchand patient care.Confident iality Notice: This e-mail and its attachments may contain privileged and confidentia linformation intended solely for the use of the IAS-USA and the recipient(s) named above. If you are notthe intended recipient, or the employee or agent respons ible for delivering this message to the intendedrecipien ts, you are hereby notified that any review, dissemination , distribution , printing, or copying of thise-mail message and/or any attachments is strictly prohibited. If you have received this transmission inerror , please notify the sender immediately and permanent ly delete this e-mai l and any attachments.From: Fauci, Anthony (NIH/N IAID) [E] ________ Cb>C_6 )Sent: Thursday, February 20, 2020 7:12 AMNIH-001686To: Donna Jacobsen <djacobsen@iasusa .org>Cc: (b)(6) 'Elaine J. Abrams, MDSharon Hillier PhD (b) (6) Hoxie, James--------======~~-:------:---:-:.:======~~------------- (b)(6); Benson, Connie ---------(b)(6); Kevin Bowen <kbowen@iasusa .org>Subject: RE: CROI COVID 19 Session; Tuesday March 10 lunchDonna:(b)(6) >;Thanks for the note. Unfortunat ely, I need to be in Washington, DC on March10, and so I will regrettabl y have to decline your kind invitation . Thank you forthin king of me.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone (b) (6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infect ious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Donna Jacobsen <djacobsen@iasusa .org>Sent: Tuesday, February 18, 2020 8:09 PM -------=-:--:= To: Fauci, Anthony (NIH/NIAID) (E] (b)(6) ------~==-------------~= Cc: (b)(6); 'Elaine J. Abrams, MD (b)(6)Sha-ro- n---H:-~i'l.~lie_r_P~h-D-;::::===:;....-----...:...--======. (b~)~(6~)>;~H~o- x~ie- ,~J-a_m_e_s_ __ _ -------=====~~------:;;::::====~~ ;, -------------(b)(6); Benson, Connie -------- (b)(6)>; Kevin Bowen <kbowen@iasusa .org>Subject : RE: CROI COVID 19 Session; Tuesday March 10 lunchDear Dr Fauci:As I mentioned on the phone, we just today decided that we will have a special session on COVID 19 atCROI. It wi ll be on Tuesday, March 10, during the lunch break; the init ial general structure will be a 10-to 15- minute overview (CDC), a 25-min talk by Ralph Barac (UNC) about the viro logy of coronavi ruses,and a 10- to 15-minute summary on what NIAID/ NIH is doing and planning. We thought that this beingNIH-001687one of the first large medical conferences in infectious diseases this year, that we address COVID 19 atCROIWe know that this is terribly last minute , but the CROI Chairs and Foundation are hoping you are free togive the NIAID/NIH update. CROI is in Boston, Mar ch 8 to 11.If you think you would be able to do this, we will send a more formal communication with details andwork with Patty on the specifics . Thank you so much Dr Fauci; we hope you will be able to join us.Best,DonnaDonna M. JacobsenExecutive Director /PresidentInternationa l Antiviral (formerly AIDS) Society-USA131 Steuart St, Ste 500San Francisco, CA 94105415-544-9400https://www .iasusa.org~ACCMEAbout IAS- USA : Established in 1992, the IAS-USA is a not-for-p rof it, professional educationorganization . The mission of the IAS-USA is to improve the prevention , treatment , care , and quality of lifefor people with or at risk of HIV , hepatitis C virus , or other viral infec tions through high-quality , relevant,balanced, and needs -oriented education and information for practitioners who are actively involved inmedica l care . The organization's educational activities are partic ularly intended to bridge clinical researchand patient care.Confident iality Notice: This e-mail and its attachments may contain privileged and confidentia linformation intended solely for the use of the IAS-USA and the recipient(s) named above. If you are notthe intended recipient, or the employee or agent respons ible for delivering this message to the intendedrecipien ts, you are hereby notified that any review, dissemination , distribution , printing, or copying of thise-mail message and/or any attachments is strictly prohibited . If you have received this transmission inerror, please notify the sender immediately and permanently delete this e-mail and any attachments.NIH-001688From:Sent :To:Subject:Attachment s:Please han dle .Anthony S. Fauci , MDDirectorFauci, Anthony (NIH/NIAIO) [E)Fri, 21 Feb 2020 13:33:20 +0000Cassetti, Cristina (NIH/NIAID) [E]FW: FDA RequestFDA Clearance Letter.pdf, Nepal Corona Vi rus Paper.pdfNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Jeff Fischer (b)(6)Sent : Friday, February 21, 2020 8:30 AMTo: Messonnier, Nancy (CDC/DDID/NCIRD/0D) (b)( >; Khabbaz, Rima(CDC/DDID/NCEZID/0D) (b)(6)'> ; Fauci, Anthony (NIH/NIAID) [E)_ _____ .(.b,.".).('"="6)Cc: Chris Helm -------- (b) (6) > Subject: FDA RequestOrs Messonnier, Khabbaz, and Fauci,The Center for Devices and Radiological Health at the FDA suggested that we reach out to COVID-19 EUAdevelo ers to (b) (4~(b) (4)NIH-001689Respectfu lly,JeffJeff FischerPresidentLonghorn Vaccines and Diagnostics LLC2 Bethesda Metro Center Suite 910Bethesda, MD 20814(b)(6)NIH-001690(b) (4)From:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Fri, 21 Feb 202010:47:53 +0000Cassetti, Cristina (NIH/NIAID) [E]FW: Fwd:Attachment s: Notes for NIH.docxPlease handle.From: RICK SAWAYA (b)(6)>Sent : Friday, February 21, 2020 1:48 AMTo: Fauci, Anthony (NIH/NIAID) [E) .------ -C,,-Hb--.= >; Cassetti, Cristina (NIH/NIAID) [E)(b)(6)Subject: Fwd:2202020Dr. Fauci:This is Dr. Rick Sawaya :Dr. Tom Betz is (b)(6) and his training is more in line with yours than mine.He submitted this mini-endorsement to you for me and my work. He has seen most of my worksand the NIH data protocol from 2016-2017.I think his background gives credibility to my ideas and lends a public health opinion which I did not haveuntilcalling him .Hope you enjoy th is.I have treated cancers, herpes, acne easily with this stuff and honestly and confidentiallyit will do anything but your income tax.Thanks, Rick Sawaya M.D.(b)(6)call between 10am and 10pm EST,---------- Forwarded message ---------From: Tom Betz (b)(6)Date: Thu, Feb 20, 2020 at 10:32 PMSubject : Re:To: RICK SAWAYA (b)(6) ----------Rick,I am attaching suggested notes for NIH. They may t hink we're both crazy but I imagine you have alreadybeen down that road and I'm interested to see what happens. Hang in there,NIH-001698TomOn Tue, Feb 18, 2020 at 2 :01 PM RICK SAWAYA ---------- (b)(6 b wrote:THIS HAS THE CELL WITH LEARS SIGNATURE ABOVE ITAND A CYSTEINE RANDOM DIAGRAMNIH-001699From:Sent :To:Subject:Import ance:Let us discuss.Fauci, Anthony (NIH/NIAIO) [E)Fri, 21 Feb 2020 02:42:07 +0000NIAIDODAMFW: CROI COVID 19 Session; Tuesday March 10 lunchHighFrom: Donna Jacobsen <djacobsen@iasusa.org>Se nt: Thursday, February 20, 2020 8:53 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [El (b)(6)>Cc: Conrad, Patricia (NIH/NIA ID) [E!l. =======~ (b")("'"=6)">Subject: RE: CROI COVID 19 Session; Tuesday March 10 lunchImport ance: HighDear Dr Fauci:We've had a lot of discussion around our COVID-19 session today. An idea that came up was possiblyhaving you do something remotely. Either a live feed in from your office at approximately 1:05 PM to1:20 PM EDT on Tuesday, March 10 if you have that time available, or have you send in a video recordedpresentation a day or 2 before that we can show at the session. Having some way to commun icate thehigh priority NIH/NIAID has on developing a vaccine and treatment would help bring the contenttogethe r.We know this is likely not possible, with the very short notice and your even more tremendously busyschedule around all of this. But it 's worth the ask.Please let me know if you think either of these is possible. And Patty, sorry for butchering your emailaddress earlier .Best,DonnaDonna M. JacobsenExecutive Director /PresidentInternational Antiviral (formerly AIDS) Society-USAExecutice Manager, CROI131 Steuart St, Ste 500San Francisco, CA 94105415-544-9400NIH-001700https://www.iasusa.orgAbout IAS- USA: Established in 1992, the IAS-U SA is a not-for-prof it, professional educat ionorganizat ion. The mission of the IAS-USA is to improve the prevention , treatme nt, care, and quality of lifefor people with or at risk of HIV, hepatitis C virus, or other vira l infections through high-quality , relevant,balanced , and needs-orien ted education and information for practitioners who are active ly involved inmedica l care. The organization's educational activities are particularly intended to bridge clinical researchand patient care.Confid entiality Notice : This e-mail and its attachmen ts may contain priv ileged and confidentia linformation intended solely for the use of the IAS-USA and the recipient(s) named above. If you are notthe intended recipient, or the employee or agent respons ible for delivering this message to the intendedrecipien ts, you are hereby notified that any review , dissemination , distribution , printing, or copying of thise-mail message and/or any attachments is strict ly prohibited . If you have received this transmission inerror, please notify the sender immediate ly and permanently delete this e-mail and any attachments.From: Fauci, Anthony (NIH/N IAID) [E] ---------- (b)(6)] Sent : Thursday, February 20, 2020 7:12 AMTo: Donna Jacobsen <djacobsen@iasusa .org>Cc: (b)(6) 'Elaine J. Abrams, MD (b)(6)Sharon Hillier PhD (b)(6)>; Hoxie, James_..,,...===~~;--::-------::-----:---:======~ ~ < (b)(6); Benson, Connie (b)(6) >; Kevin Bowen<kbowen@ iasusa.org>Subject : RE: CROI COVID 19 Session; Tuesday March 10 lunchDonna:Thanks for the note . Unfortunat ely, I need to be in Washington, DC on March10, and so I will regrett ably have to decline your kind invit ation . Thank you forthin king of me.Best rega rds,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)NIH-001701FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Donna Jacobsen <djacobsen@iasusa.org>Sent : Tuesday, February 18, 2020 8:09 PMTo: Fauci, Anthony (NIH/NIAID) [E]------= (b')"("=6)>---:-:-----:-:-::-.::::=t.....------------'="'""= Cc: (b)(6)'Elaine J. Abrams, MD (b)(6)-S-h-ar-o-n -H-il-lie=r P=hD= ===~~-:-----:---:-.:======Cb~)( 6) >~; H oxie, James ------------- (b)(6); Benson, Connie ---------(b)(6); Kevin Bowen <kbowen@iasusa.org>Subject: RE: CROI COVID 19 Session; Tuesday March 10 lunchDear Dr Fauci:As I mentioned on the phone, we just today decided that we will have a special session on COVID 19 atCROI. It will be on Tuesday, March 10, during the lunch break; the init ial general structure will be a 10-to 15- minute overview (CDC), a 25-min talk by Ralph Barac (UNC) about the viro logy of coronavi ruses,and a 10- to 15-minute summary on what NIAID/NIH is doing and planning. We thought that this beingone of the first large medical conferences in infectious diseases this year, that we address COVID 19 atCROIWe know that this is terribly last minute, but the CROI Chairs and Foundation are hoping you are free togive the NIAID/NIH update. CROI is in Boston, March 8 to 11.If you think you would be able to do this, we will send a more formal communication with details andwork with Patty on the specifics. Thank you so much Dr Fauci; we hope you will be able to join us.Best,DonnaDonna M. JacobsenExecutive Director /PresidentInternational Antiviral (formerly AIDS) Society-USA131 Steuart St, Ste 500San Francisco, CA 94105415-544-9400https://www .iasusa.orgNIH-001702NIH-001703About IAS-USA: Established in 1992, the IAS-USA is a not-for-profit , professional educationorganization . The mission of the IAS-USA is to improve the prevent ion, treatment , care, and quality of lifefor people with or at risk of HIV, hepatitis C virus, or other viral infections through high-quality, relevant,balanced , and needs-oriented education and information for practitioners who are actively involved inmedical care. The organization's educational activities are particularly intended to bridge clinical researchand patient care.Confidentiality Notice: This e-mail and its attachments may contain privileged and confidentia linformation intended solely for the use of the IAS-USA and the recipient(s) named above. If you are notthe intended recipient, or the employee or agent responsible for delivering this message to the intendedrecipients, you are hereby notified that any review, dissemination , distribution , printing, or copying of thise-mail message and/or any attachments is strict ly prohibited . If you have received this transm ission inerror, please notify the sender immediately and permanently delete this e-mail and any attachments.From:Sent :To:Subject:Donald:Fauci, Anthony (NIH/NIAI0) [E)Fri, 21 Feb 2020 01:47:03 +0000McNeil Jr, Dona ld GRE: question re the Wash Post storyYou know that I always answer your calls and e-mails, but this one I want to stay away from.Sorry.Best,TonyFrom: McNei l Jr, Donald G <mcneil@nytimes.com>Sent : Thursday, February 20, 2020 4:51 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject : Re: question re the Wash Post storyNow that I've had a chance to read the whole story -- after editors finished whirl ing --1 see it alsocontains these grafs:Are they accurate?ThanksDuring one call, the CDC's principal deputy direc tor, Anne Schuchat, argued agains ttaking the infected Americans on the plane, according to two participants. She noted theU.S. government had already told passengers they would not be evacuated with anyonewho was infected or showed symptoms. She was also concerned about infection control.Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, whowas also on the calls, recalled saying her points were valid and should be considered.But Robert Kadlec, assistant secretary for preparedness and response for theDepartment of Health and Human Services and a member of the coronavirus task force,pushed back: Officials had already prepared the plane to handle passengers who mightdevelop symptoms on the Jong flight, he argued. The two Boeing 74 7s had 18 seatscordoned off with 10-foot-high plastic on all four sides. Infectious disease doctors wouldalso be onboard .On Thu, Feb 20, 2020 at 4:24 PM McNeil Jr, Donald G <mcneil@nyt imes.com> wrote:Hi, Tony:The Washington Post has just put up a story saying that the 14 infected passengers on the busescontaining 238 American passengers from the Diamond Princess were flown home AGAINST theCDC's advice . And that the States Department overru led the CDC on this.Can you confirm whether that's true?NIH-001704NIH-001705Thanks ...DonaldStory contains these crucial grafs:In Washington, where it was still Sunday afternoon, a fierce debatebroke out: The State Department and a top Trump administrationhealth official wanted to forge ahead. The infected passengers had nosymptoms and could be segregated on the plane in a plastic-linedenclosure. But officials at the Centers for Disease Control andPrevention disagreed, contending they could still spread the virus .The CDC believed the 14 should not be flown back with uninfectedpassengers."It was like the worst nightmare," said a senior U.S. official involvedin the decision, speaking on the condition of anonymity to describeprivate conversations. "Quite frankly, the alternative could havebeen pulling grandma out in the pouring rain, and that would havebeen bad, too."Donald G. McNeil Jr.Science Correspondent(i;~t :Xt\u Uork {;imtsTel: +l 212 556 1142mcneil@nytimes.comArticles: https://www .nytime s.com/by /donald-g-mcneil-jrFrom:Sent :To:Subject :Dick:Fauci, Anthony (NIH/NIAIO) [E)Fri, 21 Feb 2020 00:13:55 +0000Richard Al len JohnsonRE: 02.20.2020 ThursdayThanks for the note. Always good to hear from you.Best,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Richard Allen Johnson (b)(6) ---------- Sent : Thursday, February 20, 2020 6:57 PM To: Fauci, Anthony (NIH/NIAID) [E] -----------=---c--c-= (b)( >; Sandra Goldste in ---------(b)(6) Subject: 02 .20.2020 ThursdayHi, Tony,------------- (b) (6) this week.We watched a life size ASF as you discussed and reassured us about Covid-19. You are simply the best.Were you running for president, I am sure that you would win the yote .Don't forget our lunch in Boston .Best,DickNIH-001706From:Sent :To:Cc:Fauci, Anthony (NIH/NIAIO) [E)Thu, 20 Feb 2020 23:48:29 +0000Conrad, Patricia (NIH/NIAID) [ElBillet, Courtney (NIH/NIAID) [ElSubject: FW: Urgent- Phone Interview Request on CoronavirusDone!Anthony S. Fauci , MDDirecto rNational Institute of Allergy and Infectious DiseasesBui lding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e -mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Qi Zhang <qizhang@caixin.com>Sent : Thursday, February 20, 2020 3:16 PM ------~~ = To: Fauci, Anthony (NIH/NIAID) [El- -------- (b)(6)> Subject: Urgent- Phone Interview Request on CoronavirusDear Dr. Fauci,Good afternoon . I am Olivia Zhang with Caixin Media, which is the front-liner of the Coronavirusreporting in China. We spoke at the very beginning of the virus and I wanted to talk to you regarding thelatest situation, especially from test, treatment point of view. I also left you a voice message. Feel free tocall me via (b) ( whenever you're free .I look forward to hearing from you.Best,OliviaQi ZHANG {Olivia)U.S. CorrespondentCaixin Media Company LimitedNIH-001707Email: qizhang@caixin.comMobile:-+- (b)(6)Twitter: @zhang_qiiiwww .caixin.com I caixingloba l.comNIH-001708From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Thu, 20 Feb 2020 23:28:04 +0000Achenbach, JoelSubject: RE: quick question: when does an epidemic become a "pandemic" officially?It is impossible to predict at this point if the current outbreak will progress to atrue pandemic. The future of this outbreak and whether it will progress to apandem ic will be determined by two factors: 1) the degree to which Chinacontrols infect ions in China, which will ultimately impact how many infect ionsleak out to other countries in the world. 2) The success or not of other countriesthat have received travel-related cases from China in preventing the developmentof sustained transmission of infections in their own country. If these othercountries are successful in containing the transmissions, then a pandemic will beavoided. If a large number of countries are unsuccessful in preventing sustainedmulti -generation transmissions , then we could witness the next pandemic .Anthony S. Fauc i, MDDire ctorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the or igina l intended recipient. If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Achenbach, Joel <Joel.Achenbach@washpost.com>Sent: Thursday, February 20, 2020 -6-:1-1- -P-M~ ~ To: Fauci, Anthony (NIH/NIAID) [E] (b)( >Subject : RE: quick question: when does an epidemic become a "pandemic" officially?Oh .... and ... the big question: How likely is it that covid-19 will become a pandemic? Would love an onthe-record assessment. Thanks. ..jo elFrom: Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6)>Sent: Thursday, February 20, 2020 6:06 PMTo: Achenbach, Joel <Joel.Achenbach@washpost.com>Subject : RE: quick question: when does an epidemic become a "pandemic" officially?NIH-001709IC AUTION: EXTERNALS ENDERJoel:There are many iteration s of the definition of a "pandemic" . However, onethat I use that is simple and under standable is as follows: An outbreak of aserious infectious disease with substantial global health consequences (usuallyone that has never before been experienced by the human populat ion) that istransmitted readily from person to person and where there is sustainedtransmission (i.e. multiple generations of person to person to person) in multiplecountries and regions of the world. In this regard, the coronavirus outbreak inChina is an "epidemic" in China, but it is not yet a pandemic since there is not"sustained" person to person transmission throughout the world. There areinfections in other countries (more than 25 countries), but these started as travelrelated cases from China and although there are several human to humaninfections in these other countries, these infections have not yet been"sustained". If we start seeing sustained, multiple generations of transmissionsin many countries throughout the world, then the outbreak will have progressedto fill the criteria of a true pandemic.Hope that this is helpful.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origi nal intended recipient . If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Achenbach, Joel <Joel.Achenbach@washpost .com >Sent: Thu rsday, February 20, 2020 5:51 PMNIH-001710To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Subject: quick question: when does an epidemic become a "pandemic " officia lly?Dear Tony Fauci:Hi! Busy times . Hope you are well. Can you explain to me how we will know if and when covid -19 hasbecome pandemic, versus whatever you'd call the current situatio n? Just in general, what 's thedefin ition of a pandemic?Thank you ... best, Joel(and thanks for calling me back last weekend , sorry I missed you)NIH-001711From:Sent:To:Subject:Attachments :Mike:Fauci, Anthony (NIH/ NIAIO) [E)Thu, 20 Feb 2020 16:45:39 +0000Michael GersonRE: Tony, I'm still working on th is, but need your react ionGerson wi th minor Fauci edits .docxThanks for sending this. It looks good . I have copied it to a WORD documentand have made some minor suggested edits for your consideration.Best regards ,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may conta in sensitiveinformat ion. It shou ld not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Michael Gerson (b)(6)>Sent: Thursda y, February 20, 2020 11:04 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject: Tony, I'm still working on this, but need your reactionMeanwhile , on the other side of the earth, th ere have been 73,000cases of coronavirus and more than 2000 deaths. This leaves Americanhealth experts hoping that the number of infections has been dramaticallyunderreported.That is not a typo. If the current nu1nbers are close to accurate, itindicates a coronavirus mortality rate upwards of 2 percent. The moralityrate for the seasonable flu is generally .1 percent. The mortality rate forpandemic flu is .3 percent. The particularly deadly flu pandemic of 1918 -NIH-001714NIH-001715which took the lives of more than 100 million people around the world -had a mortality rate of 1.8 to 2 percent.So, if 2000 deaths is the numerator, scientists hope that thedenominator is actually much larger. And that is probable, given thelikelihood that there are many more people who have the infection butdon't know it, or are not showing symptoms.The good news? The outbreak started in a single location and seemslargely contained there. There have been several hundred cases in morethan 25 countries outside of China. But the overwhelming majority havebeen travel related. The containment measures of Singapore, Hong Kongand Japan - which have the most cases - seem to have been successful. Ofthe 15 American cases (before the arrival of the cruise ship passengers), 13are travel related. The two others are spouses of people in that group. Westill have not seen widespread, sustained transmission from person toperson outside of China.The Chinese reaction to the virus has shown the weaknesses andadvantages of authoritarianism. The immediate response of a system builton fear is to a problem like this one is denial and deception. No one wantsto carry bad news. So local Chinese officials spent the first week of theoutbreak - as the disease was spreading under the radar - insisting that thetransmission of the virus was all animal to human.But only in a society like China could you have the effective lockdownof 50 million people, including the entire city of Wuhan, to slow the spreadof the disease. Public health officials in most places - who are required tobalance health needs with civil liberties - would not even consider such ameasure. Yet it appears to be working.The danger? "All that is needed is for a few countries in thedeveloping world that can't contain the coronavirus," Tony Fauci told me."This could be the second wave of the pandemic."Pandemic diseases tend to attack the weakest links - the mostvulnerable health systems - in the global chain. If there is sustainedtransmission in those places , says Fauci , "even countries with best practiceswill suffer." Countries in Africa are of particular concern. There are millionsof Chinese in Africa, and many Africans study in China. Countries such asEthiopia, Senegal and South Africa seem to be doing a good job at testingrandom samples for coronavirus in key cities. But Liberia? Guinea? SierraLeone?Seldom has there been a stronger argument for American globalengagement to strengthen African health systems, which constitute part ofown immune system against pandemics. Seldom has there been a betterNIH-001716argument to abandon "America First" posturing and to recognize that ourown fate is closely tied to the fate of other nations.Much about the future course of the disease depends on the answer toa scientific question: Is someone who has the virus but lacks symptoms - orhas symptoms so mild they hardly notice - capable of transmitting thevirus to others? "It looks like the answer is yes," says Fauci. Which wouldmake the virus far harder to control."We may find that the virus is highly transmissible, but less lethalthan we thought in the beginning," Fauci told me. In this case, the dangerwould be similar to a particularly bad influenza. And the outbreaks could beseasonal, like the flu as well. "I would not be surprised if that happened,"Fauci concluded.From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Thu, 20 Feb 2020 15:15:05 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: inquiry/suggestion re Corona virus->Please handle.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Alan DiCara Cb) (6)Sent: Wed nesday, February 19, 202-0- -8-:1-9~ ~PM To: Fauci, Anthony (NIH/NIAID) [E) (b)(6)Cc: NIAID Ocpostoffice (NIH/NIAID } <OCPOSTOFFICE@niaid.nih.gov>Subject: inqu iry/s uggestion re Corona virus->2.19.2020Dear Dr Fauci,Thanks so much for being who you are and for dedicating yourlife to protecting all of us. I write because I saw your interviewon PBS tonight and had a question pertaining to denominatorsand numerators. Please know that I profess absolutely noexpertise in areas pertaining to biology nor medicine nor diseaseand while I understood and agree with your estimation that thefatality rate of the Corona virus to date may be somewhatinflated of the number of cases is understated, I have a relatedNIH-001717NIH-001718question for you regarding info I was able to find at thissite https://www .worldometers.info/coronav irus/Regarding data this site reports, among many things, and asone scrolls down, that the 'number of active cases' reportedtoday is 57,228 and the number of these that are 'serious orcritical' is 12,064. In a worst case scenario, and taking the12,064 as the numerator and dividing it by a denominator of57,228, we get 21 .08, or about 21 %, much higher that the 1 %based on total deaths over total cases so far. Of course this is notfair but my question is this: can we know better how many ofthe patients (cases) who are 'serious or critical' and still beingtreated will recover?Thanks much for any reply-Alan DiCara, Winsted, CTFrom:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Thu, 20 Feb 2020 12:39:25 +0000David KatzSubject: RE: CoronaVirus Epidemic -- a ThoughtDavid:Thanks for the note. I hope that all is well with you. Although allogeneic/semiallogeneicblood transfus ions could be an interesting approach to serious COVID-19 disease, there are a number of existing drugs such as remdesivir (nucleotideanalogue) and Kaletra (protease inhib itor) that have some pre-clinical activityagainst the virus and these are now being tested in randomized clinical trials.Best regards,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: David Katz Cb()6 )Sent: Wed nesday, February 19, 2020 6:02 PM -----~~ To: Fauci, Anthony (NIH/NIAID) [E] ------- (b)(6)> Subject: CoronaVirus Epidem ic -- a Though tDear Tony,It has been some time since we last spoke, but this currentcatastrophe has provoked my thinking about possibletherapeutic interventions that could be immediatelyemployed -- in advance of therapies/vaccines that will takeNIH-001723NIH-001724many months to create. And I need to share thosethoughts with you.My suggestion is to treat actively-infected, and acutely ill,patients ( under carefully controlled procedures) withallogeneic/ semi-allogeneic blood transfusions . Theresulting GVHD response should theoretically combat, anderadicate the viral infection.I look forward to your thoughts on this suggestion.With best wishes to you and your family,DavidFrom: Fauci, Anthony (NIH/NIAIO) [E)Sent: Thu, 20 Feb 2020 10:51:23 +0000To: Conrad, Patricia (NIH/NIAID) [ElCc: Mars ton, Hilary (NIH/NIAID) [ElSubject: FW: GPMB: MESSAGE ON BEHALF OF THE CO-CHAIRS: PROPOSED BOARDTELECONFERENCETO DAYFYIFrom: Amelie RIOUX- --------- (b)(6)> Sent: Thursday, February 20, 2020 2:00 AMTo: As Sy (b)(6)>; Gro Harlem Brundtland (b) (6); 'Dzau Victor'------- (b)(6); Chris Elias (b)(6); Fauci, Anthony (NIH/NIAID) [El (b)(6); Fore Henrietta (b)(6l:>; Gao Fu(b)( ; Gashumba Diane (b)(6); Ilona Kiekbusch =======:::'-= (b)(6); Suzuki Yasuhiro (b)(6) ========~= -.-:------=====Cb=H6;- JV-ega Morales Jeanette (b)(6); VijayRaghavan Krishna swam y (bT(6h ; Skvortsova Veronika (b)(Cc: (b)(6)Tore Goda! (b)( ; Godal, Tore (b)(6)Subject : GPMB: MESSAGEO N BEHALFO F THE CO-CHAIRS: PROPOSED BOARD TELECONFERENCETO DAYImport ance: HighMESSAGE ON BEHALF OF THE GPMB CO-CHAIRS DR BRUNDTLAND AND MR SYDear Board Members,We would like to hold a teleconference of the Board today, 20 February at 13:00 Geneva time.The agenda for the call would be as follows:• Short update and stock taking on the coronavirus outbreak ;• Functioning of the Secretariat and improving effect iveness of the Board ;• Way forwardPlease note that this call wou ld be a closed discussion, for Board members only.We would appreciate if you could confirm your partic ipation to Amelie Rioux (at --------(b)(6)We will share with you shortly the call-in details .Thank you for your support and continued engagement . We look forward to the call.With kind regards ,Gro and AsNIH-001725From:Sent :To:Subject :Fauci, Anthony (NIH/NIAID) [E)Thu, 20 Feb 2020 03:43:40 +0000Sharon RockefellerRE: This evening's broadcastThanks, Sharon.and integrity.Best regards,TonyIt is always a pleasure to be on the PBS NewsHour. They are high on honestyFrom: Sharon Rockefeller <srockefeller@we ta.org>Sent : Wednesday, February 19, 2020 8:33 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject: This evening's broadcastDear Dr. Fauci,Thank you, once again, for appearing on the PBS News Hour and for treating so many Coronaviruspatients. Your gift of calm and clear explanations to normal people is unparalleled. Please do notexhaust yourself as you help so many others. (b) (6).Very sincerely ,SharonSent from my iPhoneNIH-001729From: Fauci, Anthony (NIH/NIAIO) [E)Sent: Thu, 20 Feb 2020 00:54:10 +0000To: Crawford, Chase (NIH/NIAID) [ElCc: Billet, Courtney (NIH/NIAID) [El;Folke rs, Greg (NIH/NIAID) [El;Conrad, Patricia(NIH/NIAID) [El;Haskins, Melinda (NIH/NIAID) [E];Selgrade, Sara (NIH/NIAID) [ElSubject: RE: Requesting your assistance: Draft NIAID Insert for Upcoming CoronavirusHearingsAttachments: Draft NIAID insert for COVID-19 hearings_to ASF - with Fauci tracked edits.docxHere it is. Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone . (b)(6)FAX: (301 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Crawford , Chase (NIH/NIAID) [El --------- (b)(6) Sent: Wednesday, February 19, 2020 6:16 PM ------ ~= To: Fauci, Anthony (NIH/NIAID) [E) (b)(6)Cc: Billet, Courtney (NIH/N IAID) [El (b)(6)>; Folkers, Greg (NIH/NIAID) [E](b)(6)>; Conrad, Patricia (NIH/NIAID) [El (b)( ; Haskins, Melinda(NIH/NIAID) [El (b)(6)>; Selgrade, Sara (NIH/NIAID) [El (b)(6)>Subject: Requesting your assistance: Draft NIAID Insert for Upcoming Coronavirus HearingsDr. Fauci:In preparation for the upcoming COVID-19 hearings of the House Committee onEnergy and Commerce Health Subcommittee and the Senate Committee on Health,Education, Labor and Pensions, we have drafted the attached N1AID insert forinclusion in the combined HHS statement for the record. The Department plans touse the same combined statement for both the House and Senate hearings.NIH-001735The attached draft has been reviewed by the Divisions and Drs. Harper, Eisinger,Lerner, and Marston , as well as Courtney Billet, Martin Johnson, Greg Folkers,and Laurie Doepel.The Deparb.nen t has asked to receive your statement by COB tomorrow, Feb .20th.Thank you for your help.ChaseChase Crawford, D.V.M., M.S.Public Health AnalystLegislat ive Affairs and Correspondence Management BranchOffice of Communicat ions and Government RelationsNIAID/NIH/DHHSBldg. 31, Room 7A17, MSC2520Bethesda, MD 20892-2520(b)(6JDisclaimer:The information in this e-mail and ony of its attachments is confidential and may contain sensitive information. It should not beused by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender anddelete it from your mailbox or any other storage devices. National Institute of Allergy and Infec tious Diseases shall not acceptliability for any statements made that are sender 's own and not expressly made on behalf of the NIAID by one of itsrepresentatives.NIH-001736From:Sent :To:Fauci, Anthony (NIH/NIAID) [ElWed, 19 Feb 2020 23:03:23 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: BioCentury coverage of mAbs to treat COVID-19Please han dle.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Karen Tkach Tuzman <ktkach@biocentury .com>Sent : Wednesday, February 19, 2020 5:56 PM -------=-:--:= To: Fauci, Anthony {NIH/NIAID) [El (b)(6)Cc: Conrad, Patricia (NIH/NIA ID) [E] (b)(6)Subject: BioCentury coverage of mAbs to treat COVID-19Import ance: HighDear Dr. Fauci,I hope all is well. BioCentury is doing a roundup of companies and institutions developing antibodiesagainst the SARS-CoV-2 virus to treat patients with COVID-19. Since you told my colleague Steve UsdinNIAID is developing its own mAbs against the virus, we'd like to include informat ion about that programin our roundup .Would you or one of your colleagues be able to answer the following questions? Any information youcould share by 5 PM Pacific Time on Thursday, Feb. 20 would be greatly appreciated .1. Are your mAb candidates being developed against specific targets on SARS-CoV-2? If so, whatare those targets?2. What platforms or processes are you using to identify mAb candidates?3. Do you have multiple mAb programs against SARS-CoV-2 proceeding in parallel, and if so, howare they distinguished?NIH-001737NIH-0017384. What is that status of each of your mAb programs? For example, have you nominated any leadcandidates, are you awaiting patient samples, etc.?5. Do you have any metrics on lead candidates available yet, such as neutra lization titers? If so,what are they?All the best,KarenKaren Tkach Tuzman, Ph.D.Head, Discovery & Preclinical DevelopmentAssociate Editor, BioCentury Inc.650-595-5333 x 144 (office )www .biocentu ry.comNotice: This communication (including any attachments) constitutes an electronic communication withinthe meaning of the Electronic Communications Privacy Act, 18 USC 2510, and its disclosure is strict lylimited to the recipient(s) intended by the sender of this message. This communication (including anyattachments) contains proprietary information, is protected under U.S. and foreign copyright and otherintellectual property law, and may contain confidential material for the sole use of the intendedrecipient. Any unauthorized review, use, disclosure, dissemination, copying or distribution of thiscommunication (including any attachments), or any of their respective contents, is strictly prohibited. Ifyou are not the intended recipient, please contact the sender by return email and destroy all copies ofthe original message.From:Sent:To:Fauci, Anthony (NIH/NIAI0) [E)Wed, 19 Feb 2020 20:27:04 +0000Conrad, Patricia (NIH/NIAID) [ElCc: Greg Folkers (b) (6)Subject : FW: Invita ti on to SpeakAttachments: lnvitation_Dr. Anthony Fauci.pdfPatty/Greg:Let us discuss.ASFAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail · (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Crow, Hilary <HCrow@USChamber.com>(b) (6)>Sent: Wed nesday, February 19, 2020 12:35 PMTo: Fauci, Anthony (NIH/NIAID) [El -------- Subject : Invitation to SpeakDear Dr. Fauci,I'm writing to share the attached invitation with you to speak at the U.S. Chamber Foundation's programon March 10 on the future of medicine.Our audience of CEOs, market leaders, and opinion leaders would be thr illed to learn more about yourperspective on the future of medicine, current issues like the Coronavirus , and futu re challenges inhealth and med icine.Please let me know if you have any questions. I'm happy to schedule a quick call to provide more detailover the phone with you or someone on your team.I hope you will be able to join us.NIH-001739Best,HilaryHilary CrowExecutive Director, ProgramsU.S. Chamber of Commerce Foundation1615 H Street, NW I Washington, DC I 20062-2000Office: 202.463.5710Mobile: ----(b)( G-~'& U..S ChamobfCe ro mmeFrocuen dationwww .uschamberfoun dation.orgNIH-001740From:Sent:To:Cc:(NIH/NIAID) [ElFauci, Anthony (NIH/NIAID) [E)Wed, 19 Feb 2020 16:51:27 +0000Marston, Hilary (NIH/NIAID) [ElConrad, Patricia (NIH/NIAID) [El;Folkers, Greg (NIH/NIAID) [El;Handley, GraySubject: RE: Invitat ion to the Consultation on Financing Coronavirus Disease 2019(COVID-19) Vaccine Development I Thursday, February 20, 2020 I 9:30am to 1:30pm I World BankHeadquarters, Washington DCIf they accept two people, you should go with Gray. Obviously, you should makeno commitments and when asked about policy issues, say that you will convey tome and we will get back to them.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(The information in this e-ma il and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone w ho is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From : Marston, Hilary (NIH/NIAID) [E] (b)(6)>Sent : Wednesday, February 19, 2020 10:09 AMTo: Fauci, Anthony (NIH/NIAID) [El (b)(6)Cc: Conrad, Patricia (NIH/NIAID) [El (b)( ; Folkers, Greg (NIH/NIAID) [El--------- (b)(6); Handley, Gray (NIH/NIAID) [E) (bH Subject : Re: Invitation to the Consultation on Financing Coronavirus Disease 2019 (COVID-19) VaccineDevelopment I Thursday, February 20, 2020 I 9:30am to 1:30pm I World Bank Headquarters,Washington DCHave you had a chance to discuss this world bank conference? You, Cliff and Libby received invites. AsGray has mentioned, this is a pledging conference, so we will need to be prepared to address funding(the person that attends wou ld need to be in sync with you on that).Obviously Cliff is on travel. Who would you like to have at the conference, if anyone?-h ilaryNIH-001741From: Anthony Fauci (b)(6)>Date: Friday, February 14, 2020 at 9:25 PMTo: NIAID AM <NIAIDODAM@niaid .nih.gov>Subject: FW: Invitation to the Consultation on Financing Coronavirus Disease 2019 (COVID-19)Vaccine Development I Thu rsday, Februa ry 20, 2020 I 9:30am to 1:30pm I World BankHeadquarters, Washington DCLet us discuss.From: Feng Zhao <fzhao@wor ldbank.org>Sent: Friday, February 14, 2020 5:22 PM To: Fauci, Anthony (NIH/NIAID) [E] ---------------- (~b)(=6) Cc: (b)(6); Mukesh Chawla <mchawla@worldbank .org>; Rocio Schmunis<rschmunis@worldbank .org>; Adrienne Kate Mcmanus <amcmanus@worldbank .org>; Gabrielle LynnWilliams <gwill iams1@worldbank.org >; WB Health Events <wbhea lthevents@worldban k.org>;Muhammad Ali Pate <mpate@worldba nk.org>Subject : Invitation to the Consultation on Financing Coronavirus Disease 2019 (COVID-19) VaccineDevelopment I Thursday, February 20, 2020 I 9:30am to 1:30pm I World Bank Headquarters,Washington DCDear Dr. Fauci,On behalf of the World Bank health team, in coordination with the Coalition for Epidemic PreparednessInnovations (CEPI), it is our pleasure to invite you to a half-day consultation on Financing CoronavirusDisease 2019 (COVID -19} Vaccine Development . The meeting is set to take place on Thursday, February20, 2020 from 9:30am to 1:30pm at the World Bank Offices in Washington DC (located at 1818 H StNW) on floor C2, conference room MC C2-125.As you know, the novel Coronavirus outbreak, which started in Wuhan, China, is evolving rapidly. As oftoday, the number of confirmed cases has increased significantly to over 60,000 and the virus hasreached 25 countries. The outbreak, a Public Health Emergency of International Concern (PHEIC), posesa threat to countries worldwide, especially those with weak health systems and low levels of pandemicpreparedness.It is of urgent importance that we move quickly to finance the development of the appropriatecountermeasures for a disease that risks becoming endemic across the globe. Two critical issues arenecessary to address: i) immediate financing for the development and scale-up of a diversified portfolioof vaccines, and ii) financing the manufacturing and procurement of vaccine for global distribution.To enhance our discussions we are working on a background paper which we will share along with anagenda at the earliest. Recognizing the short notice, we will provide remote connection details for thoseunable to travel for the meeting. A working lunch will also be provided.We hope that you will be able to participate in this important meeting. Kindly confi rm your participationto Ms. Gabrielle Williams, Health, Nutrition and Population Global Practice, World Bank(wbheal thevents@wo rldbank.org ). Please do not hesitate to reach out with any questions .NIH-001742NIH-001743Looking forward to your posit ive response.Best regards,Feng ZhaoFrom:Sent :To:Subject :Fauci, Anthony (NIH/NIAIO) [E)Wed, 19 Feb 2020 16:16:33 +0000Conrad, Patricia (NIH/NIAID) [ElFW: Potentia l Speaking Engagement: Winter 2021Please RSVP sor ry no. Too busy.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Andrew Turley Cb) (6)(b) (6J>Sent: Wednesday, February 19, 2020 10:26 AMTo: Fauci, Anthony ,.(.N.:_IH_:/.N...I_A ID_):_ [_E.:l. ...:..!=::=~~---- ..Cc : Andrew Turley (b)(6)>Subject : Potential Speaking Engagement: Winter 2021Dear Dr FauciI know th ings must be impossibly busy right now with the current coronavirus issues but wanted totouch base to see whether you may be interested in a speaking engagement next Spring as part of our(b)(6)A bit about me: I am a (b)(6)Air Force Major General and retired SES from the Department of Defense.(b)(6)is an associate professor emeritus from the School of Medicine and HealthSciences at the George Washington University . We are both longtime admirers.(b)(6) consists of people drawn from a wide variety of backgrounds, including doctors, lawyers ____.._and many from the senior tiers of the finance and corpo rate worlds up to and including former CE Os andother executives (and even a few retired senior government folks like me). It is an active, well-read andlearned community with a keen interest in current events. As an example, we have a very active ForeignPolicy Association chapter that always draws folks from across the spectrum of political and policyperspectives for interesting and well -info rmed discussions.NIH-001744Ou (b)( speaker series consists of presentations on a vast array of subjects, from literature and artto current events and public policy issues. Typically held on Tuesdays nights from December throughApril, these sessions consist of a presentation of an hour or so followed by Q&A and general discussion.We always draw standing room only crowds.Recent and upcoming speakers have included:(b)(6)The recent coronavirus outbreak has captured the interest of the nation and the world. Our folks wouldbe extremely interested in how organizations such as NIH respond and address these incrediblechallenges. A presentation by you about your work on these issues, from your groundbreaking work onAIDS onward or any other topic of your choosing, would be absolutely the height of our season.We pay transportation, lodging, an honorarium, and could even arrange for a round of golf at one of ouroutstanding golf courses! (Of equal importance is that we can offer you a brief respite from the cold ofwinter.). There are direct flights from Washington DC to West Palm Beach. We have openings inJanuary, February and March 2021.We wou ld be deeply appreciat ive of your favorable consideration. Please feel free to contact me if I cananswer any questionsF. ANDREW TURLEY(b)(6)CELL:HOM E:NIH-001745From:Sent:To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Wed, 19 Feb 2020 14:42:50 +0000Greg Folkers (b)(6)FW: Clip of Or. Fauci on NPRGood interview on NPR. Possible for Director's Page.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Lindsey Beall <lbeall@scgcorp.com>Sent: Wednesday, February 19, 2020 8:22 AMTo: Deatrick, Elizabeth (NIH/NIA ID) [C] ---------=- (b.),(.=. >; Pekoe, Ken (NIH/NIAID) [El(b)( Conrad, Patricia (NIH/NIAID) [El (b)( ; Fauci, Anthony"(:N"""1'"H.."""/'"N':.-":-1"A"'~I.D"-'):--[:E-~l====----~ (b")"("=",>; Ooepel, Laurie (NIH/NIAID ) [El (b)(6); --------- F o Iker s, Greg (NIH/NIAID) [El (b)( ; Hoffman, Hillary (NIH/NIAID) [El(b)(6); Oplinger, Anne (NIH/NIAID) [El (b)(6); Rancourt, Anne"(:N'":"l.'H.""./7':N'."' .I"A'."l'"'D:."'):.--[~:E:)-===:::::.:._:,__,:;:~ (b.H.,=... ; Lavelle, Judith (NIH/NIAID) [El (b)( ;Leitman, Laura (NIH/NIAID ) [E) (b)(6)•>; Stover, Kathy (NIH/NIAID) [El--------(b)( •>; Routh, Jennifer (NIH/NIAID) [El (b)( >; NIAID OD AM <NI A100 DAM@ n i aid. n i h. gov>; Awwad, David (NIH/NIAID) [CJ (b)(6)Cc: Osvald, Maria <mosvald@scgcorp.com>; Fabry, Cynthia (NIH/NIAID) [El --------(b)(6); Meyl in Correa <mcorrea@scgcorp.com>; Ma rcia Bache <mbache@scgcorp.com>; Megan Schartner<MSchartner@scgcorp .com>Subject: Clip of Dr. Fauci on NPRGood morning,Below is a clip of Dr. Fauci discussing corona virus on NPR's Morning Edition. This clip airedearlier this morning .NIH-001746NIH-001747https://app.criticalment ion.com/a pp/#/clip/publ ic/1 b0da 123-0cd? -40 12-90a6-b82d27c73 l 91 ?show sentiment=fa lseThanks,LindseyFrom: Critical Mention <do-not -reply@crit icalment ion.com>Sent: Wednesday, February 19, 2020 8:18 AMTo: Lindsey BeallSubject: Critical Ment ion: Megan Schartner has shared a Radio Ment ion with youe critical • e e ment1on You're always on it with Critical Mention .Megan Schartner has shared a RadioMention with you!From Megan Schartner (mschartner@scgcorp .com)No Program Name AvailableRadioProgram Name No Program Name AvailableSource WLRNFMMarket OMA: 16 Miami, FLTime Feb 19, 2020 8:07 AM ESTClip Length 07: 16.852it's morning edition from n. p. r. news on david green in culver city califomia and amilitant in washington d. c. good morning in china the death toll from the corona virushas hit two thousand world leaders in public health officials are trying to contain it butnew infections keep showing up earl golden for example he was a passenger on thediamond princess that's the cruise ship where hundreds of people got the virus wetook an aquatic clues to also alone what went wrong who knew we were going andthe crew and beautiful omar here's how he ended up in omaha earl his wife jerrywere quarantined on that ship for twelve days in a felt fine the whole time but thenthe gun on a flight back to the u. s. and earl started feeling sick or wind burke fromjapan to this day about two hours into the flight they woke up with a high fever afternapping a little bit and the doctors on board confirmed the and then on the flightlanded he tested positive for the coronavirus he's recovering now in a bio containmean unit at the university of nebraska's medical center he's going to have to spendfourteen days there and isolation well you know working %hesitation %hesitationcatering we've heard on a but one of the two days of the different doctors each day iNIH-001748NIH-001749didn't have a clue but got a little cough still you can you might want to debate left meand i'm a little to keep but maybe also because of the jet lag in the travels andeverything else on top of it no it doesn't feel any different than you know recuperatingfrom a regular coal earl's wave jerry hasn't been diagnosed with the virus is she'sbeing monitored in a different part of the hospital but their case is a good example ofsome things we know and some things we don't know about how this virus isspreading so we have called doctor anthony fauci he's director of the nationalinstitute of allergy and infectious diseases good morning sir good morning so earlcoleman was fine all those days on the ship then he gets on a plane and he gets afever what does that tell us about how this virus is spreading well the virus has theability to bind it to certain cells in your body particularly in your long so you can getanything from miles a symptomatic illness to a cough and a fever to some peopleabout oh about twenty percent of the people come to the attention of medical thanphysicians in health care providers can get serious pneumonias requiring intensivecare it sounds like this individual is on the %hesitation mild side of the illnessbecause as he said it doesn't feel much more than just a common cold and as amatter of fact corona viruses in general prior to this all one of the causes of thecommon cold okay so what does that tell us i mean bleary often looking at the caseswe're looking at a rising death toll which is tragic we look much less at the people likeearly say you know my voice is raspy a had a fever had a cough the years a widerange of stuff symptoms with this virus did do do we know why some people seem tobe doing okay and other people are getting hit really hard well whether a couplethings about that for the first thing is that any any kind of viral infection or anypathogen infection there's always a wide range of responses in the sense almost likea bill shaped curve some people get no sim is at all and we do have a symptomaticcorona virus infection with this particular episode and then there's the bulk of peoplewho get some sort of symptoms and then a small percentage of people do reallyreally very poorly now that relates to the ability of the body to handle the virus andthe one thing we know when it's not unique to this virus is that the elderly those withunderlying conditions like chronic heart disease lung disease diabetes obesity theytend to get more complications much more than for example and otherwise healthyindividual and that's the reason why if you look at the death rate which is around twopercent for this disease at this time it is disproportionately high are among the elderlyand particularly those who have underlying conditions this is interesting questioncarlin is wave terry presumably they work together the entire time they werequarantined right and if he gets the virus she does not did she just get lucky do somepeople have some sort of immune undefended don't it's a combination that's a goodquestion it's a combination of both there is no virus that has one hundred percentattack rate even the most of infectious of all viruses like measles doesn't get ahundred percent of of %hesitation vulnerable people but respiratory virusesparticularly things like influenza or the corona virus the attack rate is buryingpercentage and it was if he was really likely that his wife i don't think she necessarilyhad any on the line immune protection though that's possible the maybe some crossreaction of immune protection with other %hesitation microbes that she came intocontact with but in most likely is as you suggest the luck of the draw okay interestingand they got to patching wondered if you could clear something up because we'vebeen hearing reports about so called super spread ours these you who spread thevirus to a very high a number of other people and it sounds like a scary thing but andi just under is this a real phenomenon there that there are people who give the virusto more people than most and why is that happening well it is certainly thephenomenon of the super spreading israel we story with sars back in two thousandtwo and two thousand in three and they're episodes already with this particular newcorona virus and it's a combination of two things it's an individual whose either at aparticular moment in time shedding a very large amount of virus which makes itmuch easier to infect a group of people who are around him but you also see itsometimes in the hospital setting when you have a number of health care providerstaking care of someone and that person is shedding a lot of virus so the shortanswer to your question is there are super spread is and it's a real phenomenonokay okay what we would you say at this moment is the most important or the mostpressing question about this virus that we don't have answers to yet well what wedon't know for sure we know that there are people who are infected will withoutsymptoms or very minimal symptoms they hardly notice they're infected well we don'tknow is the extent to which people who have no symptoms are spreading it so we doknow that this can occur because we have anecdotal documented cases of peoplewho do not have symptoms who actually have infected someone usually a familymember but we don't know the extent to which this cars in the broad component ofthis outbreak doctor anthony fauci the director of the national institute of allergy andinfectious diseases sir thanks for joining us it was a pleasure to be with youCntical Me111iona llows users to SP,archg lobal TV Radio. Onlire News & Social from the United States Canada. and Eur:ipe watchvideo, edit and share coverage rere1ve real-lime emai alerts. build reports, and analyze coverage through word clouds and graphs.·Nant lO learn more about Crittcal Menton? Sign up ror a den,c ~ -NIH-001750NIH-001751From: Fauci, Anthony (NIH/N IAID) [E)Sent : Wed, 19 Feb 2020 13:03:08 +0000To: bdoherty@mrns.orgCc: lbaden@nejm.org;Fauci, Anthony (NIH/NIAID) [E];Redfield, Robert R.(C0C/O D);Lane, Cliff (NIH/NIAI D) [E];Eisinger, Robert (NIH/NIA ID) [E]Subject : RE: New England Journal of Medicine Editoria lAttachment s: H. Cliffo rd Lane's ICMJE-2013 - For Coronavirus Editorial Fauci et al -.pdfBriana:Cliff Lane has separately sent his signed CTA. I am attach ing his ICMJE Form. And so you should have all theforms for all 3 authors: Fauci, Lane, and Redfield. Please let me know if you have any questions.Best regards ,TonyAnthony S. Fauci , MDDirectorNationa l Ins titute of Allergy and Infectious Disease sBui lding 31, Room 7 A-0331 Center Driv e, MSC 2520Nat ional Institutes of HealthBethe sda , MD 20892 -2520Phone: (b) (6)FAX : (301) 496-4409E-mail: (b)(6)The information in this e-ma il and any of its attachments is confidential and may contain sensitive infom1ation . Itshould not be used by anyone who is not the orig ina l intended recip ient. If you have received this e-mai l in errorplease inform the sender and delete it from your mailbox or any other storage devices. The Nationa l Institu te ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIAID by one of its repre sentatives.-----Original Message -----From : Br iana Doherty <onbehalfof@manu scriptcentral.com >Sent : Monday , Febrnary 10, 2020 11:1-1- A-M- --~~ To: Fauci , Anthony (NlH /NlAID) [E] (b)( >Cc: lbaden@nej m.orgSubject: New England Jou rnal of Med icine Edito rialDea r Dr. Fauci ,I am delighted that you have agreed to write a signed editorial to accompany the article on the initial estima tes ofkey transm ission parame ters associated with nCoV-2019 virus by Li et al.The genera l purpose of the Journ al's editorials is to provi de the reader with an authoritative interpretation orelaboration based on the substance of the article. Since this substance is usually not within the average reader'sspecial com petence, such readers wi ll particularly benefit if the editorial avo ids techn ical jargon, explains theartic le's contribution to a field of knowledg e, and emphasizes, whenever possible, its clinical implications. Theeditorial commentary shoul d not be concerned excl usively with the article in question but rather should use thearticle as a starting point for a more genera l di scussion .Because editorials invo lve interpretation and opinion, you and your potentia l coauthor must be free of significantrelevant financia l associations (including equity interest, regular consultancies, or major research support) with acompany , or wi th a competi ng company , that stands to gain from the use of a product discus sed in the editorial.Please contact me immediately if you are conside ring a coauthor , sol can ensure that your candidate meets ourNIH-001756NIH-001757criteria. Additional information about disclosure of financial and other associations appe ars below this letter.Please bear in mind that your editorial represents your (and any coauthor's) personal opi nion. The Journal does notinclude statements of grant or other support or acknowledgments with editorials.Journal policy dictates that we must have on file a signed Copyright Transfer and Authorship Agreement from eachauthor before a manuscript can be accepted. Therefore, the enclosed form sho uld be signed by all authors and faxedto (781) 207-6529.Your editor ial is due at the Journa l on Monday, February 17, at the very latest if the deadline imposed by ourp1inting schedule is to be met. If the editorial is to include a figure, please submi t the figure at least one week beforethe due date for the editorial itself.*** Additional information about preparing and submitting your editorial is given below; please read it carefully.***The editors must reserve the right to edit (or even reject) your editorial, but whether we use it or not, the Journalcurrently offers a modest stipend of $300 .Thanks again for agreeing to write this editorial for the Journal. l look forward to receiving it.Sincerely yours,Lindsey R. Baden, M.D.Deputy EditorNew England Journal of Medicine10 Shattuck StreetBoston, MA 02115( 617) 734-9800Fax: (617) 739-9864http://www.ne jm.orgLENGTH OF YOUR EDITOR IALNEJM editorials should not exceed two printed pages. This means that your word count before editing should notexceed 750 words (approx imately 4500 characters) . Note that we spell out tiia l names and most other abbreviationsfor our readers, and we include trial registration numbers for any clinical trials mentioned; these will lengthen youreditorial if you have not included them. Please provide a title not exceeding 45 characters and a word count for thetext; the entire manuscript, including references, should be double-spaced.REFERENCESCite no more than 10 references, including the article you are writing about. The average collection of 10 referencesrequires about a quarter of a printed page.TABLE OR FIGUREA table or a figure in your editorial will requ ire a reduction in the number of words; because figures and table s varyin size, you may be asked to shmten the text of your editorial during the production process. A quarter-page tableroughly equals 250 words , and a half-page table roughly equals 500 words.DISCLOSURESWhen completing your disclosure form, please indicate, in the "Comments" field next to the type ofre lationshipbeing disclosed , the amount (in U.S. dollars) of any support you have received. Please also indicate how much ofthis support has been received over the past 2 years. Please e-mail your completed disclosure form toeditorial@nejm.org.NIH-001758ln the event of publication, each author's submitted disclosure form will be posted on the Web (with any dollaramounts redacted).COPYR IGHT TRANSFEREach author must complete a copyright transfer agreement form. Please sign it and fax it back to 78 1-207-6529 assoon as possib le.TO SUBMIT YOUR EDITORIAL*** It is important that you follow the instructions below to ensure that your article enters the correct queue. ***When you are ready to submi t your manuscript, please log in to the New England Journal of Medicine - ManuscriptCentra l site Q1ttp://mc05.manuscriptcen tral.com /nejm). Your case -sensitive USER ID is afauci@niaid .nih.gov. Forsecurity purposes, your password is not listed in this message. If you are unsure of your password , please visithltps ://mc05.manuscr iptccntral.com/nejm and enter your e-ma il address in the "Forgot Your Password?" field.Once you are logged in, the Main Menu will be displayed. Please click on the Author Center, where you will findthe manuscript listed under "Invited Manuscripts ." You can click on the "Continue Submission" button to beginsubmitting your article.NIH-001759Please wait. ..If this message is not eventually replaced by the proper contents of the document, your PDFviewer may not be able to display this type of document.You can upgrade to the latest version of Adobe Reader for Windows®, Mac, or Linux® byvisiting http ://www.adob e.com/go/reader_downl oad.For more assistance with Adobe Reader visit http ://www.adobe.com/go/acrreader.Windows is either a registered trademark or a trndemark of Microsoft Corporation in the United States and/or other countries. Mac is a trademarkof Apple Inc ., registered in the United S1ates and other countries . Linux is !he registered trademark of Linus Torvalds in the U.S. and othercountries.From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Wed, 19 Feb 2020 12:37:58 +0000Jon LaPookSubject: RE: CoronavirusIt means that you are an outstanding and committed journal ist . QAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone : CbH6JFAX: (301) 496-4409E-mail: (b)(6)The informat ion in this e-mail and any of its attachment s is confidential and maycontain sensitive informat ion. It should not be used by anyone who is not theoriginal intend ed recipient. If you have received thi s e-mail in error please informthe sender and delete it from your mailbox or any other storage devices. TheNational Institute of Allergy and Infectious Diseases (NIAID) shall not acceptliability for any statements made tha t are the sender's own and not expresslymade on behalf of the NIAID by one of its representatives.-----Original Message----- -------=-:-= From: Jon laPook (b)(6)Sent: Wednesday, February 19, 2020 7:36 AM To: Fauci, Anthony (NIH/NIAID) [E] ------------~-~- -- CbH6) Subject: Re: CoronavirusGot it . What does it mean that I'm waking up th inking about coronavirus?: )Jonathan LaPook, M.D.Chief Medi cal Correspondent, CBS NewsProfessor of MedicineNIH-001760NYU Langone HealthTwitter @DrlaPookOn Feb 19, 2020, at 7:33 AM, Fauci, Anthony (NIH/NIAID) [E]-------- CbH > wrote:Jon:Your hypothesis is certainly possible, but I think unlikely. In a NEJM paper forwhich I have just written an editorial, there were 400+ patients and none youngerthan 15 years old. I am certain that children from birth to 15 years were exposedto and primed by coronaviruses multiple times and so if 2nd infectionenhancement were an important issue, we should have seen it in children andadolescents 15 years old and younger. Just a thought, but anything is possible.Best,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious Diseases Building 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: CbH6JFAX: (301) 496-4409E-mail: CbH6)The information in this e-mail and any of its attachments is confidential and maycontain sensitive information . It should not be used by anyone who is not theoriginal intended recipient. If you have received this e-mail in error please informthe sender and delete it from your mailbox or any other storage devices. TheNational Institute of Allergy and Infectious Diseases (NIAID) shall not acceptliability for any statements made that are the sender's own and not expresslymade on behalf of the NIAID by one of its representatives.-----Original Message----- -------="'"'=" From: Jon LaPook CbH6JSent: Wednesday, February 19, 2020 7:26 AM ----------=-c-~ To: Fauci, Anthony (NIH/NIAID) [E] ---------- CbH6)NIH-001761NIH-001762Subject: CoronavirusGood morning, Tony,I woke up thinking this: given the relative sparing of young people during theCOVID-19 outbreak, could something similar to what happens with dengue begoing on? Could a second coronavirus infection - albeit with a genetically differentvariant than the first - bring about worse disease than the first? And, since up to athird of the common cold is caused by a variant of coronavirus, could older peoplesomehow have been primed by an earlier coronavirus infection?JonJonathan LaPook, M.D.Chief Medical Correspondent, CBS NewsProfessor of MedicineNYU Langone HealthTwitter @DrlaPookFrom: Fauci, Anthony (NIH/NIAIO) [ElSent : Wed, 19 Feb 2020 03:41:52 +0000To: Grigsby, Garrett (HHS/0S/OGA);Redfiel d, Robert R. (CDC/0D);Cetron, Marty(CDC/DDIO/NCEZID/DGMQ)Cc: Billet, Courtney (NIH/NIAID) [E]Subject: FW: Todays report from Dr Iwata From Kobe univ on Diamond Princess SHIPCOVID-19Folks:You should take a look at this video (see link). The person, who is a Japanese in fectiousdiseases specialist, is a bit inarticu late in the beginn ing of the video, but he provides a vivid anddisturbing description of the conditions on the Diamond Princess.TonyFrom: Larry Washburn< (b)(6)>Sent : Tuesday, February 18, 2020 9:43 PMTo: Fauci, Anthony (NIH/NIAID) [El------= (b")"c='6J>Cc: Hodes, Richard (NIH/NIA) [El (b)(6)Subject: Todays report from Dr Iwata From Kobe univ on Diamond Princess SHIP COVID-19Dr. Fauci,I am living in Japan (b)(6) and this morning I saw t his video released byDr. Kentaro Iwata a infectious disease contro l.specialistPlease have somebody on your staff review this ASAP short description of Dr lwata's 1 day visit on theship. He has experience with Ebola, Sars etc . He describes an alarming condition that you and CDCmust be aware of . Japan has no CDC and they tend to be very bureaucratic.https ://www . you tu be .com/wa t ch ?v=vt HYZkl u Kcl &featu re=youtu . beI apologize if you already have this information .Respectfu llyLarry Washburn (b) (6) Living in Japan ______ _,NIH-001765From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Wed, 19 Feb 2020 01:32:37 +0000Conrad, Patricia (NIH/NIAID) [E);NIAID OD AMSubject : RE: CROI COVID-19 Session; Tuesday March 10 lunchI am not that excited about doing this. They have CDC doing the Epi, which is fun. They haveRalph Bar ie doing the virology, which I easily can do , and they have me talking about whatNIAID is doing, which is important, but boring from a lecture standpoint.Greg:What say you?From: Conrad, Patricia (NIH/NIAID) [E] (b)(6)>Sent : Tuesday, February 18, 2020 8:22 PMTo: NIAID OD AM <NIAIDODAM @niaid.nih .gov>Subject: Fwd: CROI COVID-19 Session; Tuesday March 10 lunchSent from my iPhoneBegin forwarded message:From: Donna Jacobsen <djacobsen@ iasusa.org>Date : February 18, 2020 at 8:18:06 PM ESTTo: "Fauci, Anthony (NIH/NIAID) [E)"1~ =======:.~= Cc: "Conrad, Patr icia (NIH/N IAID) [E)" I CbH6">Ei,la ine J. Abrams, MD____ ..;___ ..,;_......; ..:..;...:...::::(:;b::):;=:ce":6':i;)j-;"::-S:-:h-a_r_o_n_H-i:l:"I.i "e.'r_P:-h:- D."(b)(6)1>, "Hoxie, James" ============-~~:--:----:--:-:. ------------ CbH6),] "Benson, Connie" ! CbH6)]>, Kevin Bowen <kbowen@iasusa.org >Subject : RE: CROI COVID- 19 Session; Tuesday M arch 10 lunch(resending with Patty's correct email address)Dear Dr Fauci:As I mentioned on the phone, we just today decided that we w ill have a special session onCOVID-19 at CROI. It will be on Tuesday, March 10, dur ing the lunch break; the initialgeneral structure will be a 10- to 15- minute overview of the epidemic (CDC), a 25-min talkby Ralph Sarac (UNC) about the viro logy of coronaviruses, and a 10- to 15-minutesummary on what NIAID/NIH is doing and planning. We thought that this being one of thefirst large med ical conferences in infec t ious diseases this year, t hat it is important that weaddress COVID 19 at CROI.NIH-001768We know that this is terribly last minute, but the CROI Chairs and Foundation are hopingyou are free to give the NIAID/NIH update . CROI is in Boston, March 8 to 11.If you think you would be able to do this, we will send a more formal communication w ithdetails and work with Patty on the specifics. Thank you so much Dr Fauci; we hope you willbe able to join us.Best,DonnaDonna M. JacobsenExecutive Director /PresidentInternational Ant iviral (formerly AIDS) Society -USA131 Steuart St, Ste 500San Francisco, CA 94105415 -544-9400https ://www.iasusa .org~ACCMfAbout IAS-USA : Established in 1992, the IAS- USA is a not-for-profit ,professiona l education organization. The mission of the IAS-USA is to improve theprevention, treatment, care, and quality of life for people with or at risk of HIV, hepatitis Cvirus, or other viral infections through high -quality, relevant, balanced, and needs-orientededucation and information for practitioners who are actively involved in medical care. Theorganizat ion's educational activities are particularly intended to bridge clinical research andpatient care .Confidentiality Notice : This e-mail and its attachments may contain privileged andconfident ial informat ion intended solely for the use of the IAS-USA and the recipient(s)named above . If you are not the intended recipient. or the employee or agent responsiblefor delivering this message to the intended recipients , you are hereby notified that anyreview , dissemination, distribution, printing, or copying of this e-mai l message and/or anyattachments is strictly prohibited . If you have received this transmission in error , pleasenotify the sender immediately and permanently delete this e-ma il and any attachments.NIH-001769From:Sent:Fauci, Anthony (NIH/NIAIO) [E)Wed, 19 Feb 2020 00:28:47 +0000To: Retzlaff, JonSubject: RE: ACTION: Invit ation to Provide Opening Remarks at the NIH-AACR Cancer,Autoimmunity, and Immunology Conference on March 23rd (on the NIH campus)Not inte rested right now. Too busy. Have Hugh or someone else do this.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Retzlaff, Jon <jon.retzlaff@aacr.org>Sent: Sunday, February 16, 2020 6:12 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E) Cc: Barasch, Kimberly (NIH/NIAID) ~[C)-- =-=-=-=-=-=-(b)=-(6)-=> -~(b-)(=6)>=; C onrad, Patricia (NIH/NIAID) [E) (b) ( 6}>Subject: ACTION: Invitation to Provide Opening Remarks at the NIH-AACR Cancer, Autoimmunity, andImmunology Conference on March 23rd (on the NIH campus)Dear Dr. Fauci ,It's pretty clear that you have been ridiculously busy over the past month+ serving as our nation'stop infectious disease doctor! Thanks so much for yom leadership and dedicat ion, Dr. Fauci!I'm actually reaching out to you on a topic other than the coronavirus, as I am writing on behalfof the co-chairs for an important NIB-American Association for Cancer Research (AACR)conference (the NIH-AACR Cancer, Autoimmunity, and Immunology Conference) that willbe taking place on March 23-24, 2020 , on the NIH campus (in the Masur Auditorium in theNIH Clinical Center).The co-chairs would like to invite you to be the opening speaker on Monday, March 23rd. Dr.Sharpless will be the opening speake r on Tuesday, March 24th . Please see the attached draftagenda.NIH-001770Now in its third year, the Cancer, Autoimm unity, and Immunology Conference focuses on: 1)understanding the biology of immune-related adverse events which have occurred in cancerpatients trea ted with immunotherapies and how that might inform the study of autoimmunedisease , and 2) defining the potential for the study of autoimmune disease to lead to greaterunderstanding of the treatment and management of immune-related adverse events during andfollowing cancer therapies. The goal of this interdisciplinary conference is to bring togetherpeople who might not typically interact to promote cross-fertilization for the betterment of bothresearch and clinical care, which is why there are four NIH !Cs very much involved in theConference, including: NCI, NIAID, NIAMS, and NIDDK.Chairing this effort on behalf of the AACR is Julie R. Brahmer, MD, Johns Hopkins Univers ity.From the NIH, we have Elad Sharon , MD, MPH, NCI; Ravi Madan , MD, NCI ; ConnieSommers, PhD, NCI; Howard Young , PhD, NCI; Katarzyna Bourc ier, PhD, NCI; MarieMancini , PhD, NIAMS; Annette Rothermel , PhD , NIAID; and Lisa Spain , PhD , NIDDK.I know the diverse audience, including patients , researchers , clinicians, industry , regulators, andothers, would be thrilled by your presence. Of couTse, we also know that you have pa1ticipatedin the previous two conference on this topic, which underscores why they would love to haveyou participate again!Plea se let us know at your earliest convenience if you are interes ted and able to participate in theconference on Monday, March 23rd. ff you have additiona l questions or concerns, you cancontact me at jon.retz laff@aacr.org or (b)(6)Thanks again , Dr. Fauci , and I look forward to hearing from you !JonJon Retzlaff, MBA, MPACHIEF POLICY OFFICERVICE PRESIDENT, SCIENCE POLICY AND GOVERNM ENT AFFAIRSOffice of Science Policy and Government AffairsAAG American Associationfor cancer ResearchFlNDINGCURES TOGETI;ER 'American Association for Cancer Research1401 H Street. NW. Suite 740 I Washin gton. DC 20005202-898-6499 Direct I 267-765-1087 Fax Ijon.retzlaff@aacr.org I www.AACR.org11 c mi am •+:Pili(b)( CellPlease note that this e-mail and any files transm itted wilh it may be privileged, confidentia l, and protected from disclosure under applicable law. Thisinformation is intended only for the person or entity to which it is addressed and may contain confidential or privileged material. Any review,NIH-001771NIH-001772retransmission, dissemination, or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intendedrecipient is prohibited. If you received this in error, please contact the sender and delete the material from any computer.From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Wed, 19 Feb 2020 00:23:40 +0000Eisinger, Robert (NIH/NIAID) [E]Subject: FW: New England Journal of Medicine - 20-02387FYI. Just to keep an eye on this. Thanks.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBui I ding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b) (6)FAX: (30 I) 496-4409E-mail: (b)(6) -------- The information in this e-mail and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipient. If you have received this e-mail in eITorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseas es (NIAID) shall not accep t liability for any stat ements made that are the sender's ownand not expressly made on behalf of the NIAID by one of its representa tives.-----Original Message-----From: New England Journal of Medicine <onbehalfof@manuscriptcentral.com>Sent: Tuesday, February 18, 2020 10:4-1- A-M- ---~~ To: Fauci, Anthony (N1H/N1AID) [E] ______ (b)(6);Lane, Cliff(NIH/NIAJD) [E].,....,._..._, ._., _.....,...(.b_)_(, __>. ; Redfield, Robert R. (CDC/OD) (b)(Subject: New England Journal of Medicine - 20-02387Dear Dr. Fauci,Thank you for submitting your manuscript, "COYID-19 : Navigating the Unchartered" to the New England Journalof Medicine.Your manuscript has been fo1warded to members of our editorial staff, wbo will make an initial evaluation anddecide whether it merits further consideration. You will be notified of the decision as soon as possible.Your manu script TD is 20-02387.Please mention the above manuscript ID in all future conespondence or when calling the of.fice for questions. Ifthere are any change s in yow· street address or e-mail addre ss, plea se log in to ScholarOne Manuscript s athtt:ps://mc05.manuscr ip tcentra l.com/nejm and edit your user infom1a tion as appropriat e. You may al so view thesta tus of your manuscript at any time by checking For Authors section of the site.We are undert aking evaluation of y our manu script with the understanding tha t neither the substance of the articlenor the figures or tables have been published or will be submitted for publication elsewhere during the period ofreview.Please provide the editors with copies of other manuscripts by you or your coauthors addressing similar or relatedresearch questions that are in preparation or under consideration at other journals. This does not apply to abstractspublished in connection with sdentific meetings or to news reports based on presentations at such meetings.The Journal's policy is explained more fully at http://www.nejm.org/page/author-center/editorial-policies.NIH-001773NIH-001774Please call us at 617-734-9800 if you have any questions.Sincerely,Eric J. Rubin , MD, PhDEditor- in-Ch iefNew England Journal of MedicineIO Shattuck StreetBoston, MA 02115(617) 734-9800Fax: (617) 739 -9864http: //www .ne jm.orgFrom:Sent:To:Subject:Fauci, Anthony (NIH/NIAI0) [E)Tue, 18 Feb 2020 23:57:32 +0000Conrad, Patricia (NIH/NIAID) [ElRE: draft response for NBC on lineSee my minor tweekAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Conrad, Patricia (NIH/NIAID) [El- ---------(b)(6) Sent: Tuesday, February 18, 2020 2-:4-8- P-M- ---:a ~aa, To: Fauci, Anthony (NIH/NIAID) [El (b)(6J> ________ ,.Subject : FW: draft response for NBC on lineOk any edits? Pis advisePatricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNat ional Institute of Allergy and Infectious DiseasesThe National Inst itutes of Health31 Center Drive, MSC 2520 - Room 7 A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaimer:The informat ion in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be usedby anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices. National Institute of Allergy and Infectious Diseases (NIAID) shall not acceptliability for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representalives.NIH-001775From: Routh, Jennifer (NIH/NIAID) (E] ---------- (b)(6) Sent: Tuesday, February 18, 2020 2:47 PM --------~~ To: Conrad, Patricia (NIH/NIA ID) (E)- --------- (b)(6J1>; OCPLPressTeam < 0 CPL Press Te am@ o d. n i h. gov>Cc: NIAID COGCORE <COGCORE@mail.nih.gov>; NIAID Media Inquiries <mediaingu iries@niaid .nih .gov>Subject: draft response for NBC on lineReporter : Jacqueline Stenson(b)(6)Organization: NBC onlinePhone #(s): ------------------- Subject: COVI0-19NBC on line asked, "What is NIAID's position on whether the SARS-CoV-2 is transmiss ible inasymptomatic people?"I would propose that we send a response to Jacqueline attributed to ASF:Early case reports indicate in certain circumstances SARS-CoV-2 is transmissible in asymptomaticpeople. We do not know the extent to which asymptomatic transmission is impacting the outbreak.However, we know that people with symptoms are usually the main driver of outbreaks of otherrespiratory diseases.Jennifer Routh [E]News and Science Writing BranchOffice of Communications and Government RelationsNational Institute of Allergy and Infectious Diseases (NIAID)NIH/HHS31 Center Drive Room 7A17CBethesda, MD 20892Direct: (b) (Disclaimer : The information in this e-mail and any of its attachments is confidential and may contain sensitive informat ion. It should not beused by anyone who is not the original intended recipient. If you have rece ived this e-ma il in error please inform the sender and delete itfrom your mailbox or any other storage devices . The National Institute of Allergy and Infectious Diseases shall not accept liability for anystatements made that are sender's own and not express ly made on behalf of the NIAID by one of its representatives.NIH-001776From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Tue, 18 Feb 2020 23:32:19 +0000Dennis GoldenCc: Monica A GoldenSubject: RE: CoronavirusDenny and Monica:Many thank s for your kind note. l hope that all is well wi th you.Warm regards ,TonyAnthony S. Fauci , MDDir ectorNational Institu te of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Ins titutes of HealthBethesda, MD 20892-2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitive infom1ation . Itshould not be used by anyone who is not the original intended recip ient. If you have received this e-mail in errorplease inform the sender and delete il from your mai lbox or any other storage devices. The National Institu te ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIAID by one of its representatives.-----Original Message-----From: Dennis Golden ------- (b~)~(= >Sent: Tuesday , February 18, 2020 4:39 PMTo: Fauci, Anthony (NlH/NlAID) [E] ------~~Cc : Monica A Golden ---------- Subject: CoronavirusTony,Our thoug hts and prayers are with you as you profe ssionally address the horrid coro navirus transmission.We salute you for not "s uga rcoating" or trying to be "diplomatic " about the Diamond Princess Cruises shipquarantine process .As always, you proved yourself to be a courageous, honest and ethical man. A man who has always done the rightthing s.We stand with you !In Hoc Signo Vinces,Denny and Monica GoldenNIH-001777From: Fauci, Anthony (NIH/NIAIO) [E)Sent: Tue, 18 Feb 2020 22:06:38 +0000To: Selgrade, Sara (NIH/NIAID) [E)Cc: Billet, Courtney (NIH/NIAID) [E);Folkers, Greg (NIH/NIAID) [E);Conrad, Patricia(NIH/NIAID) [E);NIAID OCGR legSubject: RE: Requesting your assistance: Draft NIAID Statement for UpcomingAppropriations HearingsAttachments: Draft_NIAIO FY2021 Statement for the Record_to ASF - with Fauci trackededits.docxHere it is. Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : Cb()6 )FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Selgrade, Sara (NIH/NIAID) (E) (b)(6)>Sent: Tuesday, February 18, 2020 4:18 PMTo: Fauci, Anthony (NIH/NIAID) [E]------ -(-b=)(-=6)Cc: Billet, Courtney (NIH/NIAID) [E) (b)(6); Folkers, Greg (NIH/NIAID) [E]--------- (b)( ; Conrad, Patricia (NIH/NIAID) [E) (b)( >; NIAID OCGRl eg <NIAIDOCGRLeg@mail .nih .gov>Subject: Requesting your assistance: Draft NIAID Statement for Upcoming Appropriations HearingsDr. Fauci:In preparation for the upcoming NIH budget hearings of the House and SenateAppropriations Subcommittees on Labor, HHS, Education, and Related Agencies,we have drafted the attached NIAJD statement for the record, highlighting thetopics that you previously selected.NIH-001778We have a finn 3-page limit for the statement. It has been reviewed by theDivisions and Drs. Harper, Eisinger, Lerner, and Marston, as well as CourtneyBillet, Martin Johnson, Greg Folkers, and Laurie Doepel.NIH OLPA has asked to receive your statement by this Wednesday, Feb. 19th.Please let us know if you would like us to request additional ti1ne for your review,given competing priorities.Thank you for your help.SaraSara Selgrade, Ph.D.Section Chief for Legislative ActivitiesLegislative Affairs and Con-espondence Management BranchOffice of Communications and Government RelationsNIATD/NTH/DHHSBldg. 31, Room 7Al7, MSC 2520Bethesda, MD 20892-2520Phone: (b) (6)(b)(6)Discluime,-:The i1!format ion in this e -mail and any<?( its al/ac!1mc11ts is co1!ficlc11tia!a nd may contain sen s itive informatio11. It should not beused hv a11yo11we ho is no/ the original intended recipient . /f you have received this e-mail in error please i,iform the sender anddelete fiji-011y1o ur mailbox or anv 01hers torage devices. Nationall nslitule o/Allergy and InfectiousD iseasess hall not acceptliabi!ityfor any statements made that are sender'.f own and not express(y made on behalf of the NIAID by one of ifsreprese111aetsiv.NIH-001779From:Sent:To:Cc:Subject :Rao:Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 14:37:35 +0000Venigalla B RaoCassetti, Cristina {NIH/NIAID) [E]RE: Wuhan coronavirus vaccine candidatesBest to contact Cristina Cassetti in DMID. I have copied her here .Best,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who Is not the original Intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives.From:V enigalla B Rao Cb()6 )Sent: Tuesday, February 18, 2020 9:20 AM ------~~ To: Fauci, Anthony {NIH/NIAID) [E] (b)(6) -------- Subject : Wuhan coronavirus vaccine candidatesDear Tony,Good morning!Sorry for taking your time at this very super busy time. Greatly appreciate your serviceand leadership!!NIH-001785(b)(4)With best regards,RaoOn Tue, May 23, 2017 at 11:03 AM Ven igalla B Rao <.i__ __ (b_H. ~... w rote:Dear Tony ,Just a quick update.(b) <4 • Re as accepte aoofnf he papers and t e -------------NIH-001786(b) (4)(b) (4)papers should come out back-to-back in Virology soon. I am attaching both thepdfs for your interest.From scientific perspective, it is very satisfying to see that both the papersusing completely different approaches arrived at the same virion capture model.That was not ant icipated when we initiated the work 5-years ago because thereasons to develop these assays were very different. I have mentioned toEmerman to consider highlighting the papers in the journal issue, and that youand Jim might be will ing tom write a short piece but I have not heard about this.With best regards,RaoOn Mon, May 1, 2017 at 11:33 PM, Venigalla B Rao (b)( > wrote : ____ _,Dear Tony,With best regards,Rao(b) (4)On Mon, May 1, 2017 at 9:40 PM, Fauci, Anthony (NIH/NIAID) [E] ------- (b)( 6) wrote :Rao:ao Wo.Ll:he.n.ate..aadJoe t'i'ega"'fi ,TonyFrom: Venigalla B Rao [mailto:, Cb) (6)JSent: Thursday, April 27, 2017 8:24 PMTo: Fauci, Anthony (NIH/NIAID) [E]Cc: Arthos, James (NIH/NIAID) [E]; ----- =(b=)( =6)Subject: RequestNIH-001787(b) (4)'--- ~ =(b) (4)Dear Dr. Fauci,This is Venigalla Rao from The Catholic University of America, Washington , DC. I havecommunicated with you a couple of times in the past years for different reasons. Having beeninvolved in administrative duties (miniscu le compared to yours ), I can only imagine the demandson your time . I make this request despite this trepidation and I hope that you understand .Thank you for consideration.With best regards,RaoDr. Venigalla B. RaoProfessor and ChairmanDepartment of BiologyThe Catholic University of America620 Michigan Ave., NEWashington, DC, 20064http://faculty.cua.edu/rao/Phone: (b) (6)(b) (4)NIH-001788From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Tue, 18 Feb 202014:12:48 +0000Suzanne PeskinSubject : RE: Visiting !Suzanne:Thanks for the note. lam very, very sorry, but I do not think that we will be able to connect on Sunday. TheWhite House and HHS have me going 24/7 including Saturday and Sunday with the coronavirus crisis. I have seenmy witi (b) (6) for a total of about 45 minutes over the past l 0 days. Hopefully , we can do this at some otheropportunity , but th is is a very bad time. I hope that you understand.Best regards ,TonyAnthony S. Fauci , MDDirectorNational Jnstitute of Allergy and Infectious DiseasesBuilding 3 I, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892 -2520Phone: (b) (6)FAX: (301)496-4409E-mail: (b)(6)The infom1ation in this e-mail and any of its attachments is confidential and may cont ain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recip ient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. The National Jnstitute ofAllergy and Infectious Diseases (NfAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIAID by one of its representatives.-----Original Message-----from : Suzanne Peskin -------~ (b~)-(=Sent: Monday , February 17, 2020 9:56- P--M- --~~= To: Fauci , Anthony (NTH/NTAID) [E] ._ _____ (b_H_ >Subject: Visiting !Hi Tony, r hope all is well with you and your family. r know you are busy these days witb the Coro novir us, but waswonderin g if you' re in town this weekend! (b)(6llives in DC and works for Mary land CASA as a legal fellow . J'mcom ing in Friday even ing and was planning on taking her down memory lane. She has heard so much about (b) (6)that I would love to introduce you two. (b) (6)'e are free most of Sunday if you 're in town. It's been way toolong. Would love to see you.Let me know if that is at all possible.Love,SuzanneSent from my iPadNIH-001789From:Sent:To:Subject:Attachments :Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 13:17:03 +0000Cassetti, Cristina (NIH/NIAID) [E]FW: (b) (4) for coronavirus(b)(4)Please handle. Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : Cb()6 )FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Li,Qiuhong (b) (6)Sent: Tuesday, February 18, 2020 8:04 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E)- ------- (b)(6)> Subject : ---------- (b)(4) for coronavirusDear Dr. Fauci,I'm writing to you to seek advice on potential collaborations with NIAID-funded facilit ies or otherprivate sectors to Cb()4 )(b) (4)NIH-001790Please feel free to contact me if you have any questions .Best regards,QiuhongQiuhong Li, Ph.D ,Dept. of OphthalmologyUniversity of FloridaGainesville FL32610-0284PhoneEmail:(b)(6)----(b)(6)NIH-001791(b) (4)From:Sent:To:(b)(6)Tue, 18 Feb 2020 07:00:32 -0500Collins, Francis (NIH/OD) [E]Subject : Re: Funds for CoVFrancis:TonyOn Feb 18, 2020 , at 6:22 AM, Collins, Francis (NIH/OD) [E](b) <6J >wrote:Hi Tony,Larry and I will have our regular meet ing with the Secretary today . (b) (5)--- =(b~)( =5)I will see you th is afternoon for our regular catch up, unless other events in our intenselybusy lives intervene .FrancisNIH-001792(b) (5)From:Sent :To:Subject:Bernice:Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 11:15:14 +0000Bernice Mika HuangRE: Singapore Coronavirus UpdatesThank you for this important update of information.Best regards,TonyFrom: Bernice Mika Huang -----------(b)(6) Sent : Tuesday, February 18, 2020 4:40 AM ------ --.~ To: Fauci, Anthony (NIH/NIAID) [E)- ------- (bH > Subject: Singapore Coronavirus UpdatesDear Dr. Anthony Fauci,I'm Bernice (b) (6) . ------I had read your online discussion details on USA Today which says:"Another thing that we don't know is why, with a respiratory-borne illness, are there virtually nochildren getting infected . I mean, there are no cases of kids less than 15 years old . Does that mean forsome strange reason they're not getting infected, or the illness is so mild in child ren that we're notnotic ing it? It's very clear the median age is 56 or 59."I thought it would be crucial to share updates on Singapore's coronavirus situation for your reference,because you are the expert who could help analyze the current situation . Till date, in Singapore ><6>havetwo young child ren who are infected:ONE YEAR OLD"Case 76 is a one-year-old Singaporean who was among the group evacuated from Wuhan on Feb 9.The toddler was without symptoms when he boarded the flight back to Singapore. He was put underquarantine upon landing in Singapore, and was confirmed to be infected with COVID-19 on Sundayafternoon . Advertisement He is currently warded in an isolation room at KK Women's and Children'sHospital, said MOH." Quoted from https://www .channe lnewsasia.com/news/singapore/cov id19-coronav irus-singapore -update-feb- 17-12441176SIX-MONTH OLD"COUPLE, BABY AND MAID INFECTED The 28-year-old mother - whose infection was announced onTuesday - works at Yong Thai Hang, a health product shop that primarily serves Chinese touris t s. Herhusband, a 45-year-old Singaporean tested positive on Wednesday at about 2pm, and is currentlywarded in an isolation room at the National Centre for Infectious Diseases (NCID). Both have no recenttravel history to China. The couple's child, a six-month-old boy, tested positive at the same time and iscurrently warded in an isolation room at KK Women's and Children's Hospital. The family's domestichelper was one of the confirmed cases on Tuesday. MOH said in an update on Thursday that the childNIH-001793was not in any infant care facility and was cared for at home, prior to being admitted to the hospital." -Quoted fromhttp s://www .channelnewsasia.com/new s/s ingapore/w uhan-virus-coronavirus-singapore-number-cases-12395928Thanks, Best Regards & God Bless,Bernice HuangBest Regards, Bernice(b)(6)NIH-001794From:Sent:To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 11:12:55 +0000Sheeley, Colin (NBCUniversal)RE: NBC News InquiryI know that it is frustrating for you, but they still have not changed the official number, eventhough we know that it is certainly more than 44. Sorry .From: Sheeley, Colin (NBCUniversal) <Colin.Sheeley@nbcuni.com>Sent: Tuesday, February 18, 2020 12:26 AM ------~= To: Fauci, Anthony (NIH/NIAID) [E] (b)( >Cc: Chirbas, Kurt (NBCUniversal) <Kurt.Chirbas@nbcuni.com> ; Varela, Jay (NBCUniversal)<jay.varela@nbcuni.com>; Santana, Cristian (NBCUniversal) <Cristian.Santana@nbcuni.com>; Mitchell,Alexander (NBCUniversal) <Alexander .Mitchell@nbcuni.com>; DiCasimirro, Gemma (NBCUniversal)<Gemma .DiCasimirro@nbcuni.com>; Studley, Joe (NBCUniversal) <Joe.Studley@nbcuni.com> ; Metsch,Abigail (NBCUniversal) <Abigail.Metsch@nbcuni.com>Subject : RE: NBC News InquiryThank you Tony,We heard th is evening that there were 169 new confirmed cases aboard the cruise ship. Do you know ifthis changes the "officia l public" number at all?Thanks,ColinFrom: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Sent: Monday, February 17, 2020 8:19 AMTo: Sheeley, Colin (NBCUniversal) <Colin.Sheeley@nbcuni.com >Cc: Chirbas, Kurt (NBCUniversal) <Kurt.Chi rbas@nbcuni.com >; Varela, Jay (NBCUniversal)<jay.varela@nbcuni.com >; Santana, Cristian (NBCUniversal) <Cristian.Santana@nbcun i.com>; Mitchell,Alexander (NBCUniversal) <Alexander.Mitche ll@nbcun i.com>; DiCasimirro, Gemma (NBCUniversal)<Gemma.DiCasimirro@nbcun i.com>; Studley, Joe (NBCUniversal) <Joe.Studley@nbcuni.com >; Metsch,Abigail (NBCUniversal) <Abigail.Metsch@nbcuni.com >Subject : [EXTERNAL) RE: NBC News InquiryColin:Thanks for the note. The number 44 is in flux. When I checked a couple of days ago, the"officia l public" number was 44. However, it was clear that there was likely more than thatsince the results of the tests were st ill coming back on some individuals. And so, it is aminimum of 44 infected from the cruise ship, but it is uncertain how many more than 44 areinfected . I do not know where the Americans are stayingBest,TonyNIH-001795From: Sheeley, Colin {NBCUniversal) <Colin.Sheeley@nbcuni.com >Sent : Monday, February 17, 2020 3:36 AM ------ ~= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Cc: Chirbas, Kurt (NBCUniversal) <Kurt.Chirbas@nbcuni.com >; Varela, Jay (NBCUniversal)<jay.va rela@nbcun i.com >; Santana, Cristian (NBC Un iversa I) <Cristian.Santana@nbcu ni.com>; Mitchell ,Alexander {NBCUniversal) <Alexander.Mitche ll@nbcuni.com >; DiCasimir ro, Gemma (NBCUniversal)<Gemma.DiCasimi rro@nbcun i.com>; Studley, Joe (NBCUniversal) <Joe.Studley@nbcuni.com >; Metsch,Abigail (NBCUniversal) <Abigail.Met sch@nbcun i.com>Subjec t : NBC News InquiryHi there,I'm reaching out on behalf of NBC National News -would you be able to confirm that 44 Americansaboard the Diamond Princess cruises ship have tested positive for coronavirus?Also, would you be able to say where the Americans are staying as they are being treated for the virus?Please REPLY ALL with your response, or give us a call at (212) 664-5222.Thank you,ColinNIH-001796From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 11:08:19 +0000Conrad, Patricia (NIH/NIAID) [E)Subject : FW: CNNi Interview Request: Anthony FauciLet us discuss.From: Hynds, Joanna (NE) <Joanna.Hynds@turner .com>Sent: Tuesday, February 18, 2020 5:49 AMTo: Fauci, Anthony (NIH/NIAID) [E] ------=-c (b')"("=6')Cc: Pfeifer, Hazel <Hazel.Pfeifer@turner .com>; Roobeek, Rosanne <Rosanne.Roobeek@turner .com>;Avramova, Nina (NE) <Nina .Avramova@turner.com>Subject : CNNi Interview Request: Anthony FauciDear Mr Fauci,I hope this finds you well.I'm writing to you from CNN International to see if you are available to join Becky Anderson on herprime time flagship show 'Connect the World' for a live interv iew on today to discuss the coronavirus.The show airs live between 10amET- 12pmET- do you have any availability dur ing these hours to cometo a convenient bureau?We really loved having you on the show last Sunday! As the director of the National institute of Allergyand Infectious Diseases your insight is always great fo r our global audience.Migh t it be possible to arrange something?Background on CNN• CNN Int ernational reaches more than 250 million households worldwide including in the US viaDIRECTV.• CNN Int ernational is the number one internat ional TV news channel according to all majormedia surveys across Europe, the Middle East and Africa, the Asia Pacific region and LatinAmerica.• In September 2019 CNN.com had 162 million unique readers globa lly per month and 114 millionmobile reade rs a month, leading the BBC, Yahoo and New York Times .Best,Joanna HyndsPlanning DeskCNN International+ 44 207 693 1640 (office)+ Cb) (6) ( cell)joanna .hynds@turner .comNIH-001797NIH-001798am go thereInformation in this email including any attachments may be privileged or confidential and is intendedexclusively for the addressee. The views expressed may not be official policy, but the personal views ofthe originator. If you have received this email in error, please notify the sender by return e-mail anddelete it from your system. You should not reproduce, distribute, store, retransmit, use or disclose itscontents to anyone. Please note we reserve the right to monitor all e-mail communication through ourinternal and external networks. Turner and the Turner marks are trade marks of Turner BroadcastingSystem Inc and are used under licence.Turner Broadcasting System Europe Limited (Company No. 1927955), Turner Entertainment NetworksInternational Limited (Company No. 2803512), Turner Broadcasting System Holdings (Europe) Limited(Company Number 2802926) and Cable News International Limited (Company No. 5001368) areincorporated in England and Wales and share the same registered office at Turner House, 16 GreatMarlborough Street, London WlF 7HS.From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 10:44:58 +0000Conrad, Patricia (NIH/NIAID) [E)Subject: RE: Confirmation from CNN's New DayOK. Thanks.From: Conrad, Patricia (NIH/NIAID) [E) --------- (b)(6) Sent: Tuesday, February 18, 2020 5:42 AMTo: Fauci, Anthony (NIH/NIAID) [E]-------= (b-)c(c-6-)=Subject: Fwd: Confirmation from CNN's New DayFirm hit for this morning in med arts studio at 715 amBe in studio at 7 amSent from my iPhoneBegin forwarded message:From: "Steinfe ld, Alix" <Alix.St einf eld@t urn er .com>Date: February 18, 2020 at 5:13:08 AM ESTTo: "Figliola, Mike" <Mike.Figlio la@turne r.com>, Jonathan Bennett(b)(6)>Cc: "Conrad, Patr ici. a... .(:N, _IH../:_.N_IA_I_D.): ..[.:E....):'..'. .=!=~~':'."""'-:--:--- (b-):-(6_),>, "Daniels, Ronne!(NIH/OD/ORS) [C]" (b)(6) "Ryland, Ken (NIH/OD/ORS) [E)"======= (b~)(~6)~>, "Jackson Farrar, Joy (NIH/OD/ORS) [El"(b)(6)Subject: RE: Confirmation from CNN's New DayGood MorningWe have OR. ANTHONY FAUCI on New DayHit Time; 715aESTIFB: 212.275.9225PL: 212.275.9325CONTROL: 212-275-9053PO: 660980ThanksAlixFrom: Figliola, Mike <Mike.F igliola@t urn er .com>Sent: Tuesday, February 18, 2020 5:12 AMTo: Jonathan Bennett -----------(b) (6) Steinfeld, AlixNIH-001799<Alix.Steinfeld@ t urner .com>Cc: Conrad, Patricia (NIH/NIAID) [E] (b)(6) ; Daniels, Ronnel(NI H/0 D/0 RS) [ C] :..___; ___;:....:.....::_(_b:=):(s:.6-).:~>: ;- R-y'l.a"-"nd~,-K-en- ('.N"-"1H /0 D/0 RS) [E](b)(6)>; Jackson Farrar, Joy (NIH/OD/ORS) [E]=======~ (b~)(~6)Subject: RE: Confirmat ion from CNN's New DayImportance : HighAdd ing Alix who has that infoMike Figliol aEditorial ProducerCNN's New Day(b)(6)mike .figl iola@turner .comCONF IDENT IALITY NOTICE: This e-ma il transmission , and any documents , files orprevious e-mail messages attached to it, may contain confidential information that is legallyprivileged. If you are not the intended recipient , or a person responsible for delivering it tothe intended recipient , you are hereby notified that any disclosure , copying, distr ibution oruse of any of the information contained in or attached to this message is STRIC TLYPROH IBITED. If you have received this transmissio n in error , please immediately notify usby reply e-mail at mike.fig liola@turner .com or by telephone at {917) 670 -9410, and destroythe origina l transmission and its attachments without reading them or savi ng them to disk.Thank you.From: Jonatha n Bennett (b)(6) ----------- 5 en t: Tuesday, February 18, 2020 5:05 AMTo: Figlio la, Mike <Mike.Figlio la@tu rn er.com>Cc: Conrad, Patricia (NIH/NIAID) [El CbH6>> ; Daniels, Ronnel(NIH/ OD/ 0 RS) [ C] _.;...____;_ :...;...;~= (~b)::(:6~c);-:R:y- :la- -nd-:,--K:--e: n- (:-N:'-.I" H."/'0D/0 RS) [E](b)(6); Jackson Farrar, Joy (NIH/OD/ORS) [E]=======- (~b~;(,;6~,)>Subject: Re: Confirma t ion fro m CNN's New DayMike,Received and noted . What are the contro l room and and IFB numbers?JonathanOn Tue, Feb 18, 2020, 3:14 AM Figliola, Mike <Mike .Figliola@tu rn er .com> wrote :Hi eve ryone ,NIH-001800NIH-001801This is Mike with CNN's New Day. Hope you are well.This is to confirm Dr. Fauci will be a guest today, Tuesday 02.18.20 at around 7am ESTto discuss:Latest on Americans who tested positive after evacuation from cruise ship; What weknow about how coronavirus spreads https:// www.cbsnews.com / news/ transcript-dranthony-fauci-on-face-the-nat ion-february-16-2020 /You will be solo at 7am EST for the segments.Alisyn Camerota and Jim Sciutto, in for John Berman, will both be conduct ing today'sinterview.Please arrive at the studio no later than 6:50am EST.Here is your studio confirmation:STUDIO INFO 2013424THIS INTERVIEW WILL B E FROM their NIH MED ARTS STUDIO with a direct IFBconnectionControl Room numbers are 301-827-8478 and 8479Encompass Booking and Circuit Number :Booking : 1-800-243-1995Circuit: 36TBGS104492Our IFB: 301-496-1811 (we prefer to call into the station's IFB)Video : 1080i - the audio is embedded .Please confi rm you have received this and are all set to go!Best,MMike FigliolaEditorial ProducerCNN's New Day(b)(6)mike.fiqlio la@turner .comCONFIDENTIALITY NOTICE: This e-mail transmission. and any documents. files orprevious e-mail messages attached to it, may contain confidential information that islegally privileged. If you are not the intended recipient, or a person responsible fordelivering it to the intended recipient, you are hereby notified that any disclosure ,copying, distribution or use of any of the information contained in or attached to thismessage is STRICTLY PROHIBITED. If you have received this transmission in error,please immediately notify us by reply e-mail at mike.fiqliola@turner .com or by telephoneat (917) 670-9410, and destroy the original transmission and its attachments withoutreading them or saving them to disk. Thank you.NIH-001802From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 03:08:59 +0000Holland, Steven (NIH/NIAID) [E]Subject: RE: New Coronavirus Draft MessagingShort and sweet. Looks fine. Thanks.From: Holland, Steven (NIH/NIAID) [E] (b)( 6), ________ _,Se nt: Monday, February 17, 2020 10:05 PMTo: Fauci, Anthony (NIH/NIAID) [E]-------= (b-)c(c-6-)=Subject: FW: New Coronavirus Draft MessagingTony ,When you get a moment could I get your take on this most recent iteration . Apolog ies for theintrusions.ThanksSteveDirector, Division of Intramural ResearchNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthBldg. 10/11N248 MSC 1960Bethesda, MD 20892-1960301-402-7684 voice(b) (6) fax(b)( emailAssistant lab: Eva Portillo--(b-)( email ___ C)b(6)voiceAssistant to SD: Beth Schmidt(b)(6)(b)(6)From: "Bailin, Heike (NIH/OD/ORS) [E]" (b)(6)>Date : Monday, February 17, 2020 at 10:01 PMTo: "Moss, Bradley (N IH/OD/ORS) [E]" ---------.. (b=)(=6)Cc: "Gottesman, Michae l (NIH/OD) [E]" CbH61, )Steven HollandCbH6J",S chmitt, James (NIH/OD/ORS) IE]" ~=======~~ --------~~ ---------- (b)(6) "Johnson, Alfred (NIH/OD) [E] " Cb)( "Pa Imo re, Tara (NIH/CC/OD) [E]" CbH6)>, "McGowan, ColleenNIH-001803(NIH/OD/ORS) [El" CbH6, )"Cullen, William (NIH/OD/ORS) [El"CbH6)>",N ewcomer, Derek (NIH/OD/ORS) [E]" ========~~ CbH6)>",T osten, Timothy (NIH/OD/ORS) [E]"=======~ (b;);(-6;);~Subject: Re: New Coronavirus Draft MessagingBrad- thank you . I liked much of what you did . And thanks to all who've commented and edited .Your points are well taken.For the sake of clarity and effectively steering fo lks to OMS for the proposed ICP measures Ifavor focusing the message even more. Pease find attached OMS edits:NIH-001804From:Sent :To:Subject :Attachments :Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 03:05:47 +0000Cassetti, Cristina (NIH/NIAID) [E]FW: COVID 19 Diamond Princess Patients Possible Transmission by FomitesSARS Transm ission Fomites Temperature and Humidity Variables.pdfPlease have someone respondFrom: Angela Moore (b)(6);,Sent : Monday, February 17, 2020 10:04 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E) (b)( >Subject : COVID 19 Diamond Princess Patients Possible Transmission by FomitesI am a dermatologist but also a clinical researcher and scientist.I was reading all of the news regarding concerns and questions on how the fellow patients are beinginfected .A few questions arose, based on the NIH data on SARS Coronavirus, that has been much more stud ied,and most likely less viru lent than the current COVID 19, wh ich supposedly has HIV traits as well as t raitsto increase transmission.I have wondered if COVID-19 is like Legionella, and possibly transmitted in the airborne water dropletsin the air conditioning units of the Diamond Princess ship.Even with the SARS Coronavirus, it was shown to be infective on fomites for up to 28 days unless 40degrees Celsius and 80% humidity, when it was then inactivat ed in a few hours (see the attachedarticle). I am wonder ing if the trays of food, after being passed to passengers on the ships, were thenwashed in suboptimal conditions (NOT at 40 degrees Celsium for several hours at 80% humidity)I AM concerned , that based on the reinfection of those in Wuhan, China, after they returned home, onwhether 14 days of quarantine is enough, based on the modeling and studies on the SARS Coronavirus,and whether 28 days of quarantine may actually be needed.With the HIV virus component of COVID 19, one must also wonder if the T cells are being infected andpassing the infection along with in an infected pat ient . In the U.S., we may need to beware of bloodtrans fusions from anyone infected, even asymptomatically, with COVID 19.I am sure that you have teams of clinicians and scientists working on this, and I don't know if any of theoriginal scientis ts working on the SARS models are still around at Chapel Hill to perform these relatedstudies and modeling .Angela MooreAngela Yen Moore, MDArlington Center for DermatologyArlington Research CenterNIH-001805NIH-001806711 East Lamar Blvd., Suite 200Arlington , Texas 76011phone 817-795-7546fax 817-226-7546From: Fauci, Anthony (NIH/N IAID) [E)Sent : Tue, 18 Feb 2020 02:48:13 +0000To: bdoherty@mrns.orgCc: lbaden@nejm. org;Redfiel d, Robert R. (CDC/OD); (b)(6) ;Eisinger,Robert (NIH/ NIAID) [E];Greg Folkers (b)(6)·Conrad, Pat ricia (NIH/ NIAID) [ElSubject : RE: New England Journal of Medicine Edito ria lAttachment s: NEJM Edito rial - Fauci et al - FINAL - 02-18-2020.docxBriana and Lindsey:As promised, lam attaching the invited Editorial related to the COYID-19 manuscript that we had discussed.Should l also submit it through the NEJM online website or will you talce care of this? We will send in the COi andauthorship forms in the next day or 2. Please let me know if you have any questions. Thank you.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethe sda, MD 20892-2520Phone : (b) (6)FAX : (301) 496-4409E-mai l (b) (6)The informa tion in th is e-mail and any of its attachmen ts is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the origina l intended recip ient. lf you have received this e-mai l in errorplease inform the sender and delete it from your mailbox or any other storage devices. The Nationa l Institu te ofAllergy and lnfectious Disease s (NIAID) shall not accept liabil ity for any statements made that are the sender's ownand not express ly made on behalf of ihe NIAID by one of its representatives.-----Orig inal Message-----From: Briana Doherty <onbehalfof@manuscriptcentral.com>Sent: Monday, February 10, 2020 11: I- I- A-M- --~~ To: Fauci, Anthony (NIH/NTAlD) [El (b)( 6)>Cc: lbaden@nej m.orgSubject: New England Journal of Medicine EditorialDear Dr. Fauci,I am delighted t:hat you have agreed to write a signed editorial to accompany the article on the initial estimates ofkey transmission parameters associated with nCoV-2019 virus by Li et al.The general purpose of the Journal's editorials is to provide the reader with an authoritati ve interpretat ion orelaboration based on the substance of the article. Since this substance is usually not within the average reader'sspecial competence, such readers will particularly benefit if the editorial avoids technical jargon , explains thearticle's contribu tion to a field of knowledg e, and emphasizes , whenever possible, its clinical implications. Theeditorial commentary should not be concerned exclusively with the article in question but rather should use thearticle as a starting point for a more general discussion.Because editorials involve interpretation and opinion, you and your potential coauthor must be free of significantNIH-001807NIH-001808relevant financial associations (including equity interest, regular consultancies , or major research support) with acompany, or with a competing company, that stands to gain from the use of a product discussed in the editorial.Please contact me immediate ly if you are considering a coauthor, so I can ensure that your candidate meets ourcriteria. Additional information about disclosure of financial and other associations appears below this letter.Please bear in mind that your editoria l represents your (and any coautho r's) personal opinion. The Journal does notinclude statements of grant or other support or acknowledgments with editorials.Journal po licy dictates that we must have on file a signed Copyright Transfer and Authorship Agreement from eachauthor before a manuscript can be accepted. Therefore, the enclosed form should be signed by all authors and faxedto (781) 207-6529.Your editorial is due at the Journa l on Monday, February 17, at the very latest if the deadline imposed by ourprinting schedule is to be met. ff the editorial is to include a figure, please submit the figure at least one week beforethe due date for the editorial itself.*** Additional information about preparing and submitting your editorial is given below; please read it carefully.***The editors must reserve the right to edit (or even reject) your editorial , but whether we use it or not, the Journalcurrently offers a modest stipend of$300.Thanks agaw for agreeing to write this editorial for the Journal. I look forward to receiving it.Sincerely yours,Lindsey R. Baden, M.D.Deputy EditorNew England Journal of MedicineIO Shattuck StreetBoston, MA 02115( 617) 734-9800Fax: (617) 739-9864http ://www.nejm.orgLENGTH OF YOUR EDITORIALNEJM editorials should not exceed two printed pages. This means that your word count before editing should notexceed 750 words (approximately 4500 characters). Note that we spell out trial names and most other abbreviationsfor our readers, and we include trial registration numbers for any clinical trials mentioned; these will lengthen youreditorial if you have not included them. Please provide a title not exceeding 45 characters and a word count for thetext; the entire manuscript , including references , should be double-spaced.REFERENCESCite no more than 10 references , including the article you are writing about. The average collection of 10 referencesrequires about a quarter of a printed page.TABLE OR FIGUREA table or a figure in your edito,ial will require a reduction in the number of words ; because figures and tables varyin size, you may be asked to shorten the text of your editorial during the production process. A quarter-page tableroughly equals 250 words, and a half-page table roughly equals 500 words.DISCLOSURESWhen completing your disclosure fonn, please indicate, in the "Comments" field next to the type of relationshipbeing disclosed, the amount (in U.S. dollars) of any support you have received. Please also indicate how much ofNIH-001809this support has been received over the past 2 years. Please e-mail your completed disclosure form toeditorial@nejm.org.ln the event of publication, each author's submitted disclosure form will be posted on the Web (with any dollaramounts redacted) .COPYRIGHT TRANSFEREach author must complete a copyright transfer agreement form. Please sign it and fax it back to 781-207-6529 assoon as possib le.TO SUBMIT YOUR EDITORIAL*** It is important that you follow the instructions below to ensure that your article enters the con-eel. queue. ***When you are ready to submit your manuscript, please log in to the New England Journal of Medicine - ManuscriptCentra l site (http ://mc05.manuscriptcen tral.com/nejm). Your case-sensitive USER ID is afauci@niaid.nih.gov. Forsecurity purposes, your password is not listed in this message. If you are unsure of your password , please visithttps://mc05 .manuscr iptcentral.com/nejm and enter your e-mail address in the "Forgot Your Password ?" field.Once you are logged in, the Main Menu will be displayed. Please click on the Author Center, where you will findthe manuscript listed under "Invited Manuscripts ." You can click on the "Continue Submission" button to beginsubmitting your article.From:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 02:09:48 +0000Conrad, Patricia (NIH/NIAID) [E)FW: Comment s on TedrosFYIFrom: John Lauerman (BLOOMBERG/ NEWSROOM:) <jlauerman@bloomberg.net>Se nt: Monday, February 17, 2020 10:20 AMTo: Fauci, Anthony (NIH/NIAID) [E]------ -(=b-)c(c-6=)Subject: Comments on TedrosBTW, I just saw t h at you tr ie d me ear lie r a nd I d idn ' t respond .I was in Geneva and evidently didn ' t have service . Hope we canconnect t hi s t im e . Bes t number i s my desk , +44 2035 2 51028 .Thanks aga in , JLFrom : John Laue rman (BLOOMBERGN/ EWSROO:M) At : 02/17/2 01 4 : 37 : 11To : AFAUCI @NIAID.NIH .GOVSub j ect : Comments on TedrosHi Dr . Fauci : I ' m work in g on a story about WHO DG Tedros a nd t hework that he ' s doing to contain the coronavir us epidemic . I 'mplanning on disc ussing a number of themes , incl uding thatrespo nding t o outbreaks has become t he most v i sib le job of t heDG in the past couple of decades . I ' d also like to explore theissue of how important it is t hat countries be as ope n asposs ible about d isease outbreaks , and t hat i t ' s t he DG' s job toenco urage that and move countries toward gr eater transparencyand participation in battling outbreaks . Would you ca r e tocomment on t he job t hat Tedros is doi ng in t he se areas? Ple asegiv e me a call at +44 2035 251028 or let me know when and atwhat number to call you . Thanks and re ga rds , John Lau er man ,Bloomberg NewsJohn Lauerman, Bloomberg News3 Queen Vrctona Street Lond-o-n- --U--K~ = te + l4 ,r) 20 2 12 •t:)11 (b)(6) --------- http :// www .bloombe rg .comhttp://www .bloombe rg.com/prog nos isNIH-001810From:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 02:09:18 +0000Conrad, Patricia (NIH/NIAID) [E)FW: Comment s on TedrosPlease try to set up a call with John LauermanFrom: John Lauerman (BLOOMBERG/ NEWSROOM:) <jlauerman@bloomberg.net>Se nt: Monday, February 17, 2020 9:37 AMTo: Fauci, Anthony (NIH/NIAID) [E]-------= (b-)c(c-6=)Subject: Comments on TedrosHi Dr . Fauc i: I ' m work ing on a s t ory about WHO DG Tedros a nd t hework that he ' s doin g to contain the co r onavirus epide mic . I 'mp l a nning on d i scuss in g a number of t h emes , in c l ud in g t hatrespo nding t o ou t breaks h as become t he mos t v i sib le job of t heDG in the past couple of decades . I ' d also like to explore theissue of how importa n t i t is t h at coun t ries be as open asposs ible abo u t d isease ou tb reaks , a nd t ha t i t ' s t he DG' s job t oenco u rage that and move co untries toward greater transparencyand participation in battlin g outbreaks . Would yo u ca r e tocomme n t on t he job t h at Te dros is do ing in t he se areas? Pl easegiv e me a call at +44 2035 251028 or let me know when and atwhat number to call you . Thanks and re ga rds , J ohn La u er man ,Bloomberg NewsJohn Lauerman, Bloomberg News3 Queen Victoria Street , Lond-o-n-,- U--K- ~= tel. +44 (0) 2035 251028 cell ------------ (b)(6) http :// www .bloomberq.comhttp://www .bloomberg .com/prognos isNIH-001811From:Sent :To :Fauci, Anthony (NIH/NIAIO) [E)Tue, 18 Feb 2020 02:02:35 +0000Cassetti, Cristina (NIH/NIAID) [E]Subj ect :Cristina:TonyAnthony S. Fauci , MDDirector(b) (5)National Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)(b) (5)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient . If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .NIH-0018 12From:Sent:To:(b)(6)Mon, 17 Feb 2020 20:56:50 -0500Collins, Francis (NIH/OD) [E]Subject : Re:- --------- (b) (5 for SARS-CoV-2On Feb 17, 2020, at 8:48 PM, Collins, Francis (NIH/OD) [E]------- (b) (6)>wro te:Hi Tony,FrancisNIH-0018 13(b) (5)(b) (5)From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Tue, 18 Feb 2020 00:20:01 +0000Townsend, FrancesSubject : RE: This ongoing 2019 novel coronavirus, or COVID-19, outbreak has a number ...Fran:Thanks for the note. You certainly have covered a lot of ground with your questions. I look forward to seeingyou tomorrow.Best rega rds,TonyAnthony S. Fauci , MDDirectorNational Institu te of Allergy and Iofectious DiseasesBuilding 31, Room 7 A-0331 Center Driv e, MSC 2520National Institu tes of HealthBethesda, MD 20892 -2520Phone: (b) (6)FAX: (301) 496-4409E-mail (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitive information. Itshould not be used by anyone who is not the original intended recip ient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NJAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIAID by one of its representatives.-----Original Message-----from : Townsend, Frances <FTownsend @l\1AFGRP.COM>Sent: Monday, February 17, 2020 6:55 PMTo: (b)(6) ; Shuy, Bryan (OS/ASPR/IO)Fauci, Anthony (NlH/NIAID) [E) Cb) (6) Conrad , Patricia (NJWNIAlD) [E](b)(6)Cc: Hanson, Elizabeth <ebanson@MAFGRP.COM >Subject: This ongoing 2019 novel coronavirus , or COVID -19, outbreak has a number ...(b)(6)All: Below is an outline of questions for tomorrow at CFR. Sorry to get this to you late but it seems the newschanges everyday. As you will see I focus mostly on coro navirus as 1 suspect that's where the interest will be but getto bio weapons toward the end.l am happy to take additional questions or suggestio ns. These sess ions go quickly and we have time for Q and A so Idoubt I will get through it all but wanted you all to have something to look at.Thanks again for doing this tomorrow.BestFranNIH-0018 14NIH-001815This ongoing 2019 novel coronavirus, or COVID-19 , outbreak has a number of historic firsts. It's the largestquarantine in world history with China locking down over 60 million people. It's the first mass repatriation ofAme1ican citizens into a quarantine , climbing over 1,000.Let's start with some quick basics: what is coronavirus? How contagious? What is the morbidity rate?How does it compare to SA Rs and MERs? More/less infectious? Lethal?Just to put this in perspective every year here in the US we deal with the flu. How many Americans on average dieeach year from the flu?But as I mentioned corona virus has resulted in a number of historic firsts, talk about what you expect could be ourscientific firsts and what roadblocks do those scientific firsts confront?Over the years, global economic interdependence has grown in nearly every industrial sector, including health care.But that means our health care is also globally interdependent on other systems less equipped, less transparent andperhaps less responsible global actors.China closed the wet market where the coronavirus outbreak began on 1/l , gene sequenced the virus on l/9 so theycould develop a diagnostic test but did not share the gene sequence with the global health community until 1/12.How transparent and quick was the Chinese response? What should the have done that they failed to do? What werethe consequences?China now claims more than 70K infected and almost 1800 deaths from the virus. But Jt has been widely reportedthat the Chinese have underreported both numbers. what are Countries international obligations to report accurately?To whom? How do you know the numbers are accurate?How does the cwTent outbreak impact the domestic medical supply chain? What steps could or should we considerto enhance supply chain resilience?What do the numbers suggest to you about what to expect regionally and worldwide? Have numbers peaked? Willthey continue to 1ise? With the cruise ship there re now a total of 15 Americans infected. Do you expect additionalcases? What scale? How prepared are we nationally? Locally?Looking back over the roughly past decade, emerging infectious diseases played a recurring ominous theme. Be itfrom HlNl, to ebola, then Zika, and now the 2019 novel coronavirus, the threat is clearly not dissipating. When itcomes to non-disease natural disasters , the Stafford Act provides a Disaster Relief Fund to enable immediateresponse. By comparison , there is a small Infectious Diseases Rapid Response Reserve Fund. Do we need a moreStafford Act-like mechanism to enable quicker response and research to these new threats? What other actions canwe take to better prepare?While often we see folks painting emerging infectious diseases and biodefense into separate categories , the truth isthat there is significant crossove r in terms of preparedness and research. Understanding that this is a sensitive topic,could you talk about how we should approach these risks in a comprehensive manner that can achieve public healthand national security objectives concurrent ly?I'd like to use this to transition to the topic of bio weapons which is what we originally planned to talk about. Thelandscape here has also transfom1ed. When BioShield was written and the Strategic National Stockpile establishedwe worried about State actors deploy ing banned weapons like small pox; plague and hemorrhag ic fever. And youNIH-001816still must prepare against those things as well as new and emerging threats like the toxins we have seen deployed byRussia and North Korea in more targeted assassinations.How do you stay ahead of these threats? Do we have the resources and surveillance that we need to stay ahead of thethreat? And ensure the necessary vaccines and therapeutics?The ebola outbreak may be an instructive example , it seems to be coming under some control despite the precarioussecurity situation in the Democratic Republic of Congo. But the ongo ing 2018 outbreak was the second largest inhistory following the 2013-2016 West African outbreak. As a result of these outbreaks, the United Statesgovernment has pioneered new FDA-approved diagnostics and vaccines , with promising therapeutics seeminglyaround the approval comer too. What lessons can we draw from the ebola outbreaks? How do you work with andincentivize industry to develop what you need in the event of a catastrophic bio attack? And How do you make thebest possible decisions about the stockpile?I always worried that because we are global leaders if there was a bio attack or outbreak anywhere in the world,others would look to us and to our stockpile for the answer. Are our global allies doing enough to prepare againstthese tbreats--whether they be manmade or natural? Are they maintaining adequate stockpi les of medicalcountermeasures and research bases--and should they be?Lastly (if we have time) .... the FBI recently arrested a Harvard scientist for accepting undisclosed grant money fromChina for scientific research. It bas now been reported that there are similar investigations at a number of USuniversities including Yale and MIT to name two and that the grant monies are in the billions. What are foreigngovernments looking for? Why in the US? Clearly a national security risk, is it a bio weapons concern?DISCLAIMER: This e-mail message and any attachments are intended solely for the use of the person(s) named inthe message header to whom the email is addressed and may contain information that is confidential or legallyprivileged. rfyou are not the intended recipient , you are hereby notified that any dissemination , distribution,copying , or other use of this message or its attachments is strictly prohibited . Jf you have received this message inerror, please notify the sender immediately and pennanently delete this e-mail message and any attachments (andany copies or printouts of the same).From:Sent :To:Cc:Subject:Fauci, Anthony (NIH/NIAIO) [E)Mon, 17 Feb 2020 20:29:27 +0000Cassetti, Cristina (NIH/NIAID) [E]Conrad, Patricia (NIH/NIAID) [ElFW: COVID-1Attachme nts: letter to NIAID-ICIS.pdfPlease res pond to th em. Than ks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301) 496-4409E-mail (b)(6)The information in this e-m ail and any of its attachments is confidential and may contain sensitiveinfo rmation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Fitzgerald, Kate <Kate.Fitzgerald@umassmed.edu>Se nt: Monday, February 17, 2020 1:52 PM --------:a =a<i To: Fauci, Anthony {NIH/NIAID) [El (b)(6)>Cc: Eleanor Fish <en.fish@utoronto.ca>Subject: COVI0-1Dear Dr. Fauci,On behalf of the International Cytokine and Interferon Society, please find attached a letter from usas clinic ians and scient ists committed to developing and implementing therapeutic interventions targetedagainst global viral infection outbreaks. We propose that high priority be given to evaluating thetherapeutic antiviral activities ofIFN -as/bc(clinically appro ved formulation s) against COVID-19 whichposes a potent ial threat to global health. Further information is deta iled in the attached. Tbe ICJS wouldbe happy to provide the scientific and clinical expe1tise for this program and welcome further discussion.In particular Dr. Eleanor Fish copied above has the track record and expertise in this area.Sincerely ,Kate A. Fitzgerald I Professor of MedicinePresident I International Cytokine and Interferon Society (ICIS)NIH-001817www.cytokinesociety.orgJoin us @ Cytokines 2020NIH-001818iCISFrom:Sent:To:Subject :Fauci, Anthony (NIH/NIAID) [E)Mon, 17 Feb 2020 20:22:39 +0000Conrad, Patricia (NIH/NIAID) [E)FW: Happenings Radio Q+A ...Let us discuss. She called me up today and I told her to send me an e-mail since I was on a cal l.Anthony S. Fauci, MDDirectorNational Institu te of Allergy and Iofecrious DiseasesBuilding 31, Room 7 A-0331 Center Driv e. MSC 2520National Institu tes of HealthBethesda , MD 20892-2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b)(6)For discussion.(b) (5)Tbe informa tion in tbis e-mail and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipien t. If you have received this e-mail in eITorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and lnfectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIAID by one of its representatives.-----Original Message -----From: cassidy@happeningsmag.com <cassidy@happeningsmag.com >Sent: Monda y, Febrnary l 7, 2020 3: 15 PMTo: Fauci, Anthony (NlH/NlAID) [E]_ ____ "("b"°)"('~"6)>Subject: Happenings Radio Q+A ...Hi there,This is Cassidy G-D from Happenings Magazine & Radio in Kenosha , Wl- we ever so briefly spoke on the phoneearlier today.l was reaching out with the hope of getting you on our radio program for a 20-30 minute Q+A in which we wouldtalk abou t the Coronavirus and more specifically the impact it is having on the Diamond Princ ess Cruise ship alongwith anything you would like to talk about regarding infectious diseases and or your position as director of theNational Institu te of Allergy and Infectious Diseases .Please let me know if you ha.ve any interest in being on the air with us a.nd I would be happy to provide furtherdetails. You can also get ahold ofme by our office phone at 262-564 -8800 .Hope you are well and I look forward to hearing back from you, Cassidy G-DNIH-0018 19From:Sent:To:Cc:(NIH/NIAID) [E]Subject:Cristina:Fauci, Anthony (NIH/NIAIO) [E)Mon , 17 Feb 2020 19:50:25 +0000Cassetti, Cristina (NIH/NIAID) [E]Erbeldi ng, Emily (NIH/NIAID) [E];Mascola, John (NIH/VRC) [E];Conrad , PatriciaBMGFI just spoke with Chris Carp and Trevor Mundel of the BMGF and they want totry and coordinate some of the things that they and we are doing regardingCOVID-19. I told them to give you a call to set up a teleconference to discussrespective R & D agendas of NIAID and BMGF.Thanks,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail ( Cb) C6JThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .NIH-001822From:Sent:To:Subject :Fauci, Anthony (NIH/N IAID) [ElMo n, 17 Feb 2020 18:58:46 +0000Cassetti, Cristina (NIH/NIAID) [ElFW: Info from ChinaPlease have someone respond to this person.Anthony S. Fauci , MDDirectorNational Institu te of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520Nationa l Institutes of HealthBethesda , MD 20892-2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The informatio n in this e-ma il and any of its attachmen ts is confidential and may contai n sensitive infom1ation. Itshould not be used by anyone who is not the orig inal intended recipie nt. lf you have received this e-mai l in eITorplease inform the sender and delete it from your mailbox or any other storage devices. The Nationa l Institute ofAllergy and Infe ctio us Diseases (NIAID) shall not accept liability for any stateme nts made that are the send er's ownand not express ly made on behalf of the NlAID by one of its representatives.-----Original Message-----From : Jodie Dillman --------~ (b~)~(6=)>Sent: Monday , February 17, 2020 12:42- P-M- ---~~ To: Fauci, Anthony (NlH/NlAID) [E] (b)(6) >Subject: Info from ChinaDear Dr. Fauci,lt is with trepidation that I reach out to you with information that has been shared with me regarding the real statusof the Coronavirus in China. My information comes to me from a (b) (6) who has correspondence froma nurse in Harbin , Ch ina.____ C_b~_(6_). is here on an H l V visa, employed for the past seve ral yea rs atthe international studen t program. _____________________________ _T have no reason to doubt the authent icity of the correspondence that she shared with me.This corresponde nce shows a lung X-ray, a glass containe r of bloody fluid removed from an infected lung, and amap of Harbin , China dep icting many areas of the coronaviru s outb reaks. The written correspondence reveals thatthe numbers being release d of confirmed deaths is drastical ly low due to the spread be ing too fast to test. Deaths inhospital hallway s and of medical staff is not being shared in order to preve nt panic.Protec tive gear is unavai lab le and the nurse w1iting the correspon dence is fearfu l for her life . She states that thereare five levels of screenings (tests?) before a person is reported as testing positive or of being infected with the virus .If someone dies before being confirmed , these suspected deaths are covered up and not reported. Reported numbers,even of conftnned cases are gross ly undercounted .l figure you and our government realize the infonnation and numbers coming out of China are highly inaccurate, butthis correspon dence on (b) (6) confirms it. I felt it was only ethical and moral to report this, despite____ C_b)_(6_), plea that the two people involved in the correspo ndence fear governmental retribution if it wasdiscovered that they discussed or pas sed on this confidential information .1 report this and swear it to be true and confidential. l am tnisting it will help in some way and 11ot just stir panic.NIH-001823Jolonda Dillman(b)(6)Sent from my iPhoneNIH-001824From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Mon, 17 Feb 202018:51:17 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject:outbreak.FW: Al supplementation of influenza surveillance system for COVID-19FYIAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Ed Peshko <esp@hedviginc.com>Se nt: Monday, February 17, 2020 1-:1-9- -P-M- -::-::-=, To: Fauci, Anthony (NIH/NIAID) [E)- ------- (b)(6)> Subject: Re: Al supplementat ion of influenza surveillance system for COVID-19 outbreak.ps - feel free to contact me at this address, or my personal email address, that is(b) (6).again, I have no dog in this fight aside from wanting to avoid a large scale pandemic worldwide.And I'm sincerely hoping that we throw the rulebook out - and develop a new one - to deal wi th this thesame way we did when we dealt with the 1918-1919 pandemic.On Mon, Feb 17, 2020 at 10:09 AM Ed Peshko <esp@hedviginc.com> wrote:Dr. Fauci,Like you, I've been watching the COVID-19 outbreak with great alarm . Given the current data, I'malmost positive at this point that it will hit the US hard at some point and as a student of history thatterrifies me.NIH-001825NIH-001826So I'm hoping that your department has contacted the Bill and Melinda Gates foundation and see ifyou could make the following idea national or international. It is a supplemental health system basedon Al and mobile technology and consists oftwo planks:First:- train an Al to be able to detect COVID-19 by measurements that can be done by cell phone (forexample pictures of patients, recordings of patient's respiratory system)Second:- develop and release a smart-phone application that does the following :- turns on location tracking so health authorities can see where the cell phone owner is.- allows for people to upload health measurements from their cell phone.- keeps TRACK of where the cell phone owner is. If that person then tests positive for COVID lateron, it can then automatically figure out all the contacts of that person for the last 14 days.- notifies those contacts that they have been in contact with someone with COVID-19, to isolatethemselves and regularly test themselves.The goal would be to prevent hundreds of thousands of people from descending on hospitals andoverwhelming them, and to allow for the CDC or other medical personnel to go OUT and get them -or isolate them for treatment in their own homes - rather than having them come in and infecteverybody.Now th is all hinges on the idea that Al could detect COVID-19 based on an audio recording or a simplepicture and do it reliably, but I'm fairly sure that it can based of the peer-reviewed literature. It is nota difficult Al problem assuming that the microphone can pick up sounds well enough - if not, there arealready integrated stethoscopes for cell phones that could be mass produced - and once developedto enough precision it could be deployed nationally or internationally fairly easily.For all I know something like this is already in the works but I haven't heard of anything like it - apartfrom the chinese app which AFAICT does not use any Al but DOES allow for automatic contacttracing.I sincerely hope this is already in the works. Ultimately it could be used both for detection andtreatment - assuming the current antivirals work out they could be distributed to the samecoordinates that positive diagnoses come in, perhaps by cheap drone so that nobody actually needsto be exposed to the virus to effect treatment .Anyways, thanks for your time and efforts. Personally I'm a software developer but I'm hoping thatperspective his helpful - for I view the fight against this virus as an INFORMATIONAL fight. It's like afire-suppression system or food safety measures. Again, I have no clue whether or not this is alreadybeing done, and I apologize in advance if I'm missing something and this all seems obvious .I just think that in this case it is prudent for us to be safe rather than sorry.Thanks much,NIH-001827 ~From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Mon , 17 Feb 202018:47:09 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject:outbreak.FW: Al supplementat ion of influenza surve illance system for COVID-19Please han dle .Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Ed Peshko <esp@hedv iginc.com>Se nt: Monday, February 17, 2020 1:10 PM To: Fauci, Anthony (NIH/NIAID) [E) --------------=---:(-b)(-6) := Subject: Al supplement ation of influenza surveillance system for COVID-19 outbreak .Dr. Fauci,Like you, I've been watc hing the COVID-19 outbreak with great alarm . Given the curre nt data, I'm almostpositive at th is point that it will hit the US hard at some point and as a student of history that ter rifiesme.So I'm hop ing that your department has contacted the Bill and Melinda Gates foundation and see if youcould make the fo llowing idea national or international. It is a supp lemental hea lth system based on Aland mobile technology and con sists of two planks:First:- trai n an Al to be able to detect COVID-19 by measurements tha t can be done by cell phone (forexample pictures of patients, recordings of patient's respiratory system)Second:- develop and release a smart -phone applicat ion that does the following:NIH-001828NIH-001829- turns on location tracking so health authorities can see where the cell phone owner is.- allows for people to upload health measurements from their cell phone .- keeps TRACK of where the cell phone owner is. If that person then tests positive for COVID lateron, it can then automatically figure out all the contacts of that person for the last 14 days.- notifies those contacts that they have been in contact with someone with COVID- 19, to isolatethemselves and regularly test themselves.The goal would be to prevent hundreds of thousands of people from descending on hospitals andoverwhelming them, and to allow for the CDC or other medical personnel to go OUT and get them - orisolate them for treatment in their own homes - rather than having them come in and infect everybody.Now this all hinges on the idea that Al could detect COVID-19 based on an audio recording or a simplepicture and do it reliably, but I'm fairly sure that it can based of the peer-reviewed lite rature. It is not adifficult Al problem assuming that the microphone can pick up sounds well enough - if not, there arealready integrated stethoscopes for cell phones that could be mass produced - and once developed toenough precision it could be deployed nationally or internationally fairly easily.For all I know something like this is already in the works but I haven't heard of anything like it - apartfrom the chinese app which AFAICT does not use any Al but DOES allow for automatic contact tracing.I sincerely hope th is is already in the works. Ultimately it could be used both for detection andtreatment - assuming the current antivirals work out they could be distr ibuted to the same coordinatesthat positive diagnoses come in, perhaps by cheap drone so that nobody actually needs to be exposedto the virus to effect treatment .Anyways, thanks for your time and efforts. Personally I'm a software developer but I'm hoping thatperspective his helpful - for I view the fight against this virus as an INFORMATIONAL fight. It's like a fire suppressionsystem or food safety measures. Again, I have no clue whether or not this is already beingdone, and I apologize in advance if I'm missing something and this all seems obvious.I just think that in th is case it is prudent for us to be safe rather than sorry.Thanks much,EdFrom:Sent :To:Subject:FYIFauci, Anthony (NIH/NIAIO) [E)Mon, 17 Feb 202017:42:47 +0000Conrad, Patricia (NIH/NIAID) [ElFW: PBS NewsHour inquiry for todayLet us discuss after I get off the AMA call, which is going longFrom: David Coles <dcoles@newshour .org>Sent: Monday, February 17, 2020 11:51 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [El- ------- (b)( > Subject: PBS NewsHour inqui ry for todayDr. Fauci,Might you be available to update our viewers on the latest developments in the coronav irus storytoday/tonight? We are particularly interested in getting your evaluation of the passengers who havebeen released from two cruise ships. The first, in Yokohama, Japan, where over 300 Americans releasedfrom the ship have now arrived back in the US, to go into 14 days of quarantine. 14 of those peopletested positive at some point after leaving the ship, but before they boarded the plane. The second shipwe want to focus on is in Cambodia. Something in the neighborhood of 1,000 passengers released fromthat ship have been reported to be in some state of travel to their homes, presumably around the globe.One woman who made it as far as Malaysia tested positive there and is hospitalized in Kuala Lumpur.We do know that the CDC is working with WHO and the cruise ship line to track down those travelingpeople .We would very much like to hear from you what level of concern we should have over those manyhundreds of people traveling right now, how well quarantine works, how important it is to maintain it,etc. We would also like to touch on the methods of containment and treatment being done inside Chinaand how well those methods have worked.I realize it is a holiday, and that could complicate things. But please let me know whether you couldconsider this, Doctor, and we wi ll begin to work out the logist ics.Thank you.Very best regards,DaveDavid ColesDeputy Senior Producer, National Affairs() PBS NEWSHOUR703 998 2104NIH-001830From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Mon, 17 Feb 2020 16:35:20 +0000Smith, StevenSubject: Re: i've been th inking about youAttachments : image003.pngSteven:Thanks for the note. Much appreciated. It has been 24/7 for me for the past 4 weeks. Hop ethat all is well with you.Best,TonyOn Feb 17, 2020, at 10:39 AM, Smith, Steven <Steven .Smith@. ... _ C_>b<.1.. .. wrote:Having just come back from Australia where coronavirus is hands down a nationalemergency, I've been thinking about you again and all the good work you do tokeep us safe.I was with someone who's a diplomat with the Australian government who said"it's much, much worse than the Chinese would have you believe. Much worse."Melbourne and Sydney were deserted almost immediately of Chinese tourists andstudents. I luckily flew through DOHA.Hang in there. It's always something.StevenSteven W. Smith<image003.png >(b)(6) ~(b)(6)This message, including attachments, is confidential and may be privileged. If you received this in error. please notify me byreply email and delete this messaae.NIH-001831(b)(6)
From:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Mon , 17 Feb 2020 14:14:34 +0000Conrad, Patricia (NIH/NIAID) [E)Re: Request from CNN's New DayAttachment s: image001 .jpgThanksOn Feb 17, 2020 , at 9: 11 AM, Conrad, Patr icia (NIH/N IAID ) [E](b) (6) wrot e:Working on this from med arts for tomorrow as well. Just FYISent from my iPhoneBegin forward ed message:From: "Figliola , Mike" <Mike .Figliola@turner.com >Date: Februar y 17, 2020 at 8:42:38 AM E,S-T- ------- ~= To: "Conrad, Patric ia (NIH/NIAID) [E]" ---------- (b) < Subject: RE: Request from CNN's New DayCopy will be back soonestMMike FigliolaEditorial ProducerCNN's New Day(b)(6)mike.figliola@turner .com<i mage00 I .jpg>CONFIDENTIALITY NOTICE : This e-mail transmission , and any documents,files or previous e-mail messages attached to it, may contain confident ialinformatio n that is legally privileged. If you are not the intended recipient , or aperson responsible for delive ring it to the intended recipient , you are herebynotified that any disclos ure, copying, distribution or use of any of theinformatio n contained in or attached to this message is STRICTLYPROHIB ITED. If you have received this transmission in error, pleaseNIH-001833immediately notify us by reply e-mai l at mike.figliola@turner.com or bytelephone at (917) 670-9410 , and destroy the original transmission and itsattachments without reading them or saving them to disk. Thank you.From: Conrad, Patricia (NIH/NIAID) [El- -------- (b)(6)> Se nt: Monday, February 17, 2020 8:42 AMTo: Figliola, Mike <Mike.Figliola@turner .com>Subject : RE: Request from CNN's New DayBetween 7 am - 7:50 am ETFrom : Figliola, Mike <Mike.Figliola@turne r.com>Se nt: Monday, February 17, 2020 8:40 AM ------- ~~ To: Conrad, Patricia (NIH/NIAID) [E) --------- (b)( > Subject: RE: Request from CNN's New DayWorking on timing- is there a preferred time?Mike FigliolaEditorial ProducerCNN's New Day(b)(6)mike.figliola@turner .com<image00l .jpg>CONFIDENTIALITY NOTICE: This e-ma il transmission , and any documents ,files or previous e-mail messages attached to it, may contain confident ialinformation that is legally privileged. If you are not the intended recipient, or aperson responsible for delivering it to the intended recipient. you are herebynotified that any disclosure , copying, distribution or use of any of theinformation contained in or attached to this message is STRICTLYPROHIBITED. If you have received this transmission in error, pleaseimmediately notify us by reply e-mai l at mike.figl iola@turner .com or bytelephone at (917) 670-9410, and destroy the original transmission and itsattachments without reading them or saving them to disk. Thank you.From : Conrad, Patricia (NIH/NIAID) [ElSe nt : Monday, February 17, 2020 8:40 AMTo: Figliola, Mike <Mike.Figliola@turne r.com>Subject: Re: Request from CNN's New DayWould hit time be I. The 7 am hour? Do I have exact time?Sent from my iPhoneNIH-001834(b)(6)On Feb 17, 2020, at 4:16 AM, Figliola, Mike<Mike.Figliola@turner .com> wrote:Hi Patty,Mike with cnn and new day hereHope all is wellWe are interested in checking Dr Fauci's availability forTuesday's show.May you let me know if he is avail and what time frame worksbest?Topic is CoronavirusThanks!MSent from my iPhoneOn Jan 30, 2020, at 10:05 AM, Figliola, Mike<Mike .Figliola@tu rner .com> wrote:Hi Patty!MorningIf we want Fauci for tomorrow, is he avail?Barring maj breaking news we are not planning tocancelThoughts?MMike FigliolaEditorial ProducerCNN's New Day(b)(6)mike.figliola@turner.comNIH-001835<image001.jpg>CONFIDENT IALITY NOTICE: This e-mailtransmission, and any documents, files or previouse-mail messages attached to it, may containconfidential information that is legally privileged . Ifyou are not the intended recipient, or a personresponsible for delive ring it to the intendedrecipien t, you are hereby notified that anydisclosure , copying, distribution or use of any of theinformation contained in or attached to thismessage is STRICTLY PROHIB ITED . If you havereceived this transmission in error, pleaseimmediately notify us by reply e-mail atmike.fiq liola@turner .com or by telephone at (917)670-9410, and destroy the original transmissionand its attachments without reading them or savingthem to disk. Thank you.From: Figliola, MikeSent: Thursday, January 23, 2020 10:22 AMTo: Conrad, Patricia (NIH/NIA ID) [E)(b)(6)Subject: RE: Request from CNN's New DayCopy thank you!Mike FigliolaEdito rial ProducerCNN's New Day(b)(6)mike.fiqliola@turner .com<image0Ol.jpg>CONFIDENT IALITY NOTICE: This e-mailtransmission , and any documen ts, files or previouse-mail messages attached to it, may containconfidential information that is legally privileged . Ifyou are not the intended recipient, or a personresponsible for delivering it to the intendedrecipien t, you are hereby notified that anydisclosure , copying, distribution or use of any of theinformation contained in or attached to thismessage is STRICTLY PROHIBITED. If you havereceived this transmission in error, pleaseimmediately notify us by reply e-mail atmike.figliola@turne r.com or by telephone at (917)670-9410, and destroy the original transmissionNIH-001836and its attachments without reading them or savingthem to disk. Thank you.From: Conrad, Patricia (NIH/NIAID) [E](b)(6)>Sent: Thursday, January 23, 2020 10:16 AMTo: Figliola, Mike <Mike.Figliola@turner .com>Subject: RE: Request from CNN's New DayPer our chat just now - can have himavail between 6 am - 8:15. Hard stopat 815 am ETPatricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNat ional Institute of Allergy and Infectiou sDiseasesThe National Institutes of Health31 Center Drive, MSC 2520 - Room 7A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaime r:The information in this e-mail and any of its attachments isconfidential and may contain sensitive information. It should notbe used by anyone who is not the original intended recipient. Ifyou have received this e-mail in error please inform the senderand delete it from your mailbox or any other storage devices.National Institute of Allergy and Infectious Diseases (NIAID)shall not accept liability for any statement made that aresender 's own and not expressly made on behalf of the NIAID byone of its representatives.From: Figliola, Mike <Mike .Figliola@turner .com>Sent: Thursday, January 23, 2020 10:02 AMTo: Conrad, Patricia (NIH/NIA ID) [E)(b)(6)Subject : RE: Request from CNN's New DayOk- we wont know until 1030a meeting - is it okto hold 6 and 7a until then?Mike FigliolaNIH-001837Editorial ProducerCNN's New Day(b)(6)mike.figlio la@turne r.com<image00l.jpg>CONFIDENT IALITY NOTICE: This e-mailtransmission, and any documents, files or previouse-mail messages attached to it, may containconfidential information that is legally privileged. Ifyou are not the intended recipient, or a personresponsib le for delivering it to the intendedrecipien t, you are hereby notified that anydisclosure , copying, distribu tion or use of any of theinformation contained in or attached to thismessage is STRICTLY PROHIB ITED . If you havereceived this transmission in error, pleaseimmediately notify us by reply e-mail atmike.figliola@turne r.com or by telephone at (917)670-9410 , and destroy the original transmissionand its attachments without reading them or savingthem to disk. Thank you.From: Conrad, Patricia (NIH/NIAID) [E](b)(6)Sent: Thur sday, January 23, 2020 10:00 AMTo: Figliola, Mike <Mike .Figliola@turner .com>Subject: RE: Request from CNN's New DaySorry to be a pain-if you think it will bein the 6 am hour - we might need touse a diff erent studi o ... if its in the 7 amhour we can use our remote studio ...Any thoughts as to which hour again,sorryPatricia L. ConradPublic Health Analyst andSpecial Assista nt to the DirectorNational Institute of Allergy and InfectiousDiseasesThe National Inst itutes of Health31 Center Driv e, MSC 2520 - Room 7A03NIH-001838Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaimer:The information in this e-mail and any of its attachments isconfidential and may contain sensitive information. It should notbe used by anyone who is not the original intended recipient. Ifyou have received this e-mail in error please inform the senderand dele te it from your mailbox or any other storage devices.National Institute of Allergy and Infectious Diseases (NIAID)shall not accept liability for any statement made that aresende r's own and not expressly made on behalf of the NIAID byone of its representatives .From: Figliola , Mike <Mike.Figliola@turne r.com>Sent: Thursday, January 23, 2020 9:23 AMTo: Conrad, Patricia (NIH/NIAID) [E)(b)(6)>Subject: RE: Request from CNN's New DayCopy thank youMike FigliolaEditorial ProducerCNN's New Day(b)(6)mike.figlio la@turner .com<image001 .jpg>CONFIDENTIALITY NOTICE: This e-mailtransmissio n, and any documents, files or previouse-mail messages attached to it, may containconfidentia l information that is legally privileged. Ifyou are not the intended recipient, or a personresponsible for delivering it to the intendedrecipient, you are hereby notified that anydisclosure , copying, distribution or use of any of theinformation contained in or attached to thismessage is STRICTLY PROHIBITED. If you havereceived this transmission in error, pleaseimmediately notify us by reply e-mai l atmike.figlio la@turner .com or by telephone at (917)670-9410, and destroy the original transmissionand its attachments withou t reading them or savingthem to disk. Thank you.NIH-001839From: Conrad, Patricia (NIH/NIAID) [E](b) ~ >Sent: Thursday, January 23, 2020 9:18 AMTo: Figliola, Mike <Mike.Figliola@turne r.com>Subject: RE: Request from CNN's New DayChecking now for all times between 6-9 will let you know soonestPatricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNational Institute of Allergy and Infe ctiousDiseasesThe National Inst itutes of Health31 Center Drive, MSC 2520- Room 7A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaime r:The information in this e-mail and any of its attachmen ts isconfidential and may contain sensit ive informat ion. It should notbe used by anyone who is not the original intended recipient. Ifyou have received this e-mail in error please inform the senderand delete it from your mailbox or any other storage devices.National Institute of Allergy and Infectious Diseases (NIAID)shall not accept liability for any statement made that aresender's own and not expressly made on behalf of the NIAID byone of its representatives.From: Figliola, Mike <Mike.Figliola@turne r.com>Sent: Thursday, January 23, 2020 9:10 AMTo: Conrad, Patricia (NIH/NIA ID) [El(b)(6)Subject: RE: Request from CNN's New DayHi againCould be back half of 7am but if this gets muchworse we may play it higher in the hour - is thereany time that doesn't work?Mike FigliolaEditorial ProducerCNN's New Day(b)(6)NIH-001840mike.fiqliola@turner .com<image00l.jpg>CONFIDENT IALITY NOTICE: This e-mailtransmission, and any documents, files or previouse-mail messages attached to it, may containconfidential information that is legally privileged . Ifyou are not the intended recipient, or a personresponsible for delivering it to the intendedrecipient, you are hereby notified that anydisclosure , copying, distribution or use of any of theinformation contained in or attached to thismessage is STRICTLY PROHIBITED. If you havereceived this transmission in error, pleaseimmediately notify us by reply e-mail atmike.fiqliola@turner.com or by telephone at (917)670-9410, and destroy the original transmissionand its attachments withou t reading them or savingthem to disk. Thank you.From: Conrad, Patricia (NIH/NIAID) [E](b)(6)Sent: Thursday, January 23, 2020 8:57 AMTo: Figliola, Mike <Mike .Figliola@turner .com>Subject: FW: Request from CNN's New DayHi Mike - we can make this happen .The 7 am hour is best for us but will getback to you. do you have an idea of thehit t ime? need to make sure our nihstudio is available.thxPatricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNat ional Institute of Allergy and InfectiousDiseasesThe National Inst itutes of Health31 Center Drive, MSC 2520 - Room 7 A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxNIH-001841Disc laimer:The informat ion in this e-mail and any of its attachmen ts isconfidential and may conta in sensitive informat ion. It sho uld notbe used by anyone who is not the original intended recipient. Ifyou have received this e-mail in error please inform the senderand delete it from your mailbox or any other storage devices.National Institute of Allergy and Infectious Diseases (NIAID)shall not accept liability for any statement made that aresender's own and not expressly made on behalf of the NIAID byone of its representatives .Begin forwarded message:From: "Figliola , Mike"<Mike.Fig! iola@tumer.com >Date: January 23, 2020 at 8:36:15AM ESTTo: "Fauci, Anthony (NIH/NIAID) [E]"(b)(6)Subject: RE: Request from CNN'sNew DayHi everyone,This is Mike with CNN's New DayHope you are wellWe would like to invi te Dr, Fauciback to the program to discusscoronavirusMight he be availab le tomorrowWe air 6-9am and happy to providecar service to and from the stud iowherever you are located . JohnBerman and Alisyn Camerota anchorf rom NY.Thoughts?best,MNIH-001842Mike FigliolaEditorial ProducerCNN's New Day(b)(6)mike.figliola@turner.com<image00l. jpg>CONFIDENTIALITY NOTICE: This emailtransmission, and anydocuments, files or previous e-mailmessages attached to it, may containconfident ial information that is legallyprivileged. If you are not the intendedrecipient, or a person responsible fordeliver ing it to the intended recipient,you are hereby notified that anydisclosure, copying , distribution oruse of any of the informationcontained in or attached to thismessage is STRICTLYPROHIBITED. If you have receivedthis transmission in error, pleaseimmediately notify us by reply e-mailat mike.figliola@turner.com or bytelephone at (917) 670-9410 , anddestroy the original transmission andits attachments without reading themor saving them to disk. Thank you.NIH-001843NIH-001844 mFrom:Sent :To:Cc:Fauci, Anthony (NIH/NIAIO) [E)Mon , 17 Feb 202013:50:10 +0000Natalie RahhalKadlec, Robert (OS/ ASPR/10)Subject: FW: Comments re: 14 US passengers with coronavirus and updatesNata lie :I sent the incorrect e-mail address for Dr. Kadlec. Here is the correct one.TonyFrom: Fauci, Anthony (NIH/N IAID) [E]Se nt: Monday, February 17, 2020 8:47 AMTo: Natalie Rahhal (b)(6)>Cc: (b)( ·; Conrad, Patricia (NIH/NIAID) [E] ---------(b)( > Subject: RE: Comments re: 14 US passengers with coronavi rus and updatesNata lie:Thank you for your note. Dr. Robert Kadlec, the Assistant Secretary for Preparedness andResponse (ASPR) at HHS could either answer this question or point you in the direction ofsomeone who could. I am copying him on this e-mail.Best regards,TonyFrom: Natalie Rahhal (b)(6) ------------ Sent : Monday, February 17, 2020 8:28 AM ------~= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject : Comments re: 14 US passengers with coronavirus and updatesHi Dr Fauci,I hope this note finds you well and that you've gotten a little rest over the weekend, during what I'msure is an inordinately busy time . Would you be able to elaborate on the measures taken to keep the 14US evacuees who have coronavi rus from infecting others on board the plane? I know that remdesivir,under compassionate use, was given to at least the first Amer ican coronavirus patient, and last weekNIH researchers published results early that it had preventive effects for macaques exposed to MERS.Has the US considered using this drug to protect those exposed to but not yet infected withcoronavirus?Thank you,Natalie A RahhalActing US Health EditorDaily lltail.com -NIH-001845Daily Mail Online I 51 Astor Place, 9th floor, New York NY 10003Tel: +1212402 9086Mobile : (b) (6)Twitter : https ://twi t ter .com/nata lier78?1ang=enEmail: Natalie.rahhal@mailonline.comDisclaimerThis e-mail and any attached files are intended for the named addressee only. It contains information, which maybe confidential and legally privileged and also protected by copyright. Unless you are the named addressee ( orauthorised to receive for the addressee) you may not copy or use it, or disclose it to anyone else. If you received itin error please notify the sender im mediately and then delete it from your system. Associated Newspapers Ltd.Registered Office: Northcliffe House, 2 Derry St, Kensington, London, W8 STT. Registered No 84121 England.NIH-001846From: Fauci, Anthony (NIH/NIAI0) [E)Sent : Mon, 17 Feb 202013:24:34 +0000To: Folkers, Greg (NIH/NIAID) [E]Cc: Conrad, Patricia (NIH/NIAID) [E];Doepel, Laurie (NIH/NIAID) [E];Eisinger, Robert(NIH/NIAID) [E];Lerner, Andrea (NIH/NIAID ) [E);Marston, Hilary (NIH/NIAID) [ElSubject: RE: ASF ------ attached for your review is draft abstract for Florence vaccinemeet ingAttachments :edits.docxGreg:Keystone abstract --transform ing vaccinology- - 3-16-2020 - with minor FauciThis looks great. I have made some minor edits that are tracked in the document. Pleaseaccept these and then it is ready to go. Thanks.Best,TonyFrom: Folkers, Greg (NIH/N IAID) [El --------- (b)(6)Sent: Wednesday, February 12, 2020 1:47 PM ------~= To: Fauci, Anthony (NIH/NIAID) (E] (b)( 6)>Cc: Conrad, Patricia (NIH/NIA ID) [E] (b)(6) >; Doepel, Laurie (NIH/NIAID) [E](b)(6)>; Eisinger, Robert (NIH/NIAID) [E) (b)( ; Folkers, Greg(NIH/NIAID) [E] CbH6; JLerner, Andrea {NIH/NIAID) [El (b)(6);Marston, Hilary {NIH/NIAID) [E] (b116)1>Subject : ASF ------ attached for your review is draft abstract for Florence vaccine meet ingDisclaimer : Any third -party material in this emaiJ has been shared for internal use under fair use provisionsof U.S. copyright law, without further verification of its accuracy /veracit) '. It does not necessarily repre sentmy views nor tbose of NlAlD, NIH, HHS, or the U.S. government.NIH-001847From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Sun, 16 Feb 2020 22:28:19 +0000Jon LaPookSubject : RE: CoronavirusJon:I have no idea what this guy is talking about. 1 have never said the RO was close to 5 or 6. The RO is about 2.0to 2.2. Also, the situation is as we have discussed on several occasions . In the USA, the travel restrictions seem tobe working with only 15 cases in the USA (13 travel and 2 spouses) . But, as I have said, this could change. Ifweget substantial sustained transmission in a numbe r of countries throughout the world, including the developingworld, then sooner or later there will be significant leakage of infected individuals into the USA since you cannotrestr ict inco ming travel from the whole woild. T he way we might be able to avoid a real globa l pandemic is if thenon -Chfoa countr ies can co nta in the infect ions in their respec tive count ries before there is widely distrib utedsustained transmissions. Once widely distributed sustained transmissions happen, a globa l pandemic is inevitable.What would a global pand emic mean? ft depends on the true rate s of morbidity and mortality. The curre nt lyrepo rted mortality of COVI D-19 is about 21/o. However, there are seve ra l folds more cases than are com ing to theofficial attention of health autho1ities, i.e. asymptomatic or minima lly symptomatic in fections . If you cou nt these,the denominator gets much larger and the case fa tality rate could drop to 1% of even 0.5 % or less. If that is thecase, then this could be a very severe seasona l flu (0.2% to 0.4% ; regular seaso nal flu is 0.1 %) or a typical pandemiclike 1957 or 1968 (0.5% -0.9 %). We are not sure where it is going to land .Hope this is helpful .Best,TonyAnthony S. Fauci, MDDirectorNational lnstih1te of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda, MD 20892-252 0Phone: (b) (6)FAX: (301) 496-4409E-mail (b)(6)The informatio n in this e-mail and any of its attachments is confidential and may contain sensitive infom1at ion. Itshould not be used by anyone who is not the original intended recipie nt. lfyou have received this e-mail in errorplease inform the sender and delet e it from your mailbox or any other storage devices. The Nationa l Institute ofAllergy and Jnfectio u~ Diseas es (NTAID) shall not accept liability for any stateme nts made that are the sender's ownand not expressly made on behalf of the NIAID by one of its representatives.---- -Original Message- ----From: Jon LaPook ______ __,(b"").'.(,.= >Sent: Sunday, February 16, 2020 4:39- P-M- ----.,; == To: Fauci, Ant hon y (NIH/NIAID) [El --------- (b)( Subject: CoronavirusHi Tony,l thought you would be interested to see a text (be low my ema il) I j ust got from a very smart Wall Street guy whohas been filling me in on reaction there. l've been doing my best on air to put the current situation in perspective -communicating that the risk in the U.S. is still re lative ly low while letting viewers know the situation is fluid andcould change. How would you sum up where we are now?Thanks ,JonNIH-001848NIH-001849TEXT I JUST RECEIVED:"Doc, total panic mode setting in . Tony Fauci talking R nought at closer to 5 or 6. Good biotech guys saying itmight not die down in April. People talking about 60% ofus will get it ; unstoppable in Africa. r can't scare peoplebut this is really bad. I hate bothering you on this but I know I need to take my cue from what you will say on CBS"Jonathan LaPook, M.D.Chief Medical Corresponde nt, CBS NewsProfessor of MedicineNYU Langone HealthTwitter @DrLaPo okFrom:Sent:To:Subj ect :Elisabet h:Fauci, Anthony (NIH/NIAIO) [E)Sun, 16 Feb 2020 21:16:02 +0000Lucassen, Elisabeth BRE: Coronavirus patient--secureDo you have t ime for a quick phone call?Best,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Lucassen, Elisabeth B <Elisabeth.Lucassen@providence.org>Sent : Friday, February 14, 2020 1:54 PM -------=---c-c= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject : Coronavirus patient--secureImpo rtance: HighDear Dr. Fauci,NIH-001850(b)(6)------(b-)(6) _ Any input would be most appreciated.M any thanks in advance!Sincerely,Elisabeth Lucassen(b)(6)This message is intended for the sole use of the addressee , and may contain information that is privileged, oonfldential and exempt fromdisclosure under applicable law. If you are not the addressee you are hereby notified that you may not use, copy, disclose. or distribute toanyone the message or any information contained in the message. If you have received this message in error, please immediately advise thesender by reply email and delete this message.NIH-001851From:Sent :To:Cc:Attachments :accepted .docxBob:Fauci, Anthony (NIH/NIAIO) [E)Sun, 16 Feb 2020 20:40:58 +0000Redfield, Robert R. (CDC/OD)Greg Folkers (b) ( ·)nejmoa2001316.pdf, NEJM Editorial - Fauci et al - clean with Fauci editsAs per our discussion, I am attaching the Editoria l together with the NEJM paperupon which the editorial is base d . Please take a look and give your approval. Ofcourse if you have any comments or edits, th ey are most welcome. Asmentioned, the NEJM wants the manuscript by COB tomorrow (Monday).Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892 -2520Phone: (b)(6)FAX: (301 496-4409E-mail (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.NIH-001852From:Sent:To:Fauci, Anthony (NIH/NIAIO) [ElSun, 16 Feb 2020 20:20:29 +0000Arthos, James (NIH/NIAID) [E)Subject: RE: one on oneNo prob lem. I am drowning in coronavirus and our meeting likely would havewound up being cancelled anyway. Hopefu lly, we will soon get back to some sortof normality in our meetings. Thanks.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Arthos, James (NIH/NIAID) [El --------- (b)(6)Sent: Sunday, February 16, 2020 2:-18- -P-M- --=-,--=, To: Fauci, Anthony (NIH/NIAID) [E]- -------(b)(6) Subject : one on oneHi Tony,I'm very sorry to bother you when you are so busy. Regarding this Tuesday, we are on yourschedule for a one on one and unit head meeting. something came up last minute andl amgoing to be away from Tuesday through Friday, so I won't be able to make either. Sorry for thelate notice.JimNIH-001853From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Sun, 16 Feb 2020 20:17:53 +0000Lane, Cliff (NIH/NIAID) [ElCc: Greg Folker s (b)(6)cC, onrad, Patricia (NIH/N IAID) [ElSubject : NEJM manuscriptAttachments: NEJM Editorial - Fauci et al - clean wuth additional Fauci edits - 02-15-2020.docx, NEJM Editorial - Fauci et al - clean with Fauci edits accepted.docxCliff;I am attaching 2 documents: 1) The revised manuscript that Greg worked on in which I haveadded a number of t racked changes including deleting a substantial amount to get it between800 and 900 words; and 2) A clean vers ion where I have accepted all the t racked changes(Greg's and mine). Right now I like it the way it is and would not change it much if at all. Whatit needs now is references. Greg will take a shot at adding the references . If you havereferences, please send them to Greg and me. In the meant ime, I will send it withoutreferences to Bob Redfield for his review/approval. Let us discuss by phone if you wish.Thanks,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .NIH-001854From:Sent:Fauci, Anthony (NIH/NIAIO) [E)Sun, 16 Feb 2020 19:19:00 +0000To: Greg Folkers (b)(6))Cc: Conrad, Patricia (NIH/NIAID) [E]Subject: NEJM manuscriptAttachments: NEJM Editorial - Fauci et al - clean wuth addit ional Fauci edits - 02-15-2020.docx, NEJM Editorial - Fauci et al - clean wi th Fauci edits accepted.docxGreg;I am attaching 2 documents: 1) The revised manuscript that you sent to me in which I haveadded a number of tracked changes including deleting a substantial amount to get it between800 and 900 words; and 2) A clean version where I have accepted all the tracked changes (yoursand mine. Right now I like it the way it is and would not change it much if at all. What it needsnow is references. Can you add up to 10 references? It might be easier for you to do thatrather than Cliff. If not, I will send to Cliff and see if he can do it. In the meantime, I will send itwithout references to Bob Redfield for his review/approval. Let us discuss by phone if youwish.Thanks,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please info rm the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) sha ll notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by on e of its representatives .NIH-001855From:Sent:To:Subject :Please handle.----- Original Message -----Fauci, Anthony (NIH/NIAID) [ElSun, 16 Feb 2020 12:12:58 +0000Cassetti, Cristina (NIH/NIAID) [ElFW: COVID-19 therapyFrom: Cesare Cocchi _______ _.,(,b.~..,(.,.6=,.)>Sent : Sunday, February 16, 2020 5:18 -A-M-- -~~= To: Fauci , Anthony (NIH/NIAID) [E] ..._ _____ (b_)_C_,>Subject: COVTD-19 therapyDear Doctor Fauci,J am a pediatrician from (b) (6) (IT).J was wondering if high doses of vitamin A have been tried in the therapy of COVID- 19.Do you remember the cases of viral pneumonia due to measles that take place in African infants in the late seventies.Jt seemed to work.Many sorry to bother you.Have a good job!Best regardsCesare Coccbi MDNIH-001856From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Sat, 15 Feb 2020 22:21:34 +0000Conrad, Patricia (NIH/NIAID) [E)Subject: FW: To VIMA newspaper-Greece-interview request-coronavirusFYI-----Original Message-----From: 0woropa Tcrw1c<1t1h tsoli@tovima.gr>Sent: Saturday , February 15, 2020 4:22 PMTo: NlAID NEWS (NJH/NJATD) <NIAIDNEWS @niaid.nih.gov >Cc: Fauci , Anthony (NTH/NIAID) [E] (b)(6) >Subje ct: To VIMA newsp aper-Greece-interview request-coronavirusHalloMy name is Theodora Tsoli and I am a sc ience editor for the greck newspaper To VIMA (www .tovima.gr )one of thebiggest Sunday papers in my country.I would like lo have,ifpo ss ible,a telephone interview with dr Fauci on thecorona virus outbreak for next Sunday' s paper.If he won't be ab le to speak ,could 1 send question s to which he couldanswer?Looking fotward to your replyThank you in advanceTheodora Tsoli:EtaA0l'lKaErr 6 to iPhone μou:E1iμavnK6l:l apaKcu.ro8 Eite1 11vo i]1ccocarnno noincrnc1; m8uvro<vwww.alteregomedia.org/disclaimer.htm>lImportant: Please read our disclaimer<www.alteregomedia.org/sdcilaimer.htm>lNIH-001857From: Fauci, Anthony {NIH/NIAID) [E)Sent : Tue, 5 May 2020 22:26:27 +0000To: Foikers, Greg (NIH/NIAID) [E);Billet, Courtney (NIH/ NIAID) [E];Stover, Kathy(NIH/NIAID) [E);Routh , Jennifer (NIH/N IAID) [E];Awwad , David (NIH/NIAID) [C]Cc: NIAID OD AMSubject:Attachment s:0RE: ASF RE: Dr. Fauci video reque st: Public Service Recognit ion WeekASF pub lic service recognition - w ith tracked edits -05-0 5-2020 .docxSee minor tr acked changes.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Folkers, Greg (NIH/ NIAID) [E] CbH >Sent: Tuesday, May 5, 2020 6:16 PMTo : Billet, Courtney (NIH/NIAID) [E] -----~ Cb ~H=6)>; Stover, Kathy (NIH/NIA ID) [E]CbH6J;> Routh, Jennifer {NIH/ NIAID) [E] CbH6>1A; wwad,David (NIH/NIA ID) [C] CbH6J>Cc: NIAID OD AM <NIAIDODAM@niaid.n ih.gov>Subject: ASF RE: Dr. Fauci v ideo request: Pub lic Service Recognition Wee kASFHereis a short script for Public Serv ice Recognition Week. We agreed to do a short videoASF - can u tweak as needed?David, could u record in some format that is easy? Cell phone or other I just learned they want by COBtomorrow<< File: ASF public service recogn ition.docx >>From: Seigfreid , Kim (NIH/OD) [E] CbH6J>Sent: Monday, Apri l 27, 2020 4:30 PM --------=-~ To: Billet, Courtney (NIH/NIAID) [E] (b)(6J>; Stover, Kathy (NIH/NIA ID) [E]--------- (b)(6)>; Routh, Jennifer (NIH/NIAID) [E] (b)(6)> Cc: Fine, Amanda (NIH/OD) [E] Cb)( >; Polimeni, Lydia (NIH/OD) [E](b)(6)Subject: Dr. Fauci video requ est: Public Service Recognition WeekHi there,Please see below. HHS is taking over the Partnership for Public Service IG accoun t next week for PublicService Recogn ition Week . They asked if Dr. Fauci would be willing to do a short 30-second or less prerecordedvideo thanki ng public servants for their work . It would be featured during the takeover , and alsoon NIH's other sm handles next week . It can be taken on a cell phone as sm does not require higherresolution . Let me know if you would like to accept or decline the request.Many thanks ,KimKim SeigfreidSocial Media LeadNIH Office of Communications and Public Liaisonph: (b)(6)(b)(6)From: Muhammad, Janell (HHS/ ASPA) (b)(6),Sent : Monday, Apri l 27, 2020 4:10 PM ---------~~ To: Seigfre id, Kim (NIH/OD) [E] CbH6J>; Channer, Amber (OS/OASH)---------- CbH6J>;F oster, Timothy (OS/ ASPA) CbH6)> Cc: Palczewski, And rew (HHS/ASPA) CbH6J>; Pratt, Michael (OS/ASPA)--------- (b)(6J>; Sherman, Jennifer (HHS/OASH) (b)(6) Wi lker, Michael (HHS/ASPA) (b)(6); Dine, Brooke (HHS/ASPA)(b)( 6)Subject: Public Service Recognition WeekHello All,Hope eve ryone is holding up well !OHR is taking over the Partnersh ip for Public Service (PPS) lnstag ram account during PublicService Recognit ion Week (May 3-9, 2020). The OHR team has reached out about want ing todevelop a senio r leade r "mashup " video -perhaps including the DepSec. TThey asked about the feasibility of this request. They also inquired about perhaps Dr. Fauci andthe SG doing a pre-recorded video thank ing public servants for their work.I wanted to gather the troops so we can identify what all is being planned for this week ofrecognition and provide a POC for OHR if the request is feasible.Happy to set up a call, if tha t is needed to discuss further .Thanks,JanellJanell MuhammadASPA Digital Engagement (Team Lead)U.S. Department of Health and Human ServicesEmail: (b) (6)Office: (b) (6)iPhone: Cb()6 )HHS on Facebook I HHS on Twitter I HHSLatinoFrom:Sent :To:Fauci, Anthony (NIH/N IAID) [E)Tue, 5 May 2020 22:05:41 +0000Stover, Kathy (NIH/NIAID ) [E)Cc:(NIH/N IAID) [ElSubject:Billet, Courtney (NIH/ NIAID) [El;Folkers, Greg (NIH/NIAID) [El;Conrad, PatriciaRE: FOR ASF REVIEW: Draft PR re: launch of ACTT 2 COVIO treatment studySee my minor change of my comment in red.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: __ __,. ,_, (b)(6)The information inlh ,s e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Stover, Kathy (NIH/NIAID) [El (b)( 6)r>Sent : Tuesday, May 5, 2020 1:52 PMTo: Fauci, Anthony (NIH/NIAID) [El ------ ::;..,..-,=';::::=====~~ Cc: Billet, Courtney {NIH/NIAID) [El (b)( >; Folkers, Greg (NIH/NIAID) [El_______ Cb>C6); Conrad, Patricia (NIH/NIAID) [E) (b)(6)Subject: FOR ASF REVIEW: Draft PR re: launch of ACTT 2 COVID treatment studyHi Dr. Fauci,Please find at tached fo r your review a draft press release to announce the launch of the ACTT 2COVID-19 treatment trial (remdesivir and baricitinib). Below is your draft quote:"We now have solid data showing that remdesiv ir dimin ishes to a modest degree thetime to recovery for people hospitalized with COYID-1 9," said NlAID Director Anthony S.Fauci, M.D. "ACTT 2 will examine if adding an anti-inflammatory agent to the remdes ivirregimen can provide addi tional benefit for patients , including improv ing morta lity outcome s."The trial may start enrollment tomorrow.Thanks much,KathyKathy StoverBranch ChiefNews and Science Writing BranchNational Institute of Allergy and Infectious Diseases (NIAID)Office of Communications and Government RelationsNational Institutes of Health/HHS31 Center Drive, Room 7A17EBethesda, MD 20892Phone: (b)(6)E-mail: (b)(6)NIAID Media Line: (301) 402-1663From:Sent :To:Fauci, Anthony (NIH/NIAID) [ElTue, 5 May 2020 22:00:53 +0000Cassetti, Cristina (NIH/NIAID) [ElSubject: FW: COVID-19, (b)( 4)Attachme nts: Bi rman_Fauci_Aza r Adams_Hahn_letter _May _OS _2020.docxPlease take a look at this.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institu tes of HealthBethe sda , MD 20892-2520Phone: (b) (6)FAX: (301 496-4409E-mail: (b) (6)The informa tion in this e-mail and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recip ient. If you have rece ived this e-mail in en-orplease infonn the sender and delete it from your mailbox or any other storage devices. The National Institut e ofAllergy and Infectious Diseases (NJAlD) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIAID by one of its representatives.-----Original Messag'-e-_-_-------~~From: (b)(4Sent: Tuesday, May 5, 2020 2:51 PMTo: Fauci, Anthony (NIH/NIAID) [E] (b)( >Cc: Azar, Alex M. (b)(6) > ; Adams , Jero me M.,_.,....,.._..,,(b.)(.6.) -,,-,-,-..-.-.=...-.:.-,-..:.-,:.:., .,.-,--,..,...., Subject: RE:C OVID-19 , --------(b)( 4)Dr. Anthony S. Fauci , M.D.Director , NIATDMr. Alex M. Azar TISecretary , HHSDr. Jerome M. Adam s, M.D.Surgeon General , HHSDr. Stephen M. Hahn, M.D.Commissioner of FDA , HHSDear Dr. Fauci ,Dear Mr. Azar,Dear Dr. Adams,Dear Dr. Hahn,---------(b) ( ; Hahn , Stephen (FDA)(b) (4)(b)(4From: Fauci, Anthony (NIH/NIAID) [ElSent : Tue, 5 May 2020 21:17:33 +0000To: Mascola, John (NIH/VRC) [ElCc: Conrad, Patricia (NIH/N IAID) [E);Erbeld ing, Emily (NIH/NIAID) [E];Dieffen bach,Carl (NIH/NIAID) [E];Marsto n, Hilary (NIH/NIAID) [E];Billet, Courtney (NIH/N IAID) [E);Graham, Barney(NIH/VRC) [E];Marovich , Mary (NIH/NIAID) [E]Subject: RE: 0614G mutation paperThan ks, John .Anthony S. Fauci, MDDirector(b) (5)National Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)( 6)FAX: (301 496-4409E-mail: (b) (6)(b) (5)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The Nat ional Institute of Alle rgy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From : Mascola, John (NIH/VRC) [E] CbH >Sent : Tuesday, May 5, 2020 5:04 PM ------~= To: Fauci, Anthony (NIH/NIA ID) [E] (b)(6)>Cc: Conrad, Patricia (NIH/ NIAID) [E] (b)( ; Erbelding, Emily (NIH/NIAID) [E](b)(6) ; Dieffenbach , Carl {NIH/NIAID ) [E] (b)( 6)f>; Marston ,Hilary (NIH/NIAID) [E] (b)( >; Billet, Courtney (NIH/NIAID) [E]-----=~ CbH_6); Graham, Barney (NIH/VRC) [El (b)( 6)> ; Marovic h, Mary(NIH/N IAID) [El (b)(6)Subject: FW: 0614G mutation paperTony,David Montefio ri will be on CNN tonigh t related to this paper - and story in in major newspapers.spoke with David to get some advance info . The paper is out in BioRxiV.Few key pointsJohnSpike mutation pipeline reveals the emergence of a moretransmissible form of SARS-CoV-2Korber 81, Fischer WM 1, Gnanakaran S1, Yoon Ht, Theiler Ji, Abfalterer Wt , Foley 81, Giorgi EEi,Bhattacharya T1, Parker M0 3, Partridge DG4, Evans CM4, de Silva Tl4,s, on beh alf of the Sheffi eldCOVID-19 Genomics Group#, LaBranche CC2, and Mont efiori DC2Summary(b) (5)We have developed an analysis pipelin e to facilitate real-time mutation tracking in SARS-CoV-2, focusinginitia lly on the Spike (S) protein because it mediates infect ion of human cells and is the target of mostvaccine strategies and antibody-based therapeutics. To date we have identified fourteen mutations inSpike that are accumulating. Mutations are considered in a broader phylogenetic context,geographically, and over time, to provide an early warn ing system to reveal mutations that may conferselective advantages in transmission or resistance to interventions. Each one is evaluated for evidenceof positive selection, and the implications of the mutation are explored through structural modeling . Themutation Spike 0614G is of urgent concern; it began spreading in Europe in early February, and whenintroduced to new regions it rapidly becomes the dominant form . Also, we present evidence ofrecombination between locally circulating strains, indicative of multiple stra in infections . These findinghave important implications for SARS-CoV-2 transmission, pathogenesis and immune interventions .From: David Montefiori, Ph.D. ----------- (b)(6)Sent: Tuesday, May 5, 2020 1:23 PMTo: Mascola, John (NIH/VRC) [E]_ _____ --,;(-b")('"=6")'Subject: RE: 0614GJohn,I thought you should know that the 0614G story is getting a lot of press attention today. I story cameout in the LA Times this morning that probably started it all. It will likely be on CNN tonight , and maybeother networks.Just a heads-up.DavidFrom:Sent :Fauci, Anthony (NIH/ NIAID) [E)Tue, 5 May 2020 20:43:39 +0000To: Billet, Courtn ey (NIH/ NIAID) [E];N IAID OD AMSubject:Attachments :RE: Dr. Anth ony Fauci & Avi Schiffm an/T he Webby AwardsScript to honor Avi Schiffmann - 05-05-2020.docxHere is my tracked version of the Schiffmann script.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)( 6)FAX: (3 96':44li9E-mail: (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Alle rgy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Billet, Courtney (NIH/N IAID) [E] -------- (b)(6) > Sent: Tuesday, May 5, 2020 3:06 PMTo: NIAID OD AM <NIAIDODAM@niaid.nih.gov>Subject: FW: Dr. Ant hony Fauci & Avi Schiffm an/The Webby AwardsOK- so th is is the ask from the Webby awards : a short recorded video message. They have sent aproposed scri pt below -- just an example - obvious ly we're free to change it . Avi is a prettyextrao rdinary kid. 17 years old IHere is the site he create d, back in early January. He's aggregati ng data from WHO, CDC, and ot hersources: https:ljncov2019. live/NBC Today st ory: https://www.toda y.com/parents/17-vear -old-built -website -track-coronavirus t175245New Yorker art icle about him: https://www.newyorker.com/magazine/2020/03/30/the -high-schoolerwho-beca me-a-covid-19-watchdogFrom: lesley lesleycahill roy.com <lesley@leslevcahillroy.com>Sent: Tuesday, May 5, 2020 2:32 PMTo: Billet, Courtney {NIH/NIAID) [E] ==========:,::.:= Cc: Conrad, Patricia (NIH/NIAID) [E] _______ >Subject: Re: Dr. Anthony Fauci & Avi Schiffman/The Webby AwardsHI Courtney,This would be a pre-recorded message with Dr Fauci solo. He would set up Avi's award and help tocelebrate his Webby moment for him. Avi will be sending us his 5 word Webby speech which will thenfollow Dr. Fauci's intro . Below is a draft of the introduc tion for him, let us know if he would like to makeany edits/changes. I've also attached the format for taping on his phone/computer. Please let me knowif you need any additional information and hoping we can make it work .Thank you so muchBestLesleyDR. FAUCI:I'm Dr. Anthony Fauci. Unfortunately, you've seen a lot of me lately . But thankfully, I'm here to presentsome good news and I'm excited for the opportunity to shine some light on one of the many youngpeople who have stepped up and helped us throughout a difficult time.The 24th Annual Webby Awards would like to honor Avi Schiffmann as the 2020 Person of the Year torecognize his creation of ncov2019.live to track the spread of COVID-19 across the world.As we collectively navigate the severe impact of COVID-19, including the difficult, but critica l calls fornationwide social distancing, the Internet has become the lifeblood of people looking for accurateinformation about the novel coronavirus and the necessary steps to combat it.Since launching the site on December 29th, Schiffmann's tracking tool has been an invaluable resourcethat sounded the alarm on the virus and its spread, notably calling attention to its severity long beforemany global officials .At a time when the spread of misinformation can be so detrimental to our efforts, the site has providedover 600 million visitors wit h accurate real-t ime data. Schiffmann has helped people around the globeunderstand COVID-19 and the necessity of upgrades to current health care systems and the importanceof measures to flatten the curve .For having the foresight to track the global spread of COVID-19 and for creating an essential website toprovide real-time data about the virus to people everywhere , it is my great privilege to honor AviSchiffmann as the 2020 Webby Person of the Year.On May 5, 2020, at 10:31 AM, Billet, Courtney (NIH/NIAID) [El- -------- (b)(6) wrote:Lesley- we've been discussing this. Can you tell us exactly what would be involved inthis? How many minutes would you be looking for Dr. Fauci to speak? Would this be prerecorded,with Dr. Fauci solo? Or would it be done as a Zoom or something like that, withan interaction between Dr. Fauci and Avi?From: Billet, Courtney (NIH/NIAID) [ElSent : Monday, May 4, 2020 5:31 PMTo: lesley lesleycahillroy.com <lesley@lesleycahillroy.com>Cc: Conrad, Patricia (NIH/NIA ID) [E) (b)(6)>Subject : RE: Dr. Anthony Fauci & Avi Schiffman/The Webby AwardsHI Lesley- thanks so much for reaching out. Avi is so impre ssive! I am connecting youwith Dr. Fauci's assistant and scheduler, Patty Conrad, for follow-up.From: lesley lesleycahillroy.com <lesley@lesleycahillroy.com>Sent : Monday, May 4, 2020 5:10 PM To: Billet, Courtney (NIH/NIAID) [E] ------ -(-b=)(6)Subject: Fwd: Dr. Anthony Fauci & Avi Schiffman/The Webby AwardsHi Courtney,Hope you are staying well during these uncertain times . I am a Talent Producer for TheWebby Awards and had reached out to Dr. Fauci regarding being involved in our "vir tua l"internet celebration which will showcase the artists, organizations, and creators using theirplatforms to imagine a better tomorrow through information, educat ion, movement,comedy, all whi le inspiring audiences to take action to enact positive change.Avi Schiffman is being celebrated as our Person of the Year and we would be honored if DrFauci wou ld "virtually" present him his honor. The official letter is below and would loveto discuss in more detail when you have a chance to review.Thank youBestLesleyBegin forwarded message:From: Les ley Cah ill Roy <lesle y@ lesle ycah illroy.com >Subj ect: Re: Dr. Anthony Fauci & Avi Schiffman/The WebbyAwardsDate: May 1, 2020 at 12: 13: 10 PM EDTTo: CbH6)HI Dr FauciI just wanted to follow up on below regarding Avi and The Webby Awards .Would be wonderful if you could be a part of this moment for him.Thanks so muchLesleyOn Apr 20, 2020, at 1:57 PM,lesley lesleycahil lroy.com <lesley@lesleycahil lroy .com> wrote:<6EDD370A-6106-4603-B55 7-7 AAE E9A9EF79. png>Dear Dr. Fauci,I hope you and the family are all safe and healthy during thesechallenging times. Hailed by The New York Times as "theInternet's highest honor," The Webby Awards has been thepremiere award for online excellence for over two decades,honoring the companies and people who have critically shapeddigital technology and culture .This year, due to the impact of the coronavirus The Web byAwards are moving t heir renowned award show to an onlineexperience . On May 19th, 2020, the 24th Annual Webby Awardswill bring togetherWebby Winners from around the world in anInternet Celebration wh ich will showcase the artists,organizations, and creators using their platforms to imagine abetter tomorrow through information, education, movement,comedy, all while inspiring audiences to take action to enactpositive change.The 24th Annual Webby Awards are proud to honor AviSchiffmann as the 2020 Person of the Year to recognize hiscreation of ncov2019.live to track the spread of COVID-19across the world . We would be honored if Dr. Fauci would"virtually" present Avi with his award.As we collectively navigate the severe impact of COVID-19 onthe world and late calls for nation-wide social distancing , theInternet has become the lifeblood for people looking foraccurate information about the novel coronav irus. Sincelaunching the site on December 29th , Avi Schiffmann' str acking site was a necessary tool that sounded the alarm onthe novel coronavirus and its spread, notably calling attentionto its severity long before many global officials. By providingover 100 million visitors with real -time data on the virus'spread, Schiffmann has helped peopl e around the globeunderstand COVID-19 and the necessity of upgrades to currenthealth care systems and measures to flatten the curve.For having the foresight to track the global spread of COVID-19and for creating a website to provide real -time data about thevirus to people everywhere, it is our great privilege to honorAvi Schiffmann as the 2020 Webby Person of the Year. Thecelebration will highlight the important work Avi and hisfellow winners are doing, and will mark his hallmark Webby 5-Word acceptance speech in Internet history. Dr. Fauci'spresenter speech could be recorded on his phone and we cansend you through a script for him to review, edit and detailsfor format and deadline.This year's Webby Awards will also take action, the impact ofCOVID-19 and government responses around the world, hasbrought the importance of voting into sharp focus . The WebbyAwards has partnered with Vote.or and aim to check the voterregistration status of 1 million voters in the United States,promoting the importance of voting to help ensure voterturnout this November is the highest it has ever been. Thispartnership will integrate into all elements of this year's onlinecelebration.Our thoughts are with all of you in this difficult t ime.BestLesley Cahill Roy(b)(6)From:Sent:To:Cc:Subject:unlikelyAnthony S. Fauci, MDDirectorFauci, Anthony (NIH/N IAID) [ElTue, 5 May 2020 19:49:36 +0000Conrad, Patricia (NIH/NIAID) [E)Billet, Courtney (NIH/ NIAID) [ElFW:National Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (3 96':44li9E-mail: Cb()6 )The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Konstantin Vulkov <kv@egoist .bg>Sent: Tuesday, May 5, 2020 3:42 PMTo: NIAID NEWS (NIH/NIAID) <NIAIDNEWS@niaid.nih.gov>Cc: NIAID Ocpostoffice (NIH/NIAID) <OCPOSTOFFICE@niaid.nih.gov>; Fauci, Anthony (NIH/NIAID) [El-------- (b)(6) >; Harper, Jill (NIH/NIAID) [El Cb)( > Subject:Dear Sir/Madam,My name is Konstantin Vulkov and I am Program director of the biggest Bulgarian private radio station,Darik radio (www .darikradio.bg). This is a news/talk radio station . I am a regular contributo r to BulgarianNational TV as well as several on line and print publ ications, editor -in -chief of egoist.bg as well as editor in-chief of the biannual Darik-owned publication called Dolce Far Niente .I am a document photographer as well , focusing mainly on portraits .I am covering the coronavirus pandemic extensively - visiting COVID-19 units across the country,making my daily radio programme "Mind games", writing stories for ourwebsites www.darikradio.bg. www.dnews.bg and egoist.bg.It would be an honour if I can make a short te leph one int erview with Mr. Anthony S. Fauci, M.D.Please let me know if I can call and make the interview . I promise I won't take more than 10 minutes ofMr. Fauci's time .Your help is much appreciated.Best,Konstantin***Konstantin VulkovProgram DirectorDarik Radio82, Dondukov blvd.Sofia 1504BulgariaFrom:Sent:To:Subject:Looks fin e.Anthony S. Fauci, MDDirectorFauci, Anthony {NIH/NIAID) [E]Tue, 5 May 2020 19:48 :10 +0000Lerner, Andrea {NIH/NIAID) [E]RE: AUSTRIA - Try to support - COVID 19 - StrategyNational Institute of Alle rgy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: {301 496-4409E-mail: (b)(The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in er ror please inform the sender and delete it from your mailbox or anyother storage devices. The Nationa l Institute of Allergy and Infectious Diseases (NIA ID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Lerner, Andrea {NIH/NIAID) [E) (b)(6)Sent: Tuesday, May 5, 2020 3:37 PMTo: Fauci, Anthony {NIH/NIAID) [E)_ ____ ---,;(;b..~,.c=. >Subject: Re: AUSTRIA - Try to support -COVID 19 - StrategyDr. Fauci,I will respond. Here is what I propose to say {in addition to thanki ng him) . Let me know if you'd changeanything:Sincerely ,(b) (5)AndreaFrom: "Fauci, Anthony {NIH/NIAID) [E]" (b)(6)Date: Tuesday, May 5, 2020 at 10:40 AM -------. =, To: "Lerner, Andrea (NIH/NIA ID) [E]" (b)(6)Subject: Fwd: AUSTRIA - Try to support - COVID 19 - StrategyNot a crazy note. Please respond on my behalf. ThanksBegin forwarded message:Froml (b)(6)Date: May 5, 2020 at 8:19:48 AM EDTTo: "Fauci, Anthony {NIH/NIAID) [E]" -------,; (b-),(-.=-6)Subject: AUSTRIA - Try to support - COVID 19 - StrategyDear - highly respected - Dr. FauciWhy do I try to childishly support a respected expert and personallyhighly honored Gentleman like you - Dr. Fauxi ?Because for me - it is heartbreaking and unbelievably disturbing, whatwas and is going on in the course of the last 4 months in the USA.I talk about the USA, that relieved my country - AUSTRIA - 75 yearsago from the hell of the NAZI-Regime - with American Lifes andBlood.With all my respect, my hopes, my passion, my tears, my mourningMayGrace and Blessing be with You and the USA.After running the numbers available on COVID 19 pandemic data - myexperiences as an Economist led to following analysis and proposedstrategy:COVID 19 is a true threat for humans >65 years of age with preexistingillnesses,but nearly influenza-like for humans< 65 years of age and humans>65 years of age without pre-existing illnessesAUSTRIA: Deaths by age Deaths as of 100.000 inhabitants by ageGermany- Death by age - men and women- mortality rate in %Comparison - Italy and China(3:fri,if? @D~ hr MJnntr untcr don To~nJr.;CC! 1"\,t,"MII-,. ft--~-~- ~- C..,,lt•lt-- ---Id ~~~- f<s"'1 . .,_IO•CO --lullen: mehr Covld·l~Tote als In ChinaHortalltJtsrattnt P roitndt erE rkranttenAlttrs·gruppe110·910· 1920· 2930-3940·49S0-5960·6970-79~80ITAllEN0000,30;43,S1'2,820,lA.nttlCl elr Vvsto1t>entO1b1t t 80 J•hrt• 52,3%Proposed StrategyCHINA00,20,20,20,48,0l4,81. Keep the virus 100% (totally) away from people older than 60with pre-existing illnessesIdentify, Testing, Shelter, Preserve from contact with virus, Preserve fromHospitalizat ion and ICU2. Minimize possible contact with virus for people older than 60without pre-existing illnessesIdentify , Testing, Partial Stay at Home, Social Distancing,, Preserve fromHospitalization and ICUOnce 1 and 2 are warranted:3. Handle the rest of the population with care, but keep themgoing and working - as you would do in an influenza -seasonThe criti cal factor for furth er intervent ion is the capacity of theregionally available ICU-capacityInterventions : Social Distancing, Masks, Testing, Tracing, Stay at home when ill,Quarantine at home when illRespectfully YoursGerald GlockensteinMa . Gerald Glockenstein(b)(6)From:Sent :To:(b)(6)Tue, 5 May 2020 10:47:11-0400Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: request of interview by Giuseppe Sarcina, corriere della SeraPlease try to get clearance. This is tb.e top newspaper in ItalyBegin forwarded message:From: Sarcina Giuseppe <gsa rcina@rc s.it>Date: May 5, 2020 at 8:03:29 AM EDT To: "Fauci , Anthony (NIH/NlAID) [E]" --------=-(=b)(6)- -=Subject: Re: request of intervi ew by Giuseppe Sarcina, corriere della SeraInviato da iPhoneDear Doc. Fauci,this is Giuseppe Sarcina, the us correspondent of Corriere della Sera,the main italian newspaper.I understood that you are looking at the ital ian case with greatattention.I wonder if you can grant me a short inte rview.I have sent an email march 21. But then I saw that you spoke with another italian newspape r. So I would like to have a chance to have yourvoice for our Readers as well . Corriere della Sera is a newspaper basedin Milano, Lombardy , The region most affected by the coronavirus.Thank youWarm RegardsGiuseppe SarcinaWashington de(b)(6)Oggetto: request of interview by Giuseppe Sarcina, corriere della SeraDear Doc. Fauci,this is Giuseppe Sarcina, the us correspondent of Corriere della Sera,the main italian newspaper.I understood that you are looking at the italian case with greatattention.I wonder if you can grant me a short inte rview .That would be really helpful fo r our readersThank youWarm RegardsGiuseppe SarcinaWashington deFrom:Sent :To:(b)(6)Tue, 5 May 2020 10:43:37 -0400NIAIDODAMSubject: Fwd: Invitation to Participate in Book Project on COVID-19Let us discuss. (b) (5) ---------------------Begin forwarded message:From: Dawinder Sidhu <dss@umbc.edu >Date: May 5, 2020 at 8:14:12 AM EDT -------~~ To: "Fauci, Anthony (NIH/NlAID ) [E]" (b)(6)Subject: Invitation to Participate in Book Project on COVID-19Dr. Fauci,I hope this email finds you well. I am a professor at the Universityof Maryland, an elected term member in the Counci l on ForeignRelations, and a former fellow at the Supreme Court of the UnitedStates.I am writing because I am preparing a book, tentatively ent itled"Rebuilding America: A Blueprint for Post-COVID-19 America,"consis ting of essays by leading figures on (1) how COVID-19 hasimpact ed their particu lar field , and (2) how that field shou ld bereimagined in light of the crisis. The essays will reconsider allsectors of socie ty, including law, education, healthcare, fash ion,mus ic, etc. , and collectively will be the first comprehensive guidefor post-coronavirus reconstruction efforts.I am very hopeful that you may be willing to contribute a short essayon how the curren t coronavirus has impacted public health policy , andhow such policies can and should evolve moving forward.Only 50 industry leaders are being asked to contribute. Commitmentshave been secured from an impressive group, including a retiredfour-star general and a preeminent constitutiona l scholar. I very muchhope you will take part in this inno vative projec t given your historicand unparalleled contributions to the public' s understanding of thecurrent crisis.With respect to logistics , I am hoping to receive commitments from allauthors this month , with essays due within one month, and with theessays availab le through Amazon's expedited publishing platformrough ly one month after that. Each essay should be no more than 1,000words, and I may offer light edits for the author's final approva l. Afinal note: all proceeds from the sa le of the book will be donated.I am very hopeful that you will give eve ry serious cons iderat ion tothis invitation, and will lend your voice towards reirnagining andrevitalizing a new America.

Page updated

Report abuse